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Abstract 
 
Staphylococcal infection is shaped by a large repertoire of virulence factors, 
complicating both pathology and treatment. A large number of these factors attack the 
innate immune system directly, allowing S. aureus to resist phagosomal killing and target 
phagocytes using cytolytic toxins. Many of these factors display great species-specificity 
for humans, with as few as two amino acid changes reducing binding affinity by 100-
fold. A lack of targetable components in existing in vivo models makes accurate 
representation of staphylococcal infection impossible, necessitating the creation of 
humanised models in order to fully understand the roles of these factors during 
infection. 
One component targeted by at least three virulence factors is the human C5a receptor 
(hC5aR), a critical chemotactic receptor in neutrophils. Another component targeted by 
S. aureus is the peroxidase enzyme myeloperoxidase (MPO), which potentiates the 
neutrophil respiratory burst to facilitate phagosomal killing. To investigate these 
adapted virulence factors, I generated two humanised zebrafish models that permit 
investigation of the interactions between human-adapted virulence factors and 
components of the innate immune system. I overexpressed the hC5aR and MPO as 
fluorescently-tagged fusion proteins in zebrafish neutrophils, and assessed the impact 
on neutrophil function and staphylococcal infection. 
Both constructs were successfully expressed in zebrafish neutrophils, with the hC5aR 
expressed at the cell membrane and MPO colocalising with the primary granules. 
Expression of MPO had no impact on neutrophil migration; however, expression of the 
hC5aR at the cell surface produced a broad defect in chemotaxis, likely due to disruption 
of endogenous chemotactic signals. Neutrophils expressing the hC5aR gained the ability 
to migrate to human C5a as a chemotactic agent and became susceptible to targeting 
by staphylococcal leukocidins, recapitulating human neutrophils. MPO was found to be 
enzymatically inactive in this model, potentially producing an in vivo marker of 
neutrophil granules that does not interfere with endogenous myeloperoxidase activity.
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Nuclease, βC-φS β-Haemolysin Converting Bacteriophage 
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Chapter 1: Introduction 
 
1.1 The Innate Immune System 
 
1.1.1 The Role of the Innate Immune System 
 
The human body is protected from infection by two distinct arms of the immune system: 
the adaptive and innate immunity. The adaptive immunity is highly-specific and long-
lived, but is slow to develop due to the necessary acquisition of immune memory 
followed by the expansion of specific cell types. The innate immune system is rapid and 
can recognise a broad number of pathogens, allowing the body to respond and prevent 
the initiation of infection as the first line of defence against invading microbes. The 
innate immune system is comprised of the physical barrier to infection, antimicrobial 
proteins, receptors that recognise specific molecules associated with pathogens and 
phagocytic cells that engulf and destroy microbes. The function of the innate immune 
system is to provide protection from invading pathogens where the adaptive immune 
system is unable, by preventing, recognising and destroying pathogens before they can 
establish an infection, as well as providing the signals required for efficient activation of 
the adaptive immune response.  
 
1.1.2 Components of the Innate Immune System 
 
The first line of defence an invading microbe encounters is the host tissue, such as the 
skin, respiratory tract or gut. At the cellular level, these structures are made of epithelial 
cells joined together by tight-junctions to create a continuous physical barrier to 
pathogens. Disruption of these tight-junctions is a specific strategy of many pathogens 
including C. perfringens, H.pylori and S. flexneri, and facilitates the onset of infection 
through penetration of the bacteria into the deeper tissues (Guttman and Finlay, 2009). 
A notable example of this is the enteric pathogen Salmonella enterica serovar 
Typhimurium, which utilises effectors on the SPI-1 pathogenicity island to disrupt tight-
junctions and induce uptake of the bacteria, allowing Salmonella to proliferate in an 
intracellular vacuole that is protected from lysosomal degradation (Boyle et al., 2006).  
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The physical barriers are formed of layers of tissue containing antimicrobial peptides 
(AMPs) and enzymes that act to kill or inhibit the growth of invading microbes. Among 
the largest of the classes of AMPs are the defensins, which are generally short (12-50 
amino acids), positively-charged peptides that kill bacteria by disrupting structural 
elements of the cell membrane (Selsted and Ouellette, 2005). Where these barriers fail, 
further immune defences become necessary to prevent infection. 
Once a pathogen has accessed the deeper tissues, it is essential that host cells are able 
to recognise invading cells and respond accordingly to prevent infection. This is made 
possible by pattern-recognition receptors (PRRs) which recognise specific molecules 
that are associated with pathogens, known as pathogen-associated molecular patterns 
(PAMPs). In addition to PAMPs, PRRs sense damage-associated molecular patterns 
(DAMPs), which are generated when cells become damaged or undergo necrosis, 
allowing the surrounding cells to mount an appropriate inflammatory response (Anders 
and Schaefer, 2014). The major PRRs found at the cell surface are the Toll-like Receptors 
(TLRs), which recognise a wide range of PAMPs from different pathogens including 
bacterial and fungal PAMPs (e.g. zymosan, lipopolysaccharide and peptidoglycan) and 
viral PAMPs (single and double-stranded DNA and RNA) (Kawai and Akira, 2010). In the 
cell cytoplasm, there are two groups of PRRs known as the NOD-like receptors (NLRs) 
and RIG-I-like receptors (RLRs), which sense PAMPs and DAMPs present in the 
cytoplasm. Once activated, PRRs act against invading pathogens by triggering the 
production of signalling molecules, recruiting phagocytic cells, generating bactericidal 
compounds and activating the inflammatory response (Hato and Dagher, 2015). 
The inflammatory response begins with changes in transcription that result in the 
production signalling molecules, mediated by transcription factors such as NF-κB 
(Alberts et al., 2002). Consequently, lipid signalling molecules such as prostaglandins and 
protein signalling molecules including cytokines are produced by a broad range of cells. 
Cytokines function by amplifying the production of more signalling molecules, 
stimulating the adaptive immune system and triggering the recruitment of effector cells 
such as phagocytes. These cells typically have numerous PRRs (including TLRs) that 
permit them to recognise pathogens, in addition to surface receptors that detect 
cytokines. Together, these receptors allow phagocytes to migrate up a chemical gradient 
and towards a site of infection or inflammation.  
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After reaching the site of infection, phagocytes engulf and destroy invading pathogens 
in a process known as phagocytosis. There are several types of phagocytic cells, including 
macrophages, neutrophils, dendritic cells and eosinophils; each have their own specific 
function. Dendritic cells act to bridge the innate and adaptive immune responses by 
controlling their bactericidal activity in order to present antigens to naïve T-cells, priming 
the adaptive immune system (Savina et al., 2006). Eosinophils are also able to present 
antigens to the adaptive immune system, and are specialised towards responding to 
parasitic infections (Shamri et al., 2011). During the early phases of infection, the two 
major phagocytic cells present are macrophages and neutrophils. Macrophages are 
large cells that are typically the first immune cells to respond to an infection. They reside 
in tissues throughout the body, and are found abundantly at sites where there is an 
increased risk of infection, such as the lungs and gut (Alberts et al., 2002). Once 
activated, they recruit phagocytes which in turn amplify the response by producing pro-
inflammatory cytokines like IL-8, IL-1β and TNF-α, which are sensed by their cognate 
receptors CXCR2, IL-1R and TNFR (Amulic et al., 2012; Duque and Descoteaux, 2014). In 
mammals, neutrophils are primarily found in the blood, and unlike macrophages are 
absent from healthy tissues. Despite being smaller and more short-lived than 
macrophages, they are the most abundant phagocyte found in the body, and are 
recruited in large numbers to sites of infection and inflammation (Amulic et al., 2012). 
After phagocytosis, pathogens are initially contained in a vacuole called the phagosome 
which rapidly fills with microbicidal compounds to destroy pathogens. This is achieved 
by fusion of the phagosome with lysosomes or cytotoxic granules, which contain 
enzymes that degrade bacterial cell walls, proteins and DNA, and produce a respiratory 
burst that generates antimicrobial reactive oxygen species (ROS). The respiratory burst 
is induced by the assembly of NADPH oxidase on the phagosomal membrane, initiating 
a series of reactions to produce toxic compounds including superoxide (O2-), hydrogen 
peroxide (H2O2), hypochlorous acid (HOCl), hydroxyl radical (•OH) and nitric oxide (NO). 
Although both macrophages and neutrophils are essential for destroying pathogens, 
neutrophils produce much greater levels of ROS than macrophages, which is thought to 
be a principal reason why neutrophils are the most short-lived cells in the human body 
(Amulic et al., 2012). 
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1.1.3 Stimulation of the Adaptive Immunity by the Innate Immune System 
 
The adaptive immunity is capable of two distinct effector functions, the cell-mediated 
immunity carried out by T-cells, and the humoral immunity performed by B-cells. T-cells 
act to support other leukocytes or directly kill infected cells, and B-cells function by 
producing antigen-specific proteins called antibodies, which recognise invading 
organisms and opsonise the cell surface, facilitating recognition and destruction by the 
immune system. 
The adaptive immune response is activated by the presentation of antigens on the 
surface of innate immune cells known as antigen-presenting cells (APCs); consequently, 
the adaptive immunity relies on the innate immunity for activation. The professional 
APCs include macrophages and dendritic cells, and function by phagocytosing and 
partially degrading pathogens; this allows them to retain antigens that are then 
presented to the adaptive immune system. After acquiring antigens, APCs migrate to 
the peripheral lymphoid organs and present the antigen in the context of a protein 
known as the major histocompatibility complex (MHC). 
Once APCs have presented antigen to the adaptive immunity, naïve T-cells proliferate 
and differentiate into one of two subsets of effector T-cells, both of which are necessary 
for almost all adaptive immune responses. These are the CD4+ T-helper cells, which are 
crucial for the defence against extracellular and intracellular pathogens by activating 
other immune cells, and the CD8+ cytotoxic T-cells, which kill cells directly by secreting 
enzymes and stimulating a form of cell death known as apoptosis.  
CD4+ T-helper cells are activated by antigen presentation in the context of class II MHC, 
which is performed by professional APCs including macrophages and dendritic cells. 
They support the immune system by producing cytokines and expressing a number of 
costimulatory molecules. After activation, T-helper cells differentiate further into two 
distinct subsets, known as the Th1 and Th2 cells. Th1 cells are predominantly pro-
inflammatory, producing cytokines such as IFN-γ as well as activating macrophages and 
CD8+ T-cells, while Th2 cells are anti-inflammatory, producing cytokines including IL-4, 
IL-5 and IL-10, and activating B-cells. 
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In contrast to T-helper cells, CD8+ cytotoxic T-cells are activated by the presentation of 
antigen in the context of class I MHC, which can be presented by virtually any nucleated 
cell and are collectively known as non-professional APCs. This allows CD8+ T-cells to 
directly and rapidly kill almost any infected cell, efficiently preventing the spread of 
infection. 
Antibodies are an important aspect of adaptive immunity; accordingly, it is essential that 
B-cells are successfully activated to produce antibodies. B-cells can be activated by 
direct recognition of antigens, or by CD4+ T-helper cells. B-cells are also capable of 
antigen presentation, immunomodulation of costimulatory molecules, stimulation of 
the respiratory burst, and antimicrobial factor production (Lee and Koretzky, 1998; 
Roosnek and Lanzavecchia, 1991; Yi et al., 1996). The cells of the adaptive immune 
system rely heavily on the presentation of antigens by the innate immune system, and 
represents an essential bridge between both systems that allows them to function 
effectively. 
 
1.1.4 The Complement System 
 
Adding to the central components of the innate immune system is the complement 
system, a cascade of over 30 proteins that act to ‘complement’ the immune response 
(reviewed in Serruto et al., 2010). Complement carries out three main functions during 
infection: opsonisation of the bacterial surface to enhance phagocytosis, generation of 
inflammatory signals to recruit phagocytes and the destruction of pathogens by the 
formation of the membrane attack complex (MAC). There are three distinct pathways 
of complement activation; the classical, lectin and alternative pathways, all of which are 
shown in detail in Figure 1.1. Each are initiated in different ways, with early proteins 
acting as proenzymes that sequentially cleave the next protein; importantly, all three 
converge with the cleavage of C3 by a C3 convertase. Cleavage of C3 produces C3a, a 
potent chemoattractant, and C3b, which opsonises pathogens by binding covalently 
with the pathogen surface, promoting phagocytosis and other effector functions. C3b 
bound to the pathogen surface is then able to form a proteolytic complex with other 
complement components, amplifying the cascade by cleaving more C3 and depositing 
more C3b at the cell surface. 
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The classical pathway is dependent on the adaptive immune system, as it requires 
antibody-antigen complexes (usually IgM or IgG) bound to the bacterial surface to 
initiate. It begins with the formation of the C1 complex, which is assembled after C1q 
binds to an antibody-antigen complex; this cleaves two C1r molecules, followed by two 
C1s molecules, creating the C1 complex (C1qr2s2). The C1 complex then cleaves C4 and 
C2 into C4a and C4b, C2a and C2b, forming the classical C3 convertase C4b2a. The lectin 
pathway is similar to the classical pathway, but involves the recognition of mannose 
residues on the bacterial surface by mannose-binding lectins (MBLs), instead of C1q 
binding to antibody-antigen complexes. Once MBL binds to the bacterial surface, MBL-
associated serine proteases 1 and 2 (MASP-1, MASP-2) are activated which cleave C4 
and C2, converging with the classical pathway at the formation of the classical C3 
convertase C4b2a. 
The alternative pathway differs from the other pathways in that it does not rely on 
mannose residues or antibody-antigen complexes to initiate. It is constantly active at a 
low level, and involves the constitutive hydrolysis of C3 into C3a and C3b, due to the 
breakdown of an unstable internal thioester bond. Normally, C3b generated in the fluid 
phase is instantly inactivated by factors H and I to prevent unnecessary complement 
activation, however when C3 is hydrolysed by an amino or hydroxyl group from a 
bacterial surface, the C3b that is generated is deposited on the bacterial surface. C3b 
bound to a bacterial surface cannot be inactivated by factors H and I, and the pathway 
proceeds to form the alternative C3 convertase. Surface-bound C3b recruits factor B, 
making the complex C3bB, which is cleaved by factor D into Ba and Bb. The Bb fragment 
remains associated with C3b, forming the alternative C3 convertase C3bBb. Lastly, 
binding of factor P stabilises the convertase, which greatly enhances the cleavage of C3 
and amplifies the cascade. 
As mentioned, C3 convertases cleave C3 into C3b, which opsonises bacteria and 
continues the cascade, and C3a, which acts as a chemoattractant that recruits 
phagocytic cells. Another chemoattractant produced by the complement cascade is C5a, 
which is produced when C5 is cleaved by a C5 convertase. During the classical and lectin 
pathways, the C5 convertase is formed by free C3b binding to the classical C3 convertase 
C4b2a, creating C4b2a3b. In the alternative pathway, C3b binds to the alternative C3 
convertase (C3bBb) to create the alternative C5 convertase (C3bBbC3b). C3a and C5a 
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are highly potent chemoattractants known as anaphylatoxins, acting through their 
cognate receptors (C3aR and C5aR respectively) which are expressed ubiquitously and 
at high levels in neutrophils and macrophages (Laumonnier et al., 2017; Zwirner et al., 
1999). C4a is also an anaphylatoxin, and mediates chemotaxis and ROS generation in 
neutrophils, however its functions are incompletely understood, and appear to differ 
greatly from the other anaphylatoxins (Barnum, 2015). C3a and C5a add a critical role to 
the complement system in recruiting effector cells, and also in activating the 
inflammatory response by producing cytokines including IFN-γ, TNF-α, IL-6, IL-10 and IL-
1β (Mueller-Ortiz et al., 2014; Pandey et al., 2017). 
In addition to enhancing phagocytosis, activating the inflammatory response and 
recruiting effector cells, the complement system can kill pathogens outright by forming 
pores in the cell membrane. C3b deposited on the bacterial surface activates the late-
stage proteins of the complement system, forming the membrane attack complex (MAC) 
which forms pores in the membranes of gram-negative bacteria; gram-positive bacteria 
are protected from MAC-mediated lysis by their thicker cell wall (Laarman et al., 2012). 
The MAC is composed of C5b, C6, C7, C8 and 10-16 subunits of C9, which insert 
sequentially to form a large transmembrane channel that disrupts the membrane and 
causes bacterial lysis.  
The complement system is an essential aspect of the innate immune system. Its critical 
role and range of functions is highlighted by patients with complement deficiencies, who 
exhibit predictable immune defects depending on the affected protein. C5 deficiencies 
result in impaired recruitment of phagocytes, low levels of C6-C9 correlate with an 
absence of serum bactericidal activity, and C3 deficiency produces multiple immune 
defects that are accompanied by serious illnesses, illustrating the central role of the 
complement system in immunity (Figueroa and Densen, 1991). 
 
 
  
24 
 
Fi
gu
re
 1
.1
 T
h
e 
co
m
p
le
m
en
t 
sy
st
em
. 
Fo
rm
at
io
n
 o
f 
th
e 
C
3
 a
n
d
 C
5
 c
o
n
ve
rt
as
es
 b
y 
th
e 
cl
as
si
ca
l, 
le
ct
in
 a
n
d
 a
lt
er
n
at
iv
e
 c
o
m
p
le
m
en
t 
p
at
h
w
ay
s,
 c
o
n
ve
rg
in
g 
w
it
h
 f
o
rm
at
io
n
 o
f 
th
e 
m
em
b
ra
n
e 
at
ta
ck
 c
o
m
p
le
x 
(M
A
C
).
 
25 
 
1.1.5 Complement Receptors 
 
The complement system interacts closely with the effector cells of the immune system. 
These interactions are mediated by a repertoire of cell surface receptors that allow cells 
to recognise when and where complement is activated. The five major complement 
receptors are expressed ubiquitously, and are enriched in leukocytes. These receptors 
activate effector cells, priming them for antimicrobial defence by inducing ROS 
generation, inflammatory cytokine release and amplification of the complement 
cascade.  
Complement receptor 1 (CR1) is expressed by erythrocytes, B-cells and leukocytes, and 
is enriched on the surface of neutrophils (Medof et al., 1982). CR1 recognises a broad 
range of complement components, including C1q, C4b, C3b, inactivated C3b (iC3b), 
C3b/C4b complexes and mannose-binding lectin (MBL) (Paoliello-Paschoalato et al., 
2015). CR1 stimulates complement by cleaving C3b into iC3b; it also mediates essential 
adhesion steps with bacterial surfaces prior to phagocytosis (Changelian et al., 1985; 
Medof et al., 1982). Complement receptor 3 (CR3, also known as Mac-1) is expressed 
constitutively in neutrophils and macrophages, and binds iC3b to induce phagocytosis, 
ROS generation, chemotaxis and apoptosis (Huang et al., 2011; Paoliello-Paschoalato et 
al., 2015). Notably, CR1 and CR3 are expressed at higher levels in patients with 
autoimmune or chronic inflammatory conditions such as systemic lupus erythematosus 
and rheumatoid arthritis, suggesting that these receptors must be tightly regulated to 
prevent disease (Hepburn et al., 2004). Complement receptor 2 (CR2) differs from CR1 
and CR3 in that it is predominantly expressed on B-cells, and binds a domain of C3 known 
as C3d, modulating B-cell activation and development (Bohnsack and Cooper, 1988). The 
CR2 receptor is a critical factor bridging the innate and adaptive immune responses, 
which is illustrated by extensive targeting by both viral and bacterial pathogens 
(Fingeroth et al., 1984; Ricklin et al., 2008). 
C3a and C5a are the two major chemoattractants released during complement 
activation. These proteins are recognised by their cognate receptors, C3aR for C3a, and 
C5aR1 or C5aR2 for C5a. These receptors are seven-transmembrane loop G-protein 
coupled receptors which mediate effector functions through an intracellular G-protein. 
They are expressed ubiquitously, and are enriched at the surface of innate immune 
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effector cells including macrophages and neutrophils. All three are expressed in human 
myeloid cells isolated from the blood, as well as alveolar and peritoneal macrophages, 
however their expression in other tissues is less clear (Laumonnier et al., 2017).  
All three receptors exert a broad range of complex immunomodulatory functions. C5aR1 
is primarily an inflammatory receptor, as C5aR1 activation upregulates pro-
inflammatory cytokines including IL-1β and TNF-α (Samstad et al., 2014), and is 
implicated in the chronic inflammatory condition rheumatoid arthritis (Neumann et al., 
2002). Frustrating these observations is that the function of C5aR1 is highly context-
dependent, as there is also evidence for anti-inflammatory roles of C5aR1 (Wiese et al., 
2017). Outwith inflammation, C5aR1 also has several non-immune functions, including 
regulation of metabolism and differentiation (Arbore et al., 2016; Hess and Kemper, 
2016), illustrating the complex nature of the receptor. The secondary C5a receptor, 
C5aR2, differs from C5aR1 in structure, as it is an atypical GPCR that unlike C5aR1 is not 
coupled to a G-protein. This observation led to the hypothesis that C5aR2 acts as a 
‘decoy’ receptor for C5aR1, effectively acting as an antagonistic, anti-inflammatory 
receptor. The roles of C5aR2 are now known to be similarly complex, with evidence for 
pro- and anti-inflammatory effector functions depending on the experimental context 
(Kovtun et al., 2017; Li et al., 2013). These observations also apply to the C3aR. The C3aR 
also has pro-inflammatory functions, and is important for defence against bacterial 
infections by producing IFN-γ and TNF-α (Mueller-Ortiz et al., 2014); similarly to the 
C5aR, it is also upregulated during rheumatoid arthritis (Neumann et al., 2002). 
Conversely, animal models have reported anti-inflammatory roles for the C3aR (Ames 
et al., 2001). Mixed conclusions have arisen from contradictory and context-dependent 
findings. Many of these findings have been variously supported and contradicted by in 
vivo data that is often unclear and does not accurately represent humans. Importantly, 
receptor expression is drastically different in mice compared with humans (Laumonnier 
et al., 2017), and should be considered when assessing these receptors in animal 
models. 
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1.1.6 Macrophages and Neutrophils 
 
Cells of the immune system generally develop in three distinct lineages; the lymphoid 
lineage, which gives rise to B- and T-lymphocytes, the myeloid lineage, which consists 
largely of phagocytic cells, and the erythroid lineage, which produces red blood cells. All 
cells of these lineages originate with progenitor cells. Lymphoid progenitors become T-
cells, B-cells and Natural Killer (NK) cells, while myeloid progenitors first differentiate 
into myeloblasts, mast cells and erythrocytes (red blood cells). Myeloblasts become 
monocytes, eosinophils, basophils and neutrophils and lastly, monocytes differentiate 
into macrophages (Kondo, 2010). As briefly introduced above, macrophages and 
neutrophils are critical phagocytic cells which perform important functions of the 
immune response. 
Prior to becoming macrophages, mammalian monocytes circulate in the blood, and 
differentiate into macrophages after extravasation into tissues (Auffray et al., 2007). 
Macrophages are large (~20µm) phagocytic cells that specialise in phagocytosing and 
degrading large volumes of bacteria, or dead and dying cells. They are found in all 
tissues, but are enriched at sites where infection is a recurrent threat, such as the skin, 
gut and lungs (Alberts et al., 2002). Elsewhere in the body, long-lived self-renewing 
macrophages from non-myeloid lineages are present, such as microglial cells in the 
brain, which are unique due to the immune privilege of the site.  
Macrophages recognise pathogens directly using PRRs such as the TLRs, and also 
indirectly using receptors that recognise opsonins or inflammatory signals, including 
complement receptors (CR3, C5aR1, C3aR), immunoglobulin receptors (FcγR) and 
chemotaxis receptors (FPR, CX3CR1) (Weiss and Schaible, 2015). Macrophage activation 
causes release of cytokines, generation of ROS and uptake of foreign material into an 
intracellular vesicle derived from the plasma membrane, a process known as 
phagocytosis. This vesicle is known as a phagosome, and proceeds to degrade its 
contents by acidifying using a vesicular ATPase, fusing with intracellular vesicles 
containing proteolytic/hydrolytic enzymes and generating microbicidal ROS, ultimately 
leading to the destruction of the pathogen (Weiss and Schaible, 2015).  
In addition to degrading pathogens, macrophages mediate pro- and anti-inflammatory 
cytokine signalling, depending on the macrophage subset. There are two distinct 
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programmes of macrophage behaviour, known as class M1 and M2 to reflect Th1 and 
Th2 T-helper cell subsets, which are pro- and anti-inflammatory respectively. M1 
macrophages are specialised towards phagocytosing and destroying pathogens, 
producing the pro-inflammatory cytokines TNF-α and IL-1β and initiating production of 
ROS. M2 macrophages respond to parasites, regulate the surrounding immune 
environment, clear apoptotic and dead cells and encourage tissue remodelling 
(Martinez and Gordon, 2014). Macrophages are also important for stimulating the 
adaptive immune system by acting as antigen-presenting cells. As discussed previously, 
during pathogen degradation antigens are retained and presented to T-cells in the 
context of class II MHC, stimulating T-cell development and activation (Weiss and 
Schaible, 2015). 
Neutrophils are the most abundant leukocyte in the human body, and freely circulate in 
the blood prior to recruitment to sites of infection. They are a subset of granulocytes, 
so-named for their large number of cytoplasmic ‘granules’ that contain toxic 
compounds. Neutrophils differentiate alongside two other subsets of granulocytes, 
eosinophils and basophils, which are named for their staining profiles with eosin and 
basic dyes respectively; neutrophils stain neutrally with these dyes. Neutrophils are 
small (8-10µm), short-lived cells with multi-lobed nuclei, allowing them to rapidly 
infiltrate tissues that would be limited by a circular nucleus (Kondo et al., 2003). The 
intracellular granules of neutrophils are full of proteolytic and oxidative enzymes, 
making neutrophils highly microbicidal. Arrival at a site of infection is usually followed 
by phagocytosis of pathogens, or a process known as degranulation whereby the 
intracellular contents of neutrophils are secreted, killing the pathogen extracellularly.  
Circulating neutrophils are quiescent, and are only activated after migrating to the site 
of infection/inflammation and encountering inflammatory cytokines. Neutrophils co-
ordinate chemotaxis and recognise pathogens using a number of PRRs, including 
complement receptors, chemokine receptors, Toll-like receptors, and receptors for 
protein and lipid signalling molecules (reviewed in Mayadas et al., 2014). After 
activation, neutrophils initiate a respiratory burst that produces high levels of ROS, in 
addition to becoming highly phagocytic and releasing their granule contents into the 
surrounding environment. 
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Degradation of pathogens after phagocytosis in neutrophils is similar to macrophages, 
but involves a much higher level of ROS generation. Neutrophils produce ROS by 
activating a highly potent respiratory burst, which begins with the reduction of 
molecular oxygen (O2) into superoxide (O2-) by the phagosomal enzyme NADPH oxidase. 
Neutrophils potentiate the respiratory burst using a unique enzyme known as 
myeloperoxidase (MPO), which converts hydrogen peroxide (H2O2) into hypochlorous 
acid (HOCl), a highly potent microbicidal compound. As many ROS are highly reactive 
and short-lived, MPO also adds to the antimicrobial defence by binding to the pathogen 
surface, localising the generation of ROS to the pathogen (Schürmann et al., 2017). In 
addition to MPO, granules also contain antimicrobial proteins such as α-defensins, 
degradative enzymes like lysozyme and collagenase, and compounds that limit the 
bioavailability of certain nutrients to restrict microbial metabolism, such as iron by 
lactoferrin.  
Neutrophils also undergo a specialised form of cell death known as NETosis. NETs are 
‘neutrophil extracellular traps’, which are formed when neutrophils die and form large 
‘net’ like structures composed of chromatin coated with histones, proteases and 
granular enzymes. NETosis allows neutrophils to contain pathogens over a wide area 
while minimising damage to the host, and is important to antimicrobial defence, as 
evidenced by NET-deficient mice becoming susceptible to an array of infections 
(Belaaouaj et al., 1998). Neutrophils also have anti-inflammatory and 
immunomodulatory roles, promoting inflammation resolution, wound healing, 
angiogenesis and activation/differentiation of macrophages and B-cells (Puga et al., 
2011; Selders et al., 2017). 
Despite the many important functions of neutrophils, many autoimmune conditions are 
characterised by aberrant neutrophil activity, typically as a result of the unregulated 
release of granular contents and enzymes at host tissues. Neutrophils are a major source 
of autoantigens, and are implicated in the development of a number of autoimmune 
conditions. In rheumatoid arthritis, 80-90% of the infiltrating cells at the site of 
inflammation are neutrophils, with up to 109 neutrophils isolated per day from joint 
effusions (Ohtsu et al., 2000; Wipke and Allen, 2001). NETs are also a major source of 
pathology, with 84% of NET components being directly associated with autoimmune 
conditions, including systemic lupus erythematosus, rheumatoid arthritis and vasculitis 
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(Darrah and Andrade, 2012). Additionally, neutrophils are implicated in atherosclerosis, 
Alzheimer’s disease and other chronic inflammatory conditions (Brunner et al., 2006; 
Soehnlein, 2012; Zenaro et al., 2015).  
Macrophages and neutrophils are critical effector cells of the immune system, with a 
number important and context-dependent roles and functions. These cells are essential 
for mounting the immune response during the first stages of infection. 
 
1.1.7 Myeloperoxidase 
 
As mentioned, myeloperoxidase (MPO) is a central enzyme mediating the microbicidal 
potential of neutrophils. MPO was first isolated in the 1940s from pus taken from 
patients with tuberculosis, initially named verdoperoxidase due to its green colour. After 
determining its almost exclusive production by neutrophils, it was renamed 
myeloperoxidase (Hansson et al., 2006). Of the three granule types found in neutrophils, 
MPO is located within the primary (or azurophilic) granules of neutrophils, where it is 
the primary constituent (Borregaard and Cowland, 1997). After phagocytosis, MPO is 
released into the phagolysosome, where it converts hydrogen peroxide (H2O2) and a 
chloride ion to hypochlorous acid (HOCl). HOCl is potently microbicidal, and accounts for 
much of the antimicrobial activity of neutrophils (Klebanoff et al., 2012). 
Like many other glycoproteins, MPO undergoes a complex process of proteolytic 
processing before the enzyme is produced in its active form. It is encoded by a single 
14kb gene located on chromosome 17, and expressed as two alternatively spliced mRNA 
transcripts of 3.6 and 2.9kb (Hashinaka et al., 1988). After translation, immature MPO 
(80kDa in size) undergoes several processing steps within the endoplasmic reticulum 
and trans-golgi network. During myeloid lineage development, promyelocytes and 
promyelomonocytes produce MPO, however a key maturation step as monocytes 
become macrophages is the downregulation of MPO production. MPO synthesis 
terminates as myeloid progenitors enter the myelocyte stage of differentiation, as 
demonstrated in vitro using differentiating agents (Hansson et al., 2006). PCR 
amplification of MPO transcripts has been shown in neutrophils (Yang et al., 2004), 
monocytes and macrophages (Sugiyama et al., 2001), however there is no published 
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evidence of MPO protein being actively synthesised by any cell other than malignant 
cells and myeloid precursors (Hansson et al., 2006). 
Processing and maturation of MPO into the active form is a precisely regulated sequence 
of events (reviewed in Hansson et al., 2006). The initial translation product, known as 
preproMPO, is produced as a single 80kDa peptide containing a signal peptide, 
propeptide, small β-subunit and large α-subunit, which is processed in the endoplasmic 
reticulum (ER) after co-translational cleavage of the signal peptide. PreproMPO then 
incorporates high-mannose oligosaccharide side chains that allow it to interact with the 
molecular chaperones calnexin and calreticulin, and autocatalytically acquire the haem 
group, covalently linking the β and α-subunits (Colas and De Montellano, 2004); at this 
point the product is known as proMPO. After progressing through the trans-golgi 
network, the pro-peptide of proMPO is cleaved, and proMPO is targeted to the primary 
granules. Here, proMPO dimerises with other monomeric subunits by forming 
disulphide bonds between α-subunits, producing the fully mature 150kDa active MPO 
dimer. Interestingly, if the propeptide remains uncleaved, proMPO is constitutively 
secreted out of the cell; the mechanisms and purpose of this remain unclear, but is likely 
to be significant, as human plasma contains both dimeric MPO and uncleaved proMPO 
(Olsen et al., 1986). 
The importance of MPO in clearing bacterial infections has been challenged by 
observations from MPO-deficient patients. MPO-deficiency is relatively common, 
affecting 1 in every 2,000-4,000 people across Europe and North America (Nauseef, 
1988). Despite its role in bacterial killing, MPO-deficient patients are not susceptible to 
infection, with the exception of fungal infections from Candida albicans (Lehrer and 
Cline, 1969). This observation is stark when such patients are compared against 
individuals with chronic granulomatous disease (CGD), who are deficient in the 
phagosomal enzyme NADPH oxidase that initiates the respiratory burst by converting 
molecular oxygen (O2) into superoxide (O2-). Consequently, people with CGD experience 
recurrent life-threatening infections from an array of different fungal and bacterial 
pathogens (Assari, 2006). The difference between MPO-deficient and CGD neutrophils 
is frequently attributed to the fact that all ROS remain intact with the exception of HOCl 
in MPO-deficient neutrophils, suggesting that HOCl is inherently redundant for bacterial 
killing in normal neutrophils. Indeed, modelling of MPO-deficient neutrophils suggests 
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that the absence of MPO leads to extreme levels of H2O2, which are no longer balanced 
by MPO consumption, and leak into the surrounding tissues causing inflammatory injury 
(Schürmann et al., 2017). Without MPO, H2O2 reaches levels sufficient for bacterial 
killing, illustrating how bacterial killing can proceed in the absence of MPO (Schürmann 
et al., 2017; Seaver and Imlay, 2001). 
Despite the lack of a clinical phenotype resembling CGD, MPO-deficient neutrophils 
exhibit broadly impaired phagosomal killing. In vitro studies suggest that MPO-deficient 
neutrophils kill S. aureus 60-70% slower than wild-type neutrophils, and are 300-fold 
slower in killing C. albicans (Decleva et al., 2006; Lehrer and Cline, 1969). in vivo studies 
comparing C. albicans infections between MPO-/- and CGD mice have demonstrated that 
at low fungal burdens, MPO-deficient neutrophils are able to clear infections, while at 
high burdens they become overwhelmed (Aratani et al., 2002); MPO-/- mice also become 
susceptible to bacterial infection from Klebsiella pneumoniae (Hirche et al., 2005). In 
light of these observations, it is important to bear in mind that the mouse model does 
not accurately represent human neutrophils. Murine neutrophils do not produce 
defensins, and contain 10-fold less MPO than human neutrophils (Eisenhauer and 
Lehrer, 1992; Rausch and Moore, 1975). Additionally, other oxidative enzymes are 
upregulated in MPO-deficient murine neutrophils, which are likely to compensate for its 
absence (Brovkovych et al., 2008). These observations should be considered when using 
the murine model to investigate phagosomal enzymes. Taken together, these studies 
illustrate that while MPO is not essential for bacterial killing, it contributes greatly by 
potentiating the production of ROS and enhancing microbicidal activity. 
MPO is also associated with a variety of diseases, and is implicated in inflammatory 
conditions such as cardiovascular disease (Kutter et al., 2000) and glomerulonephritis 
(Yang et al., 2004), as well as malignant conditions such as acute promyelocytic 
leukaemia (Reynolds et al., 1997). Universally, this is due to the capacity of MPO to 
enhance production of oxidative compounds, potentially leading to tissue damage and 
exacerbation of disease. While MPO expression is associated with disease, there are also 
inflammatory conditions that are associated with MPO-deficiency, including 
atherosclerosis (Brennan et al., 2001) and pulmonary fibrosis (Shvedova et al., 2012). 
These conditions highlight the role of MPO not only in potentiating ROS generation, but 
also as an immunomodulator. For example, MPO has numerous anti-inflammatory roles; 
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HOCl inactivates several chemokines, encouraging inflammation resolution (Clark and 
Klebanoff, 1979); MPO directly regulates H2O2, which acts as one of the first 
chemoattractant signals generated at sites of injury, and additionally prevents H2O2-
mediated tissue damage (Pase et al., 2012; Schürmann et al., 2017). With important 
roles to play during both infection and inflammation, MPO is an essential enzyme 
mediating the functions of neutrophils. 
 
1.2 Staphylococcus aureus 
 
Staphylococcus aureus is a facultative anaerobic, catalase-positive, gram-positive 
bacterium of the phylum Firmicutes. It is a normal part of the human microbiota, 
colonising the skin and mucous membranes of roughly 30% of the US population, and 
20% of the world population (Gorwitz et al., 2008; Kluytmans et al., 1997). The 
staphylococci are so-named due to their characteristic shape, forming spherical, ‘grape-
like’ clusters during growth, and S. aureus is named after the golden pigment that it 
produces known as staphyloxanthin, which acts to protect S. aureus from ROS (Pelz et 
al., 2005). Each cell is slightly larger than 1µm in diameter, with the ‘grape-like’ clusters 
forming as the result of incomplete fission of the cells during division (Koyama et al., 
1977). As S. aureus is a commensal organism, carriers of S. aureus do not regularly 
experience disease, despite this, S. aureus is a major pathogen worldwide, causing a 
significant disease burden. 
 
1.2.1 Disease Burden of S. aureus 
 
Despite being part of the human microbiota, S. aureus is an increasing risk to public 
health. Although carriage of S. aureus is generally asymptomatic, it is associated with an 
increased risk of infection from the carried strain, placing a large percentage of the 
population at risk (von Eiff et al., 2001). S. aureus generally resides on the skin and in 
the respiratory tract, causing infection when the skin or mucosal barriers are broken. It 
is capable of a broad range of infections depending on the site, ranging in severity from 
abscesses to necrotising pneumonia. S. aureus is predominantly an opportunistic, 
nosocomial pathogen, highlighted by the correlation between access to health care 
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services and incidence of S. aureus bacteraemia (Frimodt-Møller et al., 1997). S. aureus 
is generally unable to establish infections on its own, and typically arise from pre-existing 
foci that include indwelling devices and infections of skin, soft tissue, osteoarticular and 
pleuropulmonary regions (Tong et al., 2015). 
A major obstacle for treating S. aureus infections is the organism’s capacity for antibiotic 
resistance. The most prominent examples are the methicillin-resistant strains of S. 
aureus (MRSA), which appeared as little as 2 years after methicillin was introduced into 
hospital settings (Jevons, 1961). During the late 1980s, MRSA infections expanded in 
frequency, increasing from 8% to 22% of staphylococcal infections in the US (Wenzel et 
al., 1991). This trend continued for the next decade until as many as 50% of S. aureus 
clinical isolates were MRSA strains (Moran et al., 2006). Prompt investigation 
determined that MRSA infections were caused by a handful of epidemic clones, 
encouraging more focused study of MRSA infections (Oliveira et al., 2002). Accordingly, 
healthcare institutions responded to tackle MRSA, and successfully reduced the 
incidence of MRSA infections by as much as 50% in some regions (Stone et al., 2012). 
Despite this, strains that are resistant to last-resort antibiotics such as vancomycin have 
emerged, highlighting the capacity of S. aureus to continually adapt to current treatment 
regimens (Centers for Disease Control and Prevention (CDC), 2002). 
A second epidemic of MRSA infections occurred during the late 1990s, characterised by 
highly virulent infections in healthy individuals (Centers for Disease Control and 
Prevention (CDC), 1999). The primary symptoms suffered by those infected with 
community-acquired MRSA (CA-MRSA) strains were purulent skin infections and 
necrotising pneumonia, enabled by the production of cytolytic toxins including Panton-
Valentine Leukocidin (PVL) and phenol-soluble modulins (PSMs) (Björnsdottir et al., 
2017; Gillet et al., 2002; Stryjewski and Chambers, 2008). Despite the enhanced 
virulence of CA-MRSA strains, they are not associated with a worse clinical outcome, as 
it was observed that patients PVL-positive infections are equally or more likely to be 
cured than those with non-PVL-positive infections (Lalani et al., 2008; Peyrani et al., 
2011). While the clinical implications of these observations are unknown, they clearly 
indicate that PVL is not the primary determinant of the enhanced virulence observed in 
CA-MRSA infections, despite its association with highly virulent infections.  
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The most common infections caused by S. aureus are skin and soft tissue infections 
(SSTIs), which account for a disease burden of 48 cases per 1,000 people per year (Hersh 
et al., 2008); it is also a leading cause of bacteraemia and infective endocarditis (27.7 
and 16.6 cases per 100,000 per year respectively (Federspiel et al., 2012; Kallen, 2010)). 
In the pre-antibiotic era, bloodstream infections of S. aureus had a mortality rate of 
~80%, while more contemporary studies estimate that the current mortality rate is ~30% 
(Stryjewski and Corey, 2014; Wyllie et al., 2006). Despite significant advances, in 2011 
there were 95,000 invasive infections, and 19,000 deaths every year in the US from S. 
aureus, representing a combined mortality greater than human immunodeficiency virus 
(HIV), viral hepatitis, tuberculosis and influenza combined (Hoyert and Xu, 2012; Klevens 
et al., 2007). 
 
1.2.2 Immune Evasion by S. aureus 
 
A major reason for the success of S. aureus as a pathogen is its expression of a broad 
range of virulence factors, many of which target major components of the innate 
immune system. Using these factors, S. aureus can target antimicrobial proteins, the 
complement system, chemotaxis, phagocytic cells and the oxidative defence to evade 
destruction by the immune system and establish an infection. 
 
1.2.3 Evading Antimicrobial Proteins 
 
S. aureus employs several virulence factors that target antimicrobial proteins (AMPs) 
encountered at the skin and mucosal barriers. A major AMP is α-defensin, a small 
cationic peptide with a hydrophobic region that permits insertion into phospholipid 
bilayers, disrupting cell membranes. They are produced abundantly by neutrophils, 
accounting for 50% of neutrophil granule proteins, and are secreted into the 
surroundings or fuse with maturing phagosomes to mediate bacterial killing (Rice et al., 
1987). Staphylokinase (SAK) is an exoprotein produced by S. aureus that activates 
plasminogen, in addition to directly binding and inactivating α-defensin (Jin et al., 2004). 
SAK activity represents a major aspect of staphylococcal resistance to defensins, and 
was also shown to confer resistance to killing by defensins in vivo (Jin et al., 2004).  
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Another major group of AMPs are the cathelicidins. These small AMPs possess a 
conserved N-terminal cathelin domain and a variable C-terminal AMP domain, and 
display potent anti-staphylococcal activity. Like α-defensin, they localise with neutrophil 
granules, and are also inducibly expressed and produced by keratinocytes (Frohm et al., 
1997; Sørensen et al., 1997). The cathelicidin LL-37 is targeted by S. aureus via the 
production of aureolysin, which cleaves LL-37 at three distinct residues, rendering it 
inactive (Sieprawska-Lupa et al., 2004). This is an important step in how S. aureus is able 
to establish skin infections, as suggested by the downregulation of LL-37 levels during 
atopic dermatitis, predisposing people to S. aureus infections (Ong et al., 2002). 
An essential bactericidal enzyme produced by the human body is lysozyme, a 
muramidase that is found in the mucous secretions including tears, saliva, sweat and 
serum (Alberts et al., 2002). Lysozyme kills bacteria by attacking cell wall peptidoglycan, 
cleaving between the glycosidic β-1,4-linked residues of N-acetylmuramic acid and N-
acetylglucosamine. S. aureus is completely resistant to lysozyme, and is a major aspect 
of their ability to colonise the skin and mucous membranes. S. aureus resists lysozyme 
using an o-acetyltransferase enzyme encoded by the gene oatA, which o-acetylates 
muramic acid residues present in cell wall peptidoglycan (Bera et al., 2005). This 
modification blocks lysozyme activity by creating a steric hindrance between the cell 
wall and the active site of the enzyme. In addition to oatA, modification of the cell wall 
is a major evasion mechanism utilised by S. aureus, as exemplified by DltA and MprF. 
These enzymes modify negatively-charged cell wall teichoic acid residues into positively-
charged residues, allowing S. aureus to repel cationic AMPs including α-defensin and 
cathelicidins, greatly enhancing virulence (Kristian et al., 2003). 
 
1.2.4 Evading the Complement System 
 
After overcoming the AMPs found at the epithelial barriers, S. aureus must then contend 
with the complement system. Due to its central role in enhancing the immune response, 
evasion of complement is a priority of many pathogenic bacteria (Jarva et al., 2003; Ram 
et al., 1999). S. aureus contains a wide arsenal of virulence factors that act to disrupt 
complement, effectively impairing opsonisation, inflammatory signalling, chemokine 
production, phagocyte recruitment and bacterial killing. 
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One of the most prominent staphylococcal virulence factors is Protein A (SpA), which 
associates with the cell membrane as well as being secreted into the surrounding 
environment. The 42kDa protein contains five highly homologous regions that are 
capable of binding antibody fragments, both at the Fcγ-effector portion and the Fab 
antigen recognition region. In addition to directly preventing antibody-mediated 
effector functions, binding of the Fcγ region by SpA blocks activation of the classical 
pathway by preventing C1q binding to antibody-antigen complexes at the cell surface 
(Graille et al., 2000). Furthermore, SpA is also implicated in the progression of 
staphylococcal pneumonia by directly binding the TNF-α receptor TNFR1, which is 
present at high levels in the airway epithelia (Gómez et al., 2004). Another factor 
targeting immunoglobulins is staphylococcal superantigen-like 7 (SSL-7), a protein that 
is related to the superantigen class of toxins. SSL-7 binds to IgA1 and IgA2, disrupting IgA 
interactions with cell-surface FcαRI, and preventing FcαRI-mediated phagocytosis 
(Langley et al., 2005). SSL-7 also binds C5 from a range of species, inhibiting production 
of the C5a chemoattractant and formation of the membrane attack complex (MAC). 
As mentioned, staphylokinase (SAK) targets α-defensins by directly binding and 
inactivating them, and is also able to cleave plasminogen. Plasminogen is an inactive 
zymogen found in the blood, and is activated by cleavage into the active serine protease 
plasmin. In S. aureus, plasminogen is acquired using cell-surface receptors (Herman-
Bausier et al., 2017), which is then cleaved by SAK into plasmin; this produces a bacterial 
membrane-associated serine protease. S. aureus is then able to utilise plasmin to 
degrade IgG and C3b, conferring broad anti-opsonic activity and effectively disrupting 
all complement pathways (Rooijakkers et al., 2005). 
S. aureus is at the greatest risk of encountering the complement system while in the 
blood. Here, S. aureus manipulates its environment by modulating the activities of 
clotting factors including fibrinogen and platelets. S. aureus expresses several virulence 
factors that bind fibrinogen, however the extracellular fibrinogen-binding protein (Efb) 
also interferes with complement. Efb binds to a region of C3 known as C3d, blocking all 
complement pathways by preventing C3 cleavage, C3b deposition and C3 convertase 
formation (Lee et al., 2004). Additionally, Efb binding of C3d disrupts the adaptive 
immune response by preventing recognition of C3d fragments by B-cells, targeting both 
arms of the immune system with a single molecule (Ricklin et al., 2008). 
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A critical aspect of the alternative complement pathway is the distinction of self from 
non-self, in order to prevent the attack of host cells by complement. A key regulator of 
this mechanism is complement factor H (FH), which prevents the alternative pathway 
from proceeding on host cells. It does this by accelerating the decay of the alternative 
C3 convertase (C3bBb), cleaving surface-associated and fluid-phase C3b into an inactive 
iC3b form by acting as a cofactor for factor I, and preventing formation of the C3 
convertase by competing with factor B in binding to C3b (Wu et al., 2009). S. aureus 
exploits this mechanism by producing the extracellular complement binding protein 
(Ecb), which can bind C3b. Additionally, Ecb forms a tripartite complex with FH and C3b 
at the cell surface, utilising the regulatory activity of FH to inactivate and remove C3b, 
thereby disrupting complement (Amdahl et al., 2013). Ecb also interferes with 
recognition of C3b by neutrophils via complement receptor 1 (CR1), impairing 
phagocytosis (Amdahl et al., 2017). 
During bacterial infection, two of the earliest chemoattractants produced are C5a and 
the N-formylated tripeptide N-formylmethionyl-leucyl-phenylalanine, or ‘fMLP’. To 
prevent recognition of these molecules by innate immunity, S. aureus produces the 
chemotaxis inhibitory protein of staphylococcus (CHIPS), which is produced by 62% of S. 
aureus strains and inhibits the cognate receptors of C5a and fMLP – the C5a receptor 
(C5aR) and formyl peptide receptor (FPR) (de Haas et al., 2004). The 14.1kDa secreted 
protein acts by binding the N-terminal ligand binding regions of the C5aR and FPR using 
distinct regions of the protein, targeting both receptors simultaneously (Haas et al., 
2004; Postma et al., 2005). The most potent staphylococcal virulence factor that targets 
the complement system is the staphylococcal complement inhibitor (SCIN). Expressed 
by 90% of S. aureus strains, SCIN inhibits complement by directly binding and stabilising 
the classical and alternative C3 convertases (C4b2a and C3bBb), preventing the 
activation of all complement pathways (Rooijakkers et al., 2005b). S. aureus 
comprehensively targets the complement system to evade immune recognition by 
attacking central components such as C3b and the C3 convertases, in addition to the 
anaphylatoxins and their receptors. 
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1.2.5 Evading Phagocytes 
 
After recognition by the innate immune system, professional phagocytic cells including 
macrophages and neutrophils are recruited to sites of infection, and are required for 
effective clearance of S. aureus (Spaan et al., 2013a). As S. aureus robustly targets host 
AMPs and the complement system, phagocytic cells are among its greatest obstacles 
towards establishing an infection. Phagocytes become activated after recognising 
PAMPs or inflammatory signals, stimulating amplification of the inflammatory response, 
activation of the respiratory burst, and adherence of phagocytes to endothelial cells to 
facilitate recruitment to the infection site. Accordingly, S. aureus targets and disrupts 
each of these processes simultaneously in addition to directly targeting phagocytic cells, 
drastically impairing their ability to combat the infection. Although S. aureus produces 
virulence factors that target both macrophages and neutrophils, we will focus on those 
targeting neutrophils for simplicity.  
During S. aureus infection, some of the most potent chemoattractants produced are 
CXCL1, CXCL2, CXCL7 and CXCL8 (also known as IL-8) (Guerra et al., 2017). A major 
chemotactic receptor expressed on the neutrophil surface is CXCR2, which recognises 
all four of these cytokines. Accordingly, S. aureus secretes the cysteine protease 
Staphopain A (ScpA), which destroys CXCR2 as a functioning receptor. ScpA cleaves the 
N-terminus of CXCR2, rendering the receptor unable to function, as demonstrated by 
the absence of receptor signalling in response to CXCL1 or CXCL7, which are CXCR2-
specific (Laarman et al., 2012). However, ScpA is unable to abolish IL-8 signalling, as 
CXCR1 remains able to bind CXCL8. 
Alongside CXCR2, neutrophils express several other chemotactic receptors including the 
C5a receptor (C5aR) and formyl peptide receptor (FPR). A close relative of FPR is the 
formyl peptide receptor-like-1 (FPRL1), which binds a wide range of ligands including 
regions of the HIV-1 envelope protein gp41, the AMP LL-37 and fragments of prion 
peptides (Le et al., 2001; Su et al., 1999; De Yang et al., 2000). The FPRL1 inhibitory 
protein (FLIPr) inhibits FPRL1 with high-affinity; it is also able to inhibit FPR, albeit to a 
much lesser degree (Prat et al., 2006). S. aureus also produces a similar protein with 73% 
homology with FLIPr, known as FLIPr-like. FLIPr-like is also able to inhibit both FPRL1 and 
FPR, but has a 100-fold greater affinity for FPR over FPRL1 (Prat et al., 2009). Incubation 
40 
 
of neutrophils with FLIPr and FLIPr-like caused a complete loss of chemotactic activity 
from FPR agonists fMLP and MMK-1, but not C5a, as the C5aR remained functional (Prat 
et al., 2009). Additionally, FLIPr and FLIPr-like disrupt antibody-mediated opsonisation 
and the classical pathway by inhibiting class I, II and III IgG receptors (FcγR) (Stemerding 
et al., 2013). 
A major PRR enabling the recognition of S. aureus by phagocytes is TLR2, which binds 
peptidoglycan-associated lipoproteins; TLR2 can also recognise di- and triacylated 
lipoproteins through homotypic interactions with TLR1 and TLR6 respectively (Takeuchi 
et al., 2002a). TLR2 plays an important role in anti-staphylococcal immunity in vivo, as 
TLR2-/- mice become more susceptible to staphylococcal sepsis and nasal colonisation 
when compared with wild-type mice (Gonzalez-Zorn et al., 2005; Takeuchi et al., 2000). 
S. aureus targets TLR2 using staphylococcal superantigen-like 3 (SSL3), a superantigen 
that directly binds TLR2, preventing TLR2-mediated neutrophil functions (Bardoel et al., 
2012). Consequently, SSL3 disrupts numerous neutrophil functions including neutrophil 
adhesion, ROS generation, production of IL-8 and expression of chemokine receptors, 
which are all mediated by TLR2 (Bardoel et al., 2012; Sabroe et al., 2003). 
To migrate to sites of infection, neutrophils must be recruited from the bloodstream 
into the tissues. This process is called transmigration, and relies on a series of cell-
surface carbohydrate-binding proteins known as selectins which mediate a number of 
transient cell-cell adhesion interactions. Once expressed, neutrophils begin to adhere to 
the cell surface in a process known as rolling adhesion, before passing into the tissues 
by extravasation. There are three groups of selectins: L-selectin which is expressed by 
leukocytes and lymphocytes, E-selectin which is present on endothelial cells, and P-
selectin which is found on platelets, and can be induced in endothelial cells in response 
to inflammatory signals (Alberts et al., 2002). During transmigration, neutrophils express 
P-selectin glycoprotein ligand-1 (PSGL-1), allowing them to bind all groups of selectins 
and begin rolling adhesion (Guerra et al., 2017). By secreting the staphylococcal 
enterotoxin-like toxin X (SELX), S. aureus is able to disrupt transmigration by binding to 
glycosylated PSGL-1, preventing selectin recognition and rolling adhesion (Fevre et al., 
2014). Another virulence factor, staphylococcal superantigen-like 5 (SSL5), targets PSGL-
1 in an identical manner, binding directly to PSGL-1 and interfering with neutrophil 
recruitment (Bestebroer et al., 2007). Additionally, SSL5 is able to bind to the N-terminus 
41 
 
of several important chemotactic receptors, preventing C3a, C5a, CXCL1 and IL-8-
mediated neutrophil activation (Bestebroer et al., 2009). 
Several virulence factors that target AMPs and the complement system also display 
direct activity against phagocytic cells. SAK, CHIPS and SCIN inactivate C3 convertases, 
block immunoglobulin binding and inhibit chemotactic receptor signalling, broadly 
interfering with phagocyte recruitment and activation. Interestingly, these virulence 
factors are clustered together in a single pathogenicity island, and are distributed by 
bacteriophages (van Wamel et al., 2006). Additionally, this cluster contains 
staphylococcal enterotoxin A (SEA), which disrupts innate immune responses by 
inhibiting the chemotactic receptors CCR1 and CCR2 (Rahimpour et al., 1999). 
S. aureus also produces a number of bi-component pore-forming toxins that display lytic 
activity against cells including leukocytes and erythrocytes. To target leukocytes, these 
toxins recognise cell-surface chemokine receptors such as CXCR2 and C5aR; one 
component binds to the receptor, followed by recruitment of the second component 
which leads to the formation of a pore in the cell membrane, causing cell lysis. These 
toxins cause cell lysis at high concentrations, however at sublytic concentrations they 
also act to inhibit receptor signalling by competing with the receptor ligand. Receptor 
inhibition by pore-forming toxins has been demonstrated with Panton-Valentine 
Leukocidin (PVL), γ-Haemolysin AB and CB (HlgAB, HlgCB) and leukocidin ED (LukED), 
together inhibiting C5aR1, C5aR2, CXCR1, CXCR2, and CCR5 signalling (Alonzo III et al., 
2012; Reyes-Robles et al., 2013; Spaan et al., 2013b, 2014). Due to the range of inhibitory 
activity displayed by these toxins, their role in impairing leukocyte function at sublytic 
concentrations cannot be ignored. 
 
1.2.6 The Staphylococcal Bi-Component Leukocidins 
 
For over 100 years, we have known that S. aureus secretes factors capable of haemolytic 
and leukocidal activity (Panton and Valentine, 1932). S. aureus produces a large number 
of toxins, including α-toxin, β-toxin and phenol-soluble modulins (PSMs), however a 
particularly broad and important group of toxins are the bi-component pore-forming 
leukocidins; these toxins are secreted as two soluble monomers that combine to form a 
β-barrel pore in the cell membrane. Of this group, five are associated with human 
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infections: Panton-Valentine Leukocidin (PVL), γ-Haemolysin AB and CB (HlgAB, HlgCB), 
leukocidin ED (LukED) and leukocidin AB (LukAB). These toxins target a range of 
leukocyte receptors to cause cell lysis and exert broad leukocidal activity (Table 1.1). 
 
Table 1.1 Staphylococcal bi-component leukocidins and their targets. 
C5aR1/2, CXCR1/2 and CCR2 are chemokine receptors; CD11b* is an integrin adhesion 
molecule; DARCᶧ is an erythrocyte receptor known as the Duffy antigen/receptor for 
chemokines. 
 
The mechanism of pore-formation and cell lysis by these toxins is summarised in Figure 
1.2. All bi-component leukocidins are composed of two distinct subunits, including a 
receptor-targeting S-component (for slow migration through chromatography columns) 
and a polymerisation F-component (fast migration) (Alonzo and Torres, 2014). Both 
subunits are produced as two distinct monomers that later polymerise to induce pore 
formation, with the exception of LukAB, which is produced as a single heterodimeric 
molecule (DuMont et al., 2013). The S-component recognises and binds the target 
receptor, which permits recruitment of the F-component (Colin et al., 1994). Alternating 
insertion of the two subunits then proceeds to form an octameric pore roughly 1-2nm 
in diameter in the cell membrane (Yamashita et al., 2011). 
As shown in Table 1.1, almost all bi-component leukocidins target chemokine receptors 
that are highly expressed on the surface of phagocytes. Most of these receptors (with 
the exception of CD11b and DARC) are from the class-A rhodopsin-like family of G-
protein coupled receptors (GPCRs). This family of structurally and functionally related 
seven-transmembrane loop receptors are important for transducing extracellular 
signals through interactions with cytosolic G-proteins (Venkatakrishnan et al., 2013). 
LukAB is an exception as it does not target a GPCR for leukocidal activity, instead 
Toxin Leukocyte target Non-leukocyte 
target 
Reference 
PVL C5aR1, C5aR2  (Spaan et al., 2013b) 
LukED CCR5, CXCR1, CXCR2 DARCᶧ (Alonzo III et al., 2012; Reyes-
Robles et al., 2013; Spaan et al., 
2015) 
HlgAB CCR2, CXCR1, CXCR2 DARCᶧ (Spaan et al., 2014, 2015) 
HlgCB C5aR1, C5aR2  (Spaan et al., 2014) 
LukAB CD11b*  (DuMont et al., 2013) 
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targeting CD11b (also known as Mac-1 integrin or complement receptor 3 (CR3)), an 
important C3b-binding receptor that is expressed on the surface of monocytes, 
macrophages and neutrophils, and governs phagocytosis, bacterial killing and 
chemotaxis (DuMont et al., 2013; Hynes, 2002; Ross, 1980). Interestingly, the S-
components of HlgAB and LukED (HlgA, LukE) can also target the Duffy antigen/receptor 
for chemokines (DARC) on erythrocytes, an atypical chemokine receptor that is not 
coupled to a G-protein (Tournamille et al., 2003). S. aureus targets the DARC using HlgAB 
and LukED to liberate essential iron from haemoglobin after lysing erythrocytes, as free 
iron is scarce during infection due to restriction by the host as a form of ‘nutritional 
immunity’ (Spaan et al., 2015). 
Despite the abundance of data concerning how the bi-component leukocidins target 
host cells, it is unclear how pore formation results in cell lysis. The process of pore-
formation and cell lysis as it is currently understood is summarised in Figure 1.2. It is 
currently thought that lysis is enhanced by activation of the NOD-, LRR- and pyrin 
domain-containing 3 (NLRP3) inflammasome after pore formation, triggered by the 
leakage of divalent cations (e.g. Ca2+ and K+) which stimulates NFκB production, caspase 
1 cleavage and IL-1β release, and results in a controlled form of cell death known as 
pyroptosis (Rühl and Broz, 2015; Spaan et al., 2017). Activation of NLRP3 is also observed 
in monocytes and macrophages after exposure to PVL, HlgAB, HlgCB and LukAB, 
suggesting that it is likely to be the next step in cell lysis (Holzinger et al., 2012; Melehani 
et al., 2015; Muñoz-Planillo et al., 2009). Despite these observations, the precise 
mechanisms underlying lysis remain unclear, however, they are likely to be executed by 
the host protein gasdermin D. Briefly, NLRP3 activation results in the cleavage of 
gasdermin D, releasing an N-terminal membrane targeting domain that forms pores in 
the host cell membrane; this leads to DNA cleavage, accelerated ion leakage and cell 
swelling, resulting in lysis (Liu et al., 2016). 
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Figure 1.2 Pore formation and cell lysis by the staphylococcal bi-component 
leukocidins. 
The bi-component leukocidins are composed of two distinct subunits. The S-subunit 
initiates pore-formation by recognising and binding the receptor target, followed by 
recruitment of the F-subunit. These subunits then dimerise and insert into the cell 
membrane, eventually forming a heptamer by alternating insertion of more S and F 
subunits. Once fully formed, the heptamer undergoes a conformational change and 
extends, perforating the cell membrane and causing leakage of divalent cations, 
disrupting cell homeostasis. This causes NFκB production, caspase 1 cleavage and IL-1β 
release, activating the NLRP3 inflammasome and accelerating pore-formation by 
assembly of host Gasdermin D by the pyroptotic cell death pathway. The cell then swells 
with H2O and lyses. 
 
Leukocidins are an important part of S. aureus infection. They are expressed during 
infection in vivo, and are a prominent aspect of pathogenesis, as infected individuals 
develop antibodies against them (Adhikari et al., 2015; Dumont et al., 2011). Mutant 
strains lacking PVL, HlgAB, HlgCB or LukAB exhibit a reduced cytolytic activity in vitro 
(Melehani et al., 2015; Spaan et al., 2013b, 2014), and LukED mutant strains become 
attenuated in vivo (Reyes-Robles et al., 2013). Despite their evident significance during 
infection, the overall purpose of leukocidin production has been difficult to determine 
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due to a disconnect between animal models and the functional specificity of many of 
these toxins. Notably, in vitro studies using murine leukocytes demonstrate a resistance 
to PVL-mediated cytolytic activity (Spaan et al., 2013b; Szmigielski et al., 1999), and in 
vivo models of skin and soft-tissue infections, sepsis and pneumonia report no effect of 
PVL beyond minor and strain-dependent observations (Bubeck Wardenburg et al., 2007; 
Diep et al., 2010; Voyich et al., 2006). These negative findings were due to differential 
expression of other virulence factors in these strains, in addition to the fact that PVL is 
adapted to the human variant of the C5aR, accounting for the resistance of non-human 
models to PVL activity (Bubeck Wardenburg et al., 2007; Spaan et al., 2013b). Moreover, 
HlgCB and LukAB are also human-adapted, a factor that is a major obstacle towards 
investigating their roles and functions during infection in vivo (DuMont et al., 2013; 
Melehani et al., 2015; Spaan et al., 2014). 
 
1.2.7 Evading the Oxidative Defence 
 
After phagocytosis, S. aureus must contend with a range of bactericidal oxidative 
compounds that are generated by the respiratory burst, including superoxide (O2-), 
hydrogen peroxide (H2O2), and hypochlorous acid (HOCl). To survive the phagosome, S. 
aureus produces a number of proteins and enzymes that mitigate the level of 
bactericidal compounds, and directly inhibit central enzymes in the respiratory burst 
(summarised in Figure 1.3).  
During the respiratory burst, the first toxic compound produced is superoxide (O2-). O2- 
is generated by phagosomal NADPH oxidase, which transfers electrons from the cell to 
molecular oxygen, creating the O2- free radical. Despite having a high reduction 
potential, O2- is considered an ineffective oxidant that causes little damage or cell death, 
partly as it is easily dismutated by cellular enzymes such as superoxide dismutase 
(Winterbourn, 2008). The toxicity of O2- is context-dependent, as extracellular O2- is 
innocuous while intracellular O2- is bactericidal (Gardner and Fridovich, 1991). To tackle 
O2- in the phagosome, S. aureus produces two superoxide dismutases, SodA and SodM, 
which convert O2- into H2O2 using manganese as a cofactor. These enzymes are 
upregulated after phagocytosis, and are evidently important in resisting oxidative killing 
in the phagosome, as illustrated by an increased susceptibility to oxidative killing in SodA 
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mutant strains (Clements et al., 1999; Hampton et al., 1996). Additionally, recent studies 
found that high levels of dietary manganese are associated with an increased 
susceptibility of staphylococcal endocarditis, as a result of the enhanced potential of S. 
aureus to detoxify O2- using SodA and SodM (Juttukonda et al., 2017). Furthermore, 
SodM is expressed at significantly higher levels in S. aureus strains isolated from late-
stage cystic fibrosis (CF) patients, suggesting that SodM is important for adapting to 
long-term persistence environments (Treffon et al., 2018).  
After the production of O2-, hydrogen peroxide (H2O2) is generated by both host and 
bacterial superoxide dismutases. H2O2 is generally not the primary oxidant responsible 
for bacterial killing in the phagosome, as a milllimolar range of H2O2 is thought to be 
required for bactericidal activity in vitro, and H2O2 levels in the phagosome generally do 
not rise above the micromolar range (Winterbourn et al., 2006). In contrast, H2O2-
mediated bactericidal activity has been demonstrated at the micromolar range in vitro 
after controlling for the catalytic effect of iron in resisting oxidative damage, suggesting 
that phagocytes rely on H2O2 to enhance bacterial killing (Park et al., 2005; Seaver and 
Imlay, 2001). S. aureus resists H2O2 using its catalase KatA, which converts two H2O2 
molecules to two H2O molecules and O2 using a haem cofactor. Catalase is an important 
determinant of pathogenicity, as KatA is upregulated after phagocytosis, and catalase 
production is correlated with virulence (Das and Bishayi, 2009; Kanafani and Martin, 
1985). Despite this, katA mutant strains are only attenuated in nasal colonisation models 
that require S. aureus to compete with other bacteria, suggesting that catalase is also 
important for resisting H2O2 produced by bacterial competitors (Park et al., 2008). 
S. aureus also expresses two alkyl hydroperoxide reductases, AhpF and AhpC. These are 
reactive towards alkyl peroxides (which are peroxides that form with organic molecules) 
and H2O2. Alkyl peroxides are broken down into the corresponding alcohol and water, 
or water and molecular oxygen in the case of H2O2. Little is known about these enzymes, 
although they appear to be important for pathogenesis, as an ahpC mutant exhibited 
reduced survival in a nasal colonisation model (Cosgrove et al., 2007). 
Perhaps the most potent oxidative product that is produced in the phagosome is 
hypochlorous acid (HOCl). HOCl is produced as the result of enzymatic conversion by 
myeloperoxidase (MPO), generating HOCl from H2O2 and a chloride ion. HOCl is the 
active compound in bleach, and displays a high level of bactericidal activity across many 
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species of bacteria (Hirche et al., 2005; Lehrer and Cline, 1969; Müller et al., 2014). 
Rather than targeting HOCl, S. aureus produces a virulence factor that directly inhibits 
MPO, blocking production of HOCl. The staphylococcal peroxidase inhibitor (SPIN) is 
expressed by >90% of S. aureus strains, and inhibits MPO by occluding the active site 
and acting as a ‘molecular plug’ (de Jong et al., 2017). The SPIN gene (spn) is upregulated 
within 20 minutes post phagocytosis, and SPIN mutants (spn) exhibit an increased 
susceptibility to oxidative killing, suggesting that SPIN is an important component of 
surviving the oxidative defence, and that MPO is a key enzyme potentiating the 
antibacterial activity of neutrophils (de Jong et al., 2017). 
 
 
Figure 1.3 Staphylococcal evasion of the oxidative defence. 
Staphylococcal virulence factors produced in the phagosome to escape oxidative killing 
by neutrophils. Major products of the respiratory burst are shown numbered in black; 
oxidative host enzymes are shown in green; staphylococcal virulence factors and their 
targets are shown in orange. 
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1.2.8 Host-adaptation of S. aureus 
 
S. aureus is a highly versatile pathogen, colonising a wide array of different hosts. For 
over 30 years, S. aureus has been considered as an organism that colonises and co-
evolves with specific hosts (Kloos, 1980). This characteristic is demonstrated by the 
distinct infection scenarios presented by healthcare-associated MRSA (HA-MRSA) and 
community-associated MRSA (CA-MRSA), with each occurring in distinct environments. 
The ability of S. aureus to adapt and diversify is also exemplified by the large number of 
divergent strains, which currently numbers over 3,100 (http://saureus.mlst.net/, 
accessed August 2018). While S. aureus is a commensal organism in humans, it has also 
been isolated from a wide variety of different vertebrate species, highlighting its 
capacity to survive in different host environments (Kloos, 1980). S. aureus causes disease 
in a wide variety of economically important animal species, including cows, sheep, goats, 
poultry and rabbits, representing a major economic problem across several countries 
(Fitzgerald, 2012). Importantly, strains derived from animal infections are genotypically 
and phenotypically different from human strains, implying that S. aureus is host-
specialised, and engages in limited transmission between humans and animals (Jamrozy 
et al., 2012). 
S. aureus is responsible for a considerable disease burden among economically 
important animals. Intramammary infections in dairy cows cause mastitis, representing 
a major economic burden (Bradley, 2002); mastitis in smaller ruminants is also an issue 
in countries that rely on sheep and goat cheese (Menzies and Ramanoon, 2001). In 
poultry, S. aureus is capable of skeletal infections such as osteomyelitis, and in 
continental Europe, S. aureus causes skin abscesses, mastitis and septicaemia in rabbit 
farms (McNamee and Smyth, 2000; Vancraeynest et al., 2006). 
Despite the unique host-specificity of S. aureus, it is also capable of transmission 
between species. Generally, transmission of S. aureus from animals to humans is 
uncommon, however carriage of porcine strains in individuals who work closely with 
pigs is increasing (although infection is rare) (van den Broek et al., 2009; van Cleef et al., 
2011). Consequently, pigs may represent a reservoir for zoonotic infections of S. aureus, 
and may not be alone in this regard. Population studies comparing bovine, galline and 
equine strains of S. aureus with human strains note a disproportionately high number 
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of strains that are identical or similar to human strains, suggesting that jumps between 
humans and these animals are common (García-Álvarez et al., 2011; Lowder et al., 2009; 
Walther et al., 2009). Furthermore, there is strong evidence of equine strains that were 
originally transmitted from humans, and consequently adapted to colonise horses as a 
host. This is evidenced by genotypic similarities between certain equine and human 
strains, in addition to their expression of equine-specific pathogenicity islands (Viana et 
al., 2010; Walther et al., 2009). 
Host-adaptation of S. aureus is highly complex, involving changes to major surface 
proteins and virulence factors. S. aureus alters its cell surface by dispensing with genes 
encoding surface proteins such as protein A (SpA) or clumping factor A (ClfA), 
presumably as they are unnecessary for colonisation in both ruminant and avian hosts 
(Devriese, 1984; Herron-Olson et al., 2007). Another major mechanism of host 
adaptation in S. aureus is through changes to the core genome or the accessory genome, 
the latter consisting largely of mobile genetic elements (MGEs). MGEs can encode large 
regions containing many host-specific virulence factors, allowing it to colonise a given 
host. A common feature of animal strains is the secretion of a host-specific von-
Willebrand factor binding protein (vWfbp) that binds the serum glycoprotein von-
Willebrand factor (vWf) which is involved in the clotting cascade; unique vWfbp’s are 
observed in bovine, ovine and equine strains of S. aureus (Guinane et al., 2010; Viana et 
al., 2010). Bovine strains often carry a unique leukocidin pair known as LukMF’, which 
binds to the CCR1 chemokine receptor which is expressed on bovine neutrophils and not 
human neutrophils (Vrieling et al., 2015). Interestingly, leukocidins may be a major 
aspect of host-adaptation, as another novel leukocidin named LukPQ has been identified 
in equine strains, which target equine CXCRA and CXCR2 (Koop et al., 2017). Other 
notable host-adapted virulence factors include two distinct SCIN’s, one bovine and one 
equine-specific, and a galline cysteine protease similar to staphopain A, demonstrating 
that complement, antimicrobial proteins and phagocytes are also important targets for 
infection in animal hosts (Takeuchi et al., 2002; Guinane et al., 2010; de Jong et al., 
2018).  
In contrast to the notion that S. aureus relies heavily on MGEs for host tropism, analysis 
of the co-evolution of rabbit and human-adapted strains has revealed that human 
strains require only a single mutation in a cell wall enzyme encoded in the core genome 
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(DltB) to confer infectivity in rabbits (Viana et al., 2015). Notably, these rabbit strains 
harbour none of the accessory genes disseminated on MGEs that are characteristic of 
human-derived strains, suggesting that many of them are primary determinants of 
human tropism.  
 
1.2.9 Human-adaptation of S. aureus 
 
S. aureus has colonised humans for at least 10,000 years, according to evolutionary 
evidence of a human to cattle host jump shortly after their domestication (Weinert et 
al., 2012). As a result of this longstanding relationship, S. aureus has become highly 
specialised to the environment of the human body. The result is the existence of a wide 
range of virulence factors that are only functional against the human variant of their 
target, almost all of which are directed against central components of the innate 
immune system (Table 1.2). 
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Virulence Factor Functions Targets References 
Staphylokinase 
(SAK) 
Inhibits α-defensins, 
opsonophagocytosis, 
complement and 
chemotaxis by 
degrading C3b and IgG 
Plasminogen, α-
defensin, C3b, 
IgG 
(Gladysheva et al., 2003; 
Jin et al., 2004; 
Rooijakkers et al., 
2005a) 
Staphylococcal 
Complement 
Inhibitor (SCIN) 
Complement 
disruption by stabilising 
C3 convertases 
C3b, Factor B (Rooijakkers et al., 
2005b) 
Chemotaxis 
inhibitory protein of 
Staphylococci 
(CHIPS) 
Inhibits chemotaxis by 
blocking receptor 
ligand binding domains 
C5aR1, C5aR2, 
FPR1 
(de Haas et al., 2004) 
Staphylococcal 
Enterotoxin A (SEA) 
Activates T-cells by 
crosslinking, inhibits 
chemotaxis 
MHC and T-cell 
receptors, CCR1, 
CCR2 
(Dohlsten et al., 1993) 
Panton-Valentine 
Leukocidin (PVL) 
Kills leukocytes, inhibits 
chemotaxis at sublytic 
concentrations 
C5aR1, C5aR2 (Spaan et al., 2013b) 
Haemolysin 
(HlgCB) 
Kills leukocytes, inhibits 
chemotaxis at sublytic 
concentrations 
C5aR1, C5aR2 (Spaan et al., 2014) 
Leukocidin AB 
(LukAB) 
Kills leukocytes CD11b (DuMont et al., 2013) 
Staphylococcal 
Peroxidase Inhibitor 
(SPIN) 
Mitigates ROS 
production by blocking 
the active site of MPO 
Myeloperoxidase 
(MPO) 
(de Jong et al., 2017) 
Staphopain A (ScpA) Inhibits chemotaxis and 
phagocyte activation by 
cleaving the IL-8 
receptor 
CXCR2 (Laarman et al., 2012) 
 
Table 1.2 Human-specific virulence factors produced by S. aureus. 
 
  
52 
 
As shown in Table 1.2, S. aureus produces many human-specific virulence factors that 
target major components of the innate immune system. There is minimal variation in 
the expression of virulence factors that are associated with human infection, which is 
surprising given the high level of variation in the core and accessory genomes of 
individual strains (Koymans et al., 2017). MGEs are a major determinant of human-
specificity, and are disseminated by bacterial viruses named bacteriophages, which 
insert their viral DNA into the genome of the host. An important class of bacteriophages 
governing human-adaption of S. aureus are the β-haemolysin converting bacteriophages 
(βC-φS), which disrupt expression of the β-haemolysin toxin when integrating their DNA 
into the S. aureus genome (Coleman et al., 1986). 
The most significant MGE that allows S. aureus to colonise and infect humans is the 
immune evasion complex (IEC), which is disseminated by a βC-φS. The IEC is expressed 
by roughly 90% of human isolates, and is almost entirely absent from livestock-derived 
strains (Price et al., 2012; van Wamel et al., 2006). The IEC carries the virulence factors 
staphylokinase (SAK), staphylococcal complement inhibitor (SCIN), chemotaxis 
inhibitory protein of staphylococcus (CHIPS), and staphylococcal enterotoxin A (SEA), 
which broadly target chemotaxis, complement and antimicrobial proteins to impair the 
innate immune response. Although the IEC is found in roughly 90% of S. aureus strains, 
there are 7 distinct variants that express different virulence factors. The percentage of 
isolates that express each virulence factor is: SAK (76.6%), CHIPS (56.6%) and SEA 
(27.8%) while interestingly, 100% of isolates express SCIN, suggesting that subversion of 
the complement system is a priority for human-adaptation (van Wamel et al., 2006). 
Each factor is partially or completely inactive in studies using murine cells, and are only 
functional against the human variant of their target (Dohlsten et al., 1993; Gladysheva 
et al., 2003; de Haas et al., 2004; Rooijakkers et al., 2005b). 
Other human-specific factors expressed by the majority of S. aureus strains are 
Staphopain A (ScpA), the staphylococcal peroxidase inhibitor (SPIN), γ-haemolysin CB 
(HlgCB) and leukocidin AB (LukAB), all of which are found in the core genome of over 
99% of S. aureus strains (Golonka et al., 2004; de Jong et al., 2017; Spaan et al., 2017). 
ScpA is unable to cleave murine CXCR2, however a single amino acid substitution was 
able to confer cleavage at high concentrations (Laarman et al., 2012). SPIN is transcribed 
near the α genomic island known as νSaα, near a cluster of immune evasion factors that 
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includes the staphylococcal superantigen-like toxins (de Jong et al., 2017). SPIN is unable 
to inhibit murine, bovine, equine and rabbit myeloperoxidase, and is only active against 
human MPO (de Jong et al., 2017). The two bi-component leukocidins, HlgCB and LukAB 
are also transcribed in the core genome and expressed by roughly 99.5% of human 
isolates; both demonstrate an inability to kill murine leukocytes, and are highly cytotoxic 
to human and primate leukocytes (DuMont et al., 2013; Spaan et al., 2014). 
While these factors are expressed in almost all S. aureus strains, Panton-Valentine 
Leukocidin (PVL) is a notable exception. PVL is disseminated on the temperate 
bacteriophage φSa2, and is expressed in only 1.2% of S. aureus strains (von Eiff et al., 
2004). Although PVL is found in only a small minority of strains, it is important to note 
that PVL is expressed in almost all CA-MRSA isolates and acts as an epidemiological 
marker of these infections (Naimi et al., 2003). Immortalised monocyte-like U937 cells 
transfected with either the human, primate, mouse or rabbit C5a receptor and treated 
with PVL demonstrate that PVL is unable to lyse primate or mouse neutrophils in vitro, 
and is specifically active against the human C5a receptor (Spaan et al., 2013b). 
Unexpectedly, PVL was also able to lyse cells transfected with the rabbit C5a receptor, 
which may be explained by a greater similarity between the rabbit and human receptors 
compared with other mammals. Rabbit leukocytes are susceptible to PVL lysis in vivo, 
and a single amino acid mutation in a human-adapted strain is sufficient to confer 
infectivity in rabbits, implying that rabbits are a more representative model of S. aureus 
infection than mice (Diep et al., 2010; Viana et al., 2015). 
 
1.3 The Zebrafish (Danio rerio) 
 
Zebrafish (Danio rerio) are small, freshwater fish native to India, Burma and Pakistan. 
For over 30 years, the zebrafish has been an important model for studying 
developmental processes as an alternative to mammalian models. Subsequently, a wide 
range of tools have been developed that allow researchers to dissect aspects of biology 
from a range of perspectives.  
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1.3.1 The Zebrafish as a Model of Disease 
 
The zebrafish is a useful model for the study of human diseases. They share 70% 
homology with the human genome, are genetically tractable and are amenable to high-
throughput techniques, making the zebrafish a valuable model for studying disease from 
numerous angles (Howe et al., 2013). Since the 1980s, a wealth of tools for working with 
zebrafish has been created, including cloning (Streisinger et al., 1981), mutagenesis 
(Walker and Streisinger, 1983), transgenesis (Stuart et al., 1988) and gene mapping 
(Streisinger et al., 1986) techniques. These tools have led to established models of 
heritable diseases such as Duchenne Muscular Dystrophy and Polycystic Kidney Disease 
(Bassett et al., 2003; Sun et al., 2004) in addition to acquired diseases including 
melanoma (Haldi et al., 2006), leukaemia (Langenau et al., 2003) and neurodegenerative 
conditions (Paquet et al., 2009), that have yielded valuable insights into translational 
medicine.  
One of the most important fields of study aided by the zebrafish is the study of 
inflammatory diseases. Particularly, a transgenic zebrafish with labelled neutrophils can 
be used as a model of sterile neutrophilic inflammation; these fish recapitulate 
neutrophil recruitment and resolution over a timeframe that resembles mammalian 
inflammation (Renshaw et al., 2006a). Additionally, novel signalling pathways regulating 
inflammation have been discovered using the zebrafish. Using a ratiometric H2O2 
reporter line it was discovered that epithelial cells initiate a tissue-scale gradient of H2O2, 
which acts as the first chemoattractant produced at wound sites, which is then sensed 
by a peroxidase-sensitive kinase (Niethammer et al., 2009; Yoo et al., 2011). 
Furthermore, it was also shown that MPO is delivered to the wound site by neutrophils, 
regulating H2O2 levels and mitigating the inflammatory response, highlighting a major 
role for MPO in reducing inflammation (Pase et al., 2012). 
Zebrafish are also a useful translational model for screening and testing novel 
therapeutic agents. One such agent is Tanshinone IIA (TIIA), which was found to enhance 
inflammation resolution by initiating migration of neutrophils away from the wound 
site, known as ‘reverse migration’; this also occurs in mammalian models, and aids 
revascularisation and wound healing (Robertson et al., 2014; Wang et al., 2017). TIIA 
was discovered as the result of a compound screen which measured the effects of 
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known modulators of neutrophil function and lifespan in the zebrafish model of 
inflammation (Loynes et al., 2010; Renshaw et al., 2006b). Outwith its potential in 
discovering novel anti-inflammatory drugs, zebrafish are also a valuable screening 
platform for almost every novel compound with therapeutic applications (MacRae and 
Peterson, 2015). 
The zebrafish larva is also an insightful model for investigating the establishment and 
metastasis of tumour cells. The enhanced metastasis of tumour cells under hypoxic 
conditions has been effectively recapitulated using a larval xenograft model (Lee et al., 
2009), and mirrors the therapeutic effects observed by inhibiting the endothelial growth 
factor VEGF (Kim et al., 1993). More recently, the xenograft model has been applied 
towards identifying key determinants of specific cancer subtypes, including triple-
negative breast cancer, and has led to the identification of the chemokine receptor 
CXCR4 as a major regulator of metastasis in these cancers (Tulotta et al., 2016). 
 
1.3.2 Genetic Manipulation of Zebrafish 
 
One of the most useful features of the zebrafish model is that it is genetically tractable, 
a trait that is readily exploitable with an abundance of established tools. A variety of 
approaches are available for genetic manipulation of zebrafish, including transient and 
inducible gene expression, mutagenesis and transgenesis. The majority of these tools 
involve direct injection of DNA, RNA or enzymes into newly fertilised embryos, however 
there are also chemically-mediated methods of genetic manipulation, all of which will 
be discussed. 
Transient knockdown of gene expression is possible using morpholinos (MOs), which are 
short ~25bp stretches of small interfering RNA (siRNA) that can bind RNA in a site-
specific manner, blocking protein translation (Summerton and Weller, 1997). Two 
notable MOs that are useful for studying innate immunity are irf8, which skews myeloid 
lineage development in zebrafish embryos by suppressing the irf8 macrophage 
transcription factor (Li et al., 2011) and pu.1, which abrogates phagocyte development 
(Rhodes et al., 2005). Inducible gene expression can be accomplished using the Gal4-
UAS system, which is a bicistronic genetic element from Saccharomyces cerevisiae that 
can direct cell-specific expression of effector proteins. The Gal4 transcriptional activator 
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uses the upstream activation sequence known as UAS as a binding site. By fusing a cell-
specific promoter upstream of Gal4 and an effector protein downstream of UAS, the 
effector protein will be expressed in the specific cell type when both elements are 
present (Asakawa and Kawakami, 2008). For example, if the kdrl vascular cell promoter 
(Bertrand et al., 2010) were fused to Gal4, and the green fluorescent protein (GFP) were 
fused to UAS, vascular cells would express GFP when both elements are present. 
Mutagenesis is also readily performed using the zebrafish model with engineered 
nucleases or mutagenic chemical treatments. Two established mutagenesis 
technologies utilised in the zebrafish are zinc-finger nucleases and TALENs. Zinc-finger 
nucleases (ZFNs) are artificial proteins consisting of a site-specific zinc-finger array fused 
to a non-specific nuclease domain; the engineered protein can then be used to perform 
site-specific mutagenesis (Foley et al., 2009). Mutagenesis occurs by creating double-
strand breaks at the desired site, which can result in a frameshift mutation through non-
homologous end joining. A similar approach is to use transcription activator-like effector 
nucleases (TALENs), which contain basepair-specific domains that can be assembled to 
create site-specific nuclease activity (Moore et al., 2012).  
A more recent technique for site-specific mutagenesis in the zebrafish is to use the 
CRISPR/Cas system. CRISPR/Cas (clustered regularly interspaced short palindromic 
repeats - CRISPR-associated) is derived from a primitive bacterial immune system that 
mediates acquired resistance against viruses and plasmids (Horvath and Barrangou, 
2010). CRISPR consists of a number of DNA fragments acquired by bacteria after 
infection, and is paired with the endonuclease Cas9 to mediate site-specific nuclease 
activity. Unlike ZFNs and TALENs, CRISPR/Cas uses short stretches of RNA known as 
guide RNAs to target specific DNA sites, which are then cleaved by the Cas9 nuclease 
(Hwang et al., 2013). A related approach known as CRISPRi causes site-specific 
knockdown of gene expression, comprised of an inactivated Cas9 which blocks gene 
transcription rather than causing double-strand breaks (Qi et al., 2013). Non-specific 
methods of mutagenesis are also possible with the zebrafish, and are useful for 
performing forward genetics studies. ENU mutagenesis involves routinely treating adult 
zebrafish with the mutagen N-ethyl-N-nitrosourea, which causes chromosomal 
mutations at an average rate of one every 1x105 basepairs (de Bruijn et al., 2009). 
Treated fish are then crossed and their larvae screened for novel phenotypes, which can 
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be identified genetically. For example, ENU mutagenesis was used to create a 
myeloperoxidase-deficient zebrafish called durif (Pase et al., 2012). 
The insertion of foreign DNA elements into the zebrafish genome is also possible using 
transgenesis techniques. The most efficient approach commonly used in zebrafish is 
Tol2 transgenesis, which utilises transposon-derived sequences to deliver genetic 
elements into the genome by transposase-mediated insertion (Kwan et al., 2007). By 
placing these sites at positions flanking a DNA sequence, the Tol2 transposase enzyme 
is then able to insert the sequence randomly and in one efficient step into the target 
genome.  
While Tol2 is currently the most efficient means of delivering construct DNA into the 
zebrafish genome, there are numerous ways to create genetic constructs prior to 
transgenesis. An efficient means of generating constructs of roughly 10-20kb in size is 
using a multisite recombination technology known as Gateway® cloning, which allows 
genetic constructs to be assembled in a modular fashion, facilitating future 
experimentation (Kwan et al., 2007). Gateway® cloning is based on the att site-specific 
recombination system from lambda phage, which allows up to three individual genetic 
elements known as ‘entry clones’ to be assembled to form one large genetic construct 
(Hartley et al., 2000). Entry clones typically contain promoters, effector proteins or 
fluorescent markers, and are created by adding att sites to either end of a genetic 
element using PCR; these att sites allow the element to carry out site-specific 
recombination events with a specific donor vector to insert the element into the vector 
(Figure 1.4A). The att sites depend on whether the entry clone will be placed at a 5’, 
middle or 3’ position in the full-length construct. For example, for a middle-entry clone 
the genetic element will have an attB1 and an attB2 site, allowing it to recombine with 
a donor vector containing an attP1 and attP2 site. Site-specific recombination between 
a genetic element and a donor vector is carried out in a reaction known as a ‘BP 
reaction’, which utilises a BP clonase to catalyse recombination events between attB 
and attP sites, inserting the genetic element into the donor vector (Kwan et al., 2007). 
The final construct is assembled in an ‘LR reaction’, which uses attL and attR sites to fuse 
all entry clones together in order before inserting the assembled sequence into a 
destination vector (Figure 1.4B). 
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Figure 1.4 Gateway® cloning of genetic constructs for transgenesis into the 
zebrafish. 
A) Creation of entry clones via a BP reaction. B) Assembly of a full-length construct from 
three entry clones via an LR reaction. Adapted from Kwan et al., 2007.  
 
One drawback of Tol2-mediated insertion of Gateway® constructs is that these 
constructs are limited by size, as Tol2 integration rates begin to drop for sequences over 
10kb (Suster et al., 2011). This often means that genes cannot be inserted in their 
entirety (i.e. with regulatory elements and introns intact), and therefore may not be 
expressed in an identical pattern to the endogenous gene. Another method of delivering 
genetic elements into the zebrafish genome is to use a bacterial artificial chromosome 
(BAC)-targeting method, which can insert constructs as large as 300kb into the genome, 
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and may be enhanced using Tol2 (Suster et al., 2011). Although BAC targeting is very 
useful for inserting complete genes into the zebrafish genome, they are limited by being 
more cumbersome than Gateway constructs from a practical standpoint. 
 
1.3.3 The Zebrafish Immune System 
 
As the zebrafish genome shares 70% homology with the human genome, the zebrafish 
immune system is highly analogous to humans, with many examples of orthologous 
immune components (Howe et al., 2013). Zebrafish have an innate and adaptive 
immune system, which develop separately. The innate system is active from fertilisation, 
while the adaptive system is not present until ~3 weeks post-fertilisation (Herbomel et 
al., 1999; Wang et al., 2009). This has implications for studying infection in the zebrafish, 
as embryos possess only an innate immune response. While this is useful for studying 
the innate immune system in isolation, it can also be an obstacle for studying 
interactions between the innate and adaptive systems. 
Zebrafish have a number of innate immune cells, including macrophages, neutrophils, 
dendritic cells and natural killer cells. Dendritic cells and natural killer cells have been 
identified in the zebrafish, but are unlikely to be present in the embryo before 5 days 
post-fertilisation (dpf), before larval transparency is reduced (Lugo-Villarino et al., 2010; 
Yoder et al., 2010). Subsequently, the major immune effector cells of the developing 
larva are the macrophages and neutrophils, which are capable of phagocytosing and 
degrading a range of human pathogens. Macrophages are present in embryos from 25 
hours post fertilisation (hpf), and primarily phagocytose pathogens in the fluid-phase 
such as the circulation (Colucci-Guyon et al., 2011; Herbomel et al., 1999). Neutrophils 
are observed shortly afterwards from 33hpf, and become the dominant phagocyte in 
the larva by 48hpf (Ellett et al., 2011). Contrasting with macrophages, zebrafish 
neutrophils predominantly phagocytose surface-associated microbes, for example in 
the somite tail muscle or otic vesicle (Colucci-Guyon et al., 2011). Macrophages and 
neutrophils can be imaged during infection in vivo with a variety of transgenic lines, 
illustrating the potential of the zebrafish in studying the roles of phagocytes (Ellett et al., 
2011; Gray et al., 2011; Hall et al., 2007; Renshaw et al., 2006a). 
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The adaptive immune system can also be studied using the zebrafish model. As 
mentioned, zebrafish have an adaptive immune system by roughly 3 weeks post 
fertilisation; at this point zebrafish are able to mount a humoral immune response, and 
utilise two conserved immunoglobulin classes (IgM and IgD) and two novel classes (IgT 
and IgZ) (Hu et al., 2010; Zhang et al., 2010). The humoral response in zebrafish is 
mediated by B-cells, which are observable using the transgenic IgM1:eGFP line by 20dpf 
(Page et al., 2013). Zebrafish also possess T-cells, with T-lymphocyte progenitors being 
observable in the thymus with the transgenic p56lck:eGFP line from 68hpf (Langenau et 
al., 2004). Furthermore, while it is unclear whether zebrafish possess all T-cell subsets 
found in humans, they do have T-helper CD4+ cells, cytotoxic CD8+ T-cells and 
unconventional γδ T-cells (Wan et al., 2016). While zebrafish can be used to study the 
adaptive immune system, imaging studies are hampered by the loss of transparency that 
occurs when zebrafish melanise by 6-8dpf (van der Sar et al., 2004). To this end, non-
melanising zebrafish lines have been generated, namely the nacre (Lister et al., 1999) 
and casper lines (White et al., 2008a). 
Zebrafish also possess a number of orthologous pattern recognition receptors (PRRs) 
that permit cells to recognise invading pathogens and danger signals and mount an 
appropriate immune response; among these are the Toll-like receptors (TLRs) (Jault et 
al., 2004), RIG-I-like receptors (RLRs) (Zou et al., 2015) and NOD-like receptors (NLRs) 
(Oehlers et al., 2011). Orthologous genes for all human TLRs are found in fish (except 
TLR6, which is TLR1); they also possess several novel TLRs, as well as some duplicated 
versions of existing TLRs (Kawai and Akira, 2010). In addition to TLRs 1-10 which are 
found in humans, zebrafish possess TLR18, TLR19, TLR20a, TLR20f, TLR21 and TLR22, 
most of which are believed to be ohnologues, non-functional pseudogenes that arose 
from a genomic duplication event that occurred during evolution (Meijer et al., 2004; 
Van de Peer et al., 2003; Taylor et al., 2001); this is also believed to be the reason that 
zebrafish have two copies of TLR4, TLR5 and TLR8 (Meijer et al., 2004). Despite the 
differences between human and zebrafish TLRs, zebrafish remain able to respond to a 
complete repertoire of PAMPs from viruses and bacteria (Meijer et al., 2004; Phelan et 
al., 2005). 
Zebrafish neutrophils possess their own orthologue of myeloperoxidase (Mpx), which 
they use to aid resolution of inflammation and infection (Pase et al., 2012). The mpx 
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gene is expressed from 19hpf, and is detectable with peroxidase-sensitive staining by 
33hpf (Lieschke et al., 2001). The catalytic domain of Mpx has 51% and 52% amino acid 
identity with human and murine MPO respectively, suggesting that Mpx functionally 
represents human MPO as well as the mouse model (Lieschke et al., 2001). While the 
importance of Mpx in orchestrating the innate immune response is unclear, the 
zebrafish may offer several advantages over the murine model, as mice possess 10-fold 
less MPO than human neutrophils, and lack several transcription factor binding domains 
present in human MPO (Nauseef, 2001; Rausch and Moore, 1975). Mice are also highly 
resistant to S. aureus in terms of dose (bacteraemia: ~4x107cfu), while zebrafish 
succumb to infections at doses several-fold lower (1,500cfu) (Connolly et al., 2017). 
Orthologous genes of many major components of the complement system have been 
identified in zebrafish, which is expected, as complement is observed in virtually all 
vertebrates (Sunyer et al., 1997). However, several important components have not 
been genetically identified, including complement receptor 1 (CR1), complement 
receptor 2 (CR2), and crucially, C3b and iC3b (Zhang and Cui, 2014). Additionally, the 
functionality of a number of key components is almost entirely unexplored. Despite this, 
several complement-dependent functions during infection have been identified in the 
zebrafish. The lectin pathway is active in zebrafish embryos, and potentiates the 
phagocytic response to Escherichia coli and S. aureus infection (Yang et al., 2014). Also, 
zebrafish C3 is essential for bacteriolytic activity against E. coli, which is active from 
fertilisation and mediated by the membrane attack complex (MAC) utilising components 
C5b-C9 (Wang et al., 2009). While these processes are functional in the embryo, the 
extent to which the zebrafish relies on complement for opsonophagocytosis (C3b 
deposition) or chemotaxis (C3a and C5a) is unknown. Furthermore, the importance of 
chemotactic complement receptors utilised by professional phagocytes and immune 
cells is unclear; although encouragingly, the C5a receptor (C5aR1) appears to play a role 
in cardiac regeneration, suggesting that complement also plays a role in regenerative 
responses in the zebrafish; this is also observed in humans (Mastellos et al., 2013; 
Natarajan et al., 2018). 
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1.3.4 The Zebrafish as an Infection Model 
 
Two common limitations of existing infection models include a lack of amenability to in 
vivo imaging and high-throughput data collection; the zebrafish larva corrects these 
issues with near-transparency and a high fecundity that permits infection of large 
numbers of fish in a single experiment. The zebrafish has been used to study a wide 
array of infections including fungal (Bojarczuk et al., 2016), viral (Passoni et al., 2017) 
and parasitic pathogens (Akle et al., 2017). These studies focus on interactions between 
pathogens and the host, and can be manipulated with a wide variety of tools. For 
example, host immune cells such as neutrophils or macrophages can be labelled by 
transgenic expression of fluorescent proteins downstream of cell-specific promoters 
(Brannon et al., 2009; Elks et al., 2013; Renshaw et al., 2006a), and combined with 
fluorescently-labelled pathogens that constitutively express or are stained with 
fluorescent markers (Harvie et al., 2013; van der Sar et al., 2003). These techniques allow 
host-pathogen interactions to be visualised with ease and at high resolution. 
Zebrafish are a valuable model for the study of bacterial infection, offering insights into 
how both gram-positive (Elks et al., 2013; Harvie et al., 2013; Torraca et al., 2017) and 
gram-negative (Brannon et al., 2009; Mazon-Moya et al., 2017; van der Sar et al., 2003) 
bacteria interact with the host to cause infection. Zebrafish embryos can be injected at 
a number of sites depending on the pathogen, and includes systemic infections via the 
caudal vein (Elks et al., 2013), trunk (Torraca et al., 2017) or circulation valley (Prajsnar 
et al., 2008, 2012), and acute infections in compartmentalised tissues such as the otic 
vesicle (Colucci-Guyon et al., 2011; Deng et al., 2012), somite tail muscle (Colucci-Guyon 
et al., 2011), and hindbrain ventricle (Mazon-Moya et al., 2017; Willis et al., 2016). These 
studies utilise the zebrafish model to its full potential, and dissect host-pathogen 
interactions by genetic manipulation of host and pathogen (Harvie et al., 2013; Prajsnar 
et al., 2008; van der Sar et al., 2003), measuring changes in inflammatory cytokine 
expression using in vivo reporter lines (Mazon-Moya et al., 2017), and dissecting 
virulence determinants using survival models (Brannon et al., 2009; Harvie et al., 2013; 
Prajsnar et al., 2008). 
A number of novel host-pathogen interactions have been elucidated in the zebrafish 
larva, incorporating a variety of bacterial infection models. An important link between 
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metabolism and the immune system during Salmonella enterica serovar Typhimurium 
infection was uncovered when the Immunoresponsive gene 1 (irg1) was demonstrated 
to affect production of mitochondrial ROS by regulating fatty acid metabolism, which in 
turn fuels oxidative phosphorylation (Hall et al., 2013). A key function of the 
inflammasome in regulating bacterial clearance was also shown using a Salmonella 
infection model (Tyrkalska et al., 2016), and is also implicated in the immune response 
to an engineered strain of Listeria monocytogenes that expresses monomeric flagellin 
from Legionella pneumophila (Sauer et al., 2011). Interestingly, a novel therapeutic 
approach to antibiotic-resistant infections has been demonstrated in vivo using the 
predatory bacterium Bdellovibrio bacteriovorus, which invades and consumes gram-
negative bacteria (Willis et al., 2016). In a hindbrain ventricle model of acute multidrug-
resistant Shigella flexneri infection, it was observed that B. bacteriovorus acts in concert 
with phagocytic cells to clear an otherwise untreatable bacterial infection. This 
highlights the therapeutic potential of B. bacteriovorus, effectively acting as a ‘living 
antibiotic’. 
It is important to note that the zebrafish model has some limitations with regards to 
studying infection. Due to ethical considerations, infection studies generally do not 
exceed 5dpf, as after this point zebrafish larvae have developed higher 
neurophysiological sensitivity. At this point, zebrafish larvae have a functional innate 
immune system, although adaptive immunity is not present until roughly 3 weeks post 
fertilisation (Herbomel et al., 1999; Wang et al., 2009). Consequently, studies using the 
zebrafish larva focus on the innate immune system in isolation from the adaptive 
system. Another limitation is that zebrafish are kept at 28°C, whereas human pathogens 
grow optimally at 37°C. This may result in differences in gene expression in the pathogen 
and should be carefully considered when using this model. 
As discussed, bacterial pathogens can display high levels of host-specificity, 
necessitating the use of human cells and humanised models to fully represent human 
infection. Currently, there are no studies in which expression of human proteins is 
induced in the zebrafish model, beyond transient expression of human RUNX1 – a 
transcriptional regulator of haematopoiesis – in one study (Kalev-Zylinska et al., 2002). 
Accordingly, studies involving the expression of human proteins in the zebrafish in order 
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to determine the impact on infection and the immune system would be entirely novel 
in this regard. 
 
1.3.5 The Zebrafish as a Model of S. aureus Infection 
 
Over the last decade, the zebrafish has served as an insightful model of staphylococcal 
interactions with the host during infection. The embryo can be infected as early as 
30hpf, at which point it is able to mount an innate immune response governed by 
phagocytes including macrophages and neutrophils (Prajsnar et al., 2008). The most 
commonly used injection route is to induce systemic infection by injecting the embryo 
in the circulation valley (a major blood vessel located near the heart), resulting in 
reproducible survival data at a mid-range dose of S. aureus (1,200-1,700 colony forming 
units - cfu). Other injection sites have been tested, but proved to be either too toxic at 
mid-range doses (yolk sac) (Li and Hu, 2012; Prajsnar et al., 2008) or required doses as 
high as 6,500cfu to induce significant mortality (eye, pericardial cavity) (Li and Hu, 2012). 
However, other sites remain useful for studying infection at distinct locations, for 
example, infection in the somite tail muscle produces a localised, neutrophil-driven 
immune response that is amenable to imaging the phagocyte response to infection 
(Ellett et al., 2015). 
Control and clearance of systemic staphylococcal infection in zebrafish embryos was 
demonstrated to be dependent on the presence of phagocytes (Prajsnar et al., 2008). 
Embryos injected with the pu.1 morpholino have a depleted phagocyte population and 
exhibit reduced survival against infection. Additionally, the embryo recapitulated 
attenuated virulence phenotypes observed in other studies, underlining its usefulness 
as a model to screen for novel virulence determinants. Moreover, embryos with 
overwhelming bacteraemia that later succumb to infection were shown to have a 
reduced number of neutrophils compared with embryos that survived. This mirrors the 
finding that leukopenia is highly correlated with mortality in individuals with 
community-acquired pneumonia and bacteraemia (Fine et al., 1996), suggesting that the 
embryo accurately models clinical staphylococcal infection. 
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S. aureus is primarily considered an extracellular pathogen that does not need to reside 
within host cells to establish and maintain infection. However, there is a considerable 
amount of evidence that S. aureus invades and persists within numerous cell types 
including endothelial cells, epithelial cells, fibroblasts, osteoblasts, keratinocytes, 
macrophages and neutrophils (Alexander and Hudson, 2001; Garzoni and Kelley, 2009). 
Persistence within host cells offers two main advantages to the bacteria; intracellular 
bacteria are less exposed to antimicrobial compounds such as antibiotics, allowing them 
to survive, and, residing in host cells provides a means of dissemination to other sites, 
promoting the spread of infection. Evaluation of the activity of β-lactam and 
glycopeptide antibiotics against extracellular S. aureus and S. aureus residing within 
THP-1 macrophages shows a reduced capacity to kill intracellular bacteria, highlighting 
the benefit of residing intracellularly during infection (Barcia-Macay et al., 2006; Lemaire 
et al., 2009). 
As mentioned, invasion of host cells permits S. aureus to disseminate throughout the 
host, primarily via motile cells such as macrophages and neutrophils. These phagocytic 
cells are critical to the immune defense against S. aureus, and are required for 
containment and clearance of infection by the host (Foster, 2005; Spaan et al., 2013a). 
However, they may also act as intracellular niches in which S. aureus can persist and 
disseminate. In vitro, staphylococci are known to replicate within leukocytes, persisting 
for several days without affecting the viability of the infected cells, and even upregulate 
anti-apoptotic pathways to prolong the lifespan of the inhabited cell (Koziel et al., 2009; 
Kubica et al., 2008; Melly et al., 1960). In vivo studies have also demonstrated the 
proficiency of S. aureus as an intracellular pathogen. In a mouse model of chronic 
mastitis, neutrophils, macrophages and mammary epithelial cells were observed to 
contain live S. aureus that perpetuated the chronic infection state (Craven and 
Anderson, 1979). Furthermore, using a murine model of infectious peritonitis, 
fluorescent microscopy revealed a high proportion of neutrophils containing S. aureus, 
suggesting that invasion into phagocytes is a major step during infection in this model 
(McLoughlin et al., 2006). 
Once S. aureus arrives in the bloodstream, metastatic infection occurs before treatment 
in 30% of patients, which if left unchecked can lead to bacteraemia (Fowler et al., 2003; 
Thwaites and Gant, 2011). The ability of S. aureus to metastasise is directly associated 
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with neutrophil levels, and the expression of virulence factors that facilitate phagosomal 
survival. Patients with neutropenia show reduced metastasis, and are less likely to 
develop bacteraemia (Velasco et al., 2006). Mutant strains of global virulence regulators 
agr and SarA are defective in several virulence factors that facilitate phagosomal survival 
or escape, including α-haemolysin (Hla), Staphylokinase (SAK), staphopain A (ScpA) and 
aureolysin (Pragman and Schlievert, 2004; Shompole et al., 2003), and accordingly 
exhibit an impaired ability to disseminate and cause bacteraemia in a neonatal mouse 
model of pneumonia (Heyer et al., 2002). Furthermore, strains lacking the 
staphylococcal peroxidase inhibitor (SPIN), which mitigates ROS production by inhibiting 
neutrophil myeloperoxidase (MPO), are less able to survive within neutrophils (de Jong 
et al., 2017). These findings suggest that the ability to reside within host cells, 
particularly macrophages and neutrophils, is an important aspect of staphylococcal 
infection. 
The intracellular lifestyle of S. aureus is also well-represented by the zebrafish embryo. 
By coinfecting embryos with two fluorescent, but otherwise isogenic strains, it was 
observed that late stages of infection are typically dominated by a single strain, 
suggesting the existence of a population bottleneck that skews infection towards one 
strain (Prajsnar et al., 2012). After depleting phagocytes using the pu.1 morpholino, this 
population bottleneck was no longer observed, suggesting that phagocytic cells 
represent an intracellular niche for S. aureus that results in a clonal population of 
bacteria at late stages of infection. Outwith the zebrafish model, this bottleneck 
phenomenon was also observed in a murine model of systemic staphylococcal infection 
in two separate studies, suggesting that the zebrafish accurately reflects the murine 
model of systemic infection (McVicker et al., 2014; Prajsnar et al., 2012). 
The systemic infection model has also been used to determine whether well-known S. 
aureus mutant strains are attenuated, and has revealed novel determinants of 
staphylococcal infection. Three existing mutants which are attenuated in the murine 
model include PheP (a phenylalanine transport gene), PerR (a peroxide regulon 
repressor) and SaeR (a regulator of accessory virulence factors), all of which are 
significantly attenuated when compared with a wild-type strain in the zebrafish infection 
model (Prajsnar et al., 2008). Virulence factors required for growth in human blood were 
also investigated using the zebrafish model. These three genes include two genes 
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involved in purine biosynthesis (purA, purB) and pabA, which is important for folate 
biosynthesis. Mutant strains of these genes are all attenuated in the zebrafish model, 
revealing that nucleotide metabolism is an important aspect of staphylococcal infection 
(Connolly et al., 2017). 
Overall, the zebrafish embryo is a useful model of staphylococcal infection. As early as 
30hpf, embryos possess macrophages and neutrophils that are rapidly recruited to the 
site of infection, and effectively phagocytose and destroy S. aureus by acidifying and/or 
producing ROS (Ellett et al., 2015; Prajsnar et al., 2008). These phagocytes are essential 
to controlling and clearing infection in zebrafish embryos, emphasising their importance 
during staphylococcal infection (McVicker et al., 2014; Prajsnar et al., 2008, 2012). 
Importantly, these embryos also possess a complement system (i.e. the lectin pathway) 
which is important during the early response to S. aureus in the zebrafish, and enhances 
opsonophagocytosis in the zebrafish larva (Yang et al., 2014). The doses required for 
infection in the embryo are more representative of human infection when compared 
with the mouse model, and is illustrated by a study in which a dose of 1,500cfu of S. 
aureus was sufficient for systemic infection in the embryo, while a dose of 4x107cfu was 
required to cause an equivalent infection in mice (Connolly et al., 2017). Aspects of 
clinical bacteraemia observed in human patients are also mirrored in the zebrafish, 
specifically leukopenia during late stages of infection, suggesting that the systemic 
infection model reflects the physiology of patients with fatal bacteraemia (Fine et al., 
1996; Prajsnar et al., 2008). Lastly, the embryo is useful for studying the intracellular life 
cycle of S. aureus, which has proven difficult to study, and has value towards 
characterising novel virulence determinants that are important for establishing and 
maintaining staphylococcal infection. 
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1.4 Thesis Aims 
 
The aims of this thesis are: 
• To create transgenic zebrafish lines expressing human proteins in zebrafish 
neutrophils that are targeted by S. aureus during infection. 
• To assess how expression of these proteins affects neutrophil development and 
function. 
• To determine whether expression of these proteins results in enhanced targeting 
by specific virulence factors, and whether this results in an enhanced 
susceptibility to staphylococcal infection. 
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Chapter 2: Materials and Methods 
 
2.1 General Materials 
 
2.1.1 Zebrafish Lines 
 
Zebrafish Line Description Origin 
AB Wild-type N/A 
London-Wild Type (LWT) Wild-type (survival assays) N/A 
Nacre Non-pigmented mutant of AB (Lister et al., 1999) 
Tg(lyz:MPO.mEmerald)sh496 Drives myeloid expression of 
human myeloperoxidase with a 
C-terminal fusion of the 
fluorescent protein mEmerald 
This study 
Tg(lyz:hC5aR.Clover)sh505 Drives myeloid expression of 
the human C5a receptor with a 
C-terminal fusion of the 
fluorescent protein clover 
This study 
Tg(lyz:nfsB.mCherry)sh260 Drives myeloid expression of 
mCherry in the cell cytoplasm 
Renshaw lab 
mpx -/- NL144 AB/TL (Tupfel Long-Fin) wild-
type with a premature stop 
codon in the first exon of the 
mpx gene; does not fully 
translate myeloperoxidase 
(Elks et al., 2014) 
 
Table 2.1 Zebrafish lines used in this study 
 
2.1.2 Bacterial Strains 
 
All bacterial strains used in this study are shown below in Table 2.2. S. aureus strains 
were inoculated from -80°C MicrobankTM (Pro-lab Diagnostics) stocks onto BHI agar 
plates containing the appropriate selection where necessary. For short term storage 
plate cultures were kept at 4°C; for long term storage eight colonies were picked, 
inoculated into MicrobankTM stocks and kept at -80°C. E. coli stocks containing DNA 
constructs were inoculated from -80°C stocks containing 50% liquid culture and 50% 
glycerol (Calbiochem), then maintained on BHI agar with appropriate selection. For short 
70 
 
term storage plate cultures were kept at 4°C; cryotubes containing 500l overnight 
liquid culture and 500l glycerol were used for long term storage at -80°C. 
Strain Genotype Reference 
Staphylococcus aureus 
USA300 CA-MRSA typical strain 
USA300 wild-type 
(Tenover and Goering, 
2009) 
USA300 SPIN USA300 SPIN (transposon 
knockout) 
A kind gift from Nienke 
de Jong, Utrecht 
Medical Center 
USA300 CHIPS USA300CHIPS 
(transposon knockout) 
A kind gift from Michiel 
van Gent, Utrecht 
Medical Center 
CHIPS HlgC USA300HlgC (transposon 
knockout) 
A kind gift from Michiel 
van Gent, Utrecht 
Medical Center 
pSPIN-GFP USA300 USA300 with GFP fused to 
the SPIN promoter on the 
νSaα pathogenicity island. 
CmR 
(de Jong et al., 2017) 
USA300-GFP USA300 containing GFP 
plasmid. Constitutively 
expressed. CmR 
A kind gift from Nienke 
de Jong, Utrecht 
Medical Center 
Escherichia coli 
OneshotTM Top10 
chemically competent 
(DH10B) 
F- mcrA Δ( mrr-hsdRMS-
mcrBC) Φ80lacZΔM15 Δ 
lacX74 recA1 araD139 Δ( 
araleu)7697 galU galK rpsL 
(StrR) endA1 nupG 
ThermoFisher Scientific 
 
Table 2.2 Bacterial strains used in this study.  
CmR, chloramphenicol resistant. 
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2.1.3 Antibiotics 
 
All antibiotics used in this study are listed in Table 2.3 below. Stock solutions were 
dissolved in the appropriate solvent, filter-sterilised (0.22m pore size) and stored at -
20°C. Solution concentrations were added to agar plates once they had cooled to below 
55°C to avoid antibiotic degradation; for liquid cultures, antibiotics were added just 
before use. 
Antibiotic Stock 
Concentration 
Dissolved in: Solution 
Concentration 
Carbenicillin (Carb) 50mg/ml dH2O 50g/ml 
Kanamycin (Kan) 50mg/ml dH2O 50g/ml 
Tetracycline (Tet) 5mg/ml 100% Ethanol 5g/ml 
Chloramphenicol (Cm) 10mg/ml dH2O 10µg/ml 
 
Table 2.3 Antibiotics used in this study.  
Carbenicillin was used as an alternative to Ampicillin due to its improved stability. 
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2.1.4 Primers 
 
Primer 
Name 
Sequence (5’-3’) Description 
hC5aR 
MEC F 
ggg gac aag ttt gta caa aaa agc agg ctC 
CAT GAA CTC CTT CAA TTA TAC CAC 
Forward primer used to amplify 
the hC5aR gene, contains an 
attB1 site. 
hC5aR 
Correct 
MEC R 
NOSTOP 
ggg gac cac ttt gta caa gaa agc tgg gtG 
CAC TGC CTG GGT CTT CTG G 
Reverse primer used to amplify 
the hC5aR gene with no stop 
codon, contains an attB2 site. 
hC5aR 
Correct 
MEC R 
STOP 
ggg gac cac ttt gta caa gaa agc tgg gtG 
CTA CAC TGC CTG GGT CTT CTG G 
Reverse primer used to amplify 
the hC5aR gene with a stop 
codon, contains an attB2 site. 
hC5aR 
MEC 1/2 
TCA GCA AAC ACT GGA GCA AC Forward primer annealing ~50bp 
upstream of the attB1 site of 
pDestTol2CG2 lyz:hC5aR.Clover. 
Used to sequence the final 
construct. 
hC5aR 
MEC 2/2 
CTC AAC ATG TAC GCC AGC AT Forward primer annealing 
midway through the hC5aR gene 
in pDestTol2CG2 
lyz:hC5aR.Clover. Used to 
sequence the final construct. 
MPO-N 
Linker 
GAC AAC ACA GGC ATC ACC AC Forward primer annealing at the 
linker between MPO and 
mEmerald in pDestTol2CG2 
lyz:MPO.mEmerald. Used to 
sequence the final construct. 
MPO-C 
Linker 
AGC ACC CAG TCC AAG CTG Forward primer annealing at the 
linker between mEmerald and 
MPO in pDestTol2CG2 
lyz:mEmerald.MPO. Used to 
sequence the final construct. 
MPO 
attB1 For 
TCA GCA AAC ACT GGA GCA AC Forward primer annealing at the 
attB1 site at the beginning of 
both MPO.mEmerald and 
mEmerald.MPO consructs. Used 
to sequence final constructs. 
mpx 
Spotless 
For 1 
CTA GCA AAG GAA CTG CGG GA Forward primer used to amplify 
the mpx gene during genotyping. 
mpx 
Spotless 
Rev 1 
AAT CAC GTG CTC CTC TCG AT Reverse primer used to amplify 
the mpx gene during genotyping. 
*Lower case denotes att sites; upper case denotes complementary regions. 
Table 2.4 Primers used in this study 
73 
 
2.1.5 Plasmids 
 
Plasmid Description Reference 
mEmerald-MPO-C-18  Contains mEmerald with a C’ terminal fusion of 
human MPO. KanR  
Addgene Plasmid #54186 
(Dr. Michael Davidson’s Lab) 
mEmerald-MPO-N-18 Contains mEmerald with an N’ terminal fusion of 
human MPO. KanR  
Addgene Plasmid #54187 
(Dr. Michael Davidson’s Lab) 
pME MCS Empty middle entry vector with a multiple cloning 
site, contains attP1 and attP2 sites. KanR 
N/A 
pDestTol2CG2 LR construct backbone vector, contains cmlc2:GFP 
green heart marker. AmpR 
(Kwan et al., 2007),(Huang 
et al., 2003) 
pIRES-hC5aR (No 
FLAG) 
Plasmid containing IRES site and hC5aR gene. 
AmpR 
A kind gift from Michiel van 
Gent – Utrecht Medical 
Center 
lyz 5’EC 5’ entry vector containing neutrophil specific 
promoter lyz, contains attL4 and attR1 sites. KanR 
(Hall et al., 2007) 
PolyA 3’EC 3’ entry vector containing polyadenylation tail, 
contains attR2 and attL3 sites. KanR 
(Kwan et al., 2007) 
pDONR221 middle donor vector; attP1-P2 flanking insert 
chlor/ccdB cassette. KanR 
N/A 
pDestTol2CG2 pDestTol2CG2 with ~2 kb extraneous sequence 
removed. Contains cmlc2:GFP, green heart 
marker. AmpR 
N/A 
pDestTol2CG2 
lyz:hC5aR.Clover 
Full-length plasmid containing the neutrophil-
specific promoter lyz driving expression of a C-
terminally labelled hC5aR. Contains cmlc2-GFP, 
green heart marker. AmpR 
This study 
pDestTol2CG2 
lyz:MPO.mEmerald 
Full-length plasmid containing the neutrophil-
specific promoter lyz driving expression of MPO 
with a C-terminal fusion of mEmerald. Contains a 
cmlc2:GFP green heart marker. AmpR 
This study 
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pDestTol2CG2 
lyz:mEmerald.MPO 
Full-length plasmid containing the neutrophil-
specific promoter lyz driving expression mEmerald 
with a C-terminal fusion of MPO. Contains a 
cmlc2:GFP green heart marker. AmpR 
This study 
 
Table 2.5 Plasmids used in this study 
AmpR, Ampicillin resistance gene; KanR, Kanamycin resistance gene. Carbenicillin was 
used as an alternative to Ampicillin due to its improved stability. 
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2.1.6 Proteins 
 
Protein Concentration  Resuspended in Reference 
Panton-Valentine 
Leukocidin S-subunit 
(LukS-PV)  
300µg/ml Toxin buffer (2.3.3) A kind gift from Angelino 
Tromp – Utrecht Medical 
Center 
Panton-Valentine 
Leukocidin F-subunit 
(LukF-PV) 
1,089µg/ml Toxin buffer (2.3.3) A kind gift from Angelino 
Tromp – Utrecht Medical 
Center 
γ-Haemolysin C-
subunit (HlgC) 
299µg/ml Toxin buffer (2.3.3) A kind gift from Angelino 
Tromp – Utrecht Medical 
Center 
γ-Haemolysin B-
subunit (HlgB) 
1,430µg/ml Toxin buffer (2.3.3) A kind gift from Angelino 
Tromp – Utrecht Medical 
Center 
Human C5a (hC5a) 112µg/ml PBS (2.3.1) A kind gift from Michiel 
van Gent – Utrecht 
Medical Center 
Zebrafish C5a (drC5a) 1,000µg/ml PBS (2.3.1) A kind gift from Michiel 
van Gent – Utrecht 
Medical Center 
 
Table 2.6 Protein stocks and concentrations used in this study. 
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2.2 Bacterial Media 
 
All bacterial media was prepared using distilled water (dH2O) and sterilised by 
autoclaving for 20 minutes at 121°C and 15 psi. 
 
2.2.1 Brain Heart Infusion (BHI) Broth 
 
Brain Heart Infusion (Oxoid) 37g/l 
Oxoid Agar Bacteriological (Agar No. 1 (1.5% weight per volume w/v)) was added for BHI 
agar. 
 
2.2.2 Luria-Bertani (LB) Broth 
 
LB broth (Lennox) microbial growth medium tablets (Sigma) were used, adding every 
1.1g tablet to 48.3millilitres (ml) dH2O. 
Tryptone 10g/l 
Yeast Extract 5g/l 
NaCl 5g/l 
Inert Binding Agents 2.2g/l 
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2.2.3 Luria-Bertani (LB) Broth with Agar 
 
LB broth with agar (Lennox) microbial growth medium tablets (Sigma) were used, adding 
every 1.68g tablet to 48.3mls dH2O. 
 
Agar 13.72g/l 
Tryptone 9.14g/l 
Yeast Extract 4.57g/l 
NaCl 4.57g/l 
Inert Binding Agents 1.6g/l 
 
 
2.3 Buffers and Solutions 
 
All buffers and solutions were made using distilled H2O (dH2O) and autoclaved where 
necessary. All were then kept at room temperature. 
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2.3.1 Phosphate Buffered Saline (PBS) 
 
NaCl 8g/l 
Na2HPO4 1.4g/l 
KCl 0.2g/l 
KH2PO4 0.2g/l 
 
Solutions were then pH adjusted using 1M HCl or 3 M NaOAc (Affymetrix) to a normal 
working pH of 7.4. 
 
2.3.2 TAE (50x) 
 
Tris base 242g/l 
Glacial acetic acid 0.57% (v/v) 
EDTA 0.05 M 
Before use the 50x stock was diluted 1 in 50 to create a normal working 1x solution of 
TAE. 
 
2.3.3 Toxin Buffer 
 
Panton-Valentine Leukocidin (PVL) is resuspended in toxin buffer: 
Tris base (50mM) 6.057g/l 
NaCl (300mM) 17.53g/l 
Add dH2O to 1L and adjust to pH 7, then autoclave. As an added measure, filter-sterilise 
into 50ml FalconTM tubes prior to use. 
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2.4 Zebrafish Reagents 
 
2.4.1 E3 Medium (x10) 
 
E3 medium was used to maintain developing zebrafish embryos. 
NaCl 50 mM 
KCl 1.7 mM 
CaCl2 3.3 mM 
MgSO4 3.3 mM 
10x stock was diluted to 1x using dH2O. To prevent fungal contamination E3 can be 
supplemented with 3 drops of methylene blue per litre; this was not done in this study, 
to maintain embryo transparency. 
 
2.4.2 Methylcellulose 
 
Methylcellulose was prepared in non-methylene blue supplemented E3 at a 
concentration of 3% (w/v). To facilitate solubilisation the mixture was partially frozen, 
mixed and defrosted several times. This solution was then aliquoted into 10ml syringes 
and kept frozen for long-term storage. For use in survival assays and short-term storage 
the aliquots were kept at 28.5°C. 
 
2.4.3 Zebrafish Anaesthesia 
 
Stock solution of 0.4% (w/v) 3-amino benzoic acid ester (also known as Tricaine or 
MS322, Sigma) was made using 20mM Tris-HCl, adjusted to pH 7 and stored at -20°C. 
For short-term storage, Tricaine was kept at 4°C in the dark due to photosensitivity. 
Zebrafish embryos were anaesthetised in a final concentration of 0.02% (w/v) Tricaine 
prior to experiments. 
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2.5 Cloning, DNA and Transgenesis methods 
 
2.5.1 Visualisation of DNA 
 
Visualisation of plasmids and constructs was carried out by agarose gel electrophoresis 
using 1% agarose dissolved in 1x TAE buffer and then microwaved at full power until 
clear. One drop of Ethidium Bromide (Dutscher Scientific) was added to the gel for every 
50ml of agarose. DNA was loaded using 5x loading buffer (Bioline) and run at 100V for 
45 minutes on average, alongside 5l HyperLadderTM 1kb plus (Bioline). 
 
2.5.2 Gel Extraction and Purification 
 
DNA bands to be recovered from agarose gels for cloning purposes were first visualised 
under a low-level UV lamp to prevent DNA damage. Bands of DNA were then excised 
from the gel using a scalpel blade and the remaining gel visualised using a 
transilluminator. Gel extractions were carried out using a MinElute® Gel Extraction kit 
according to manufacturers instructions. DNA was eluted in a final volume of 10l buffer 
EB. 
 
2.5.3 DNA Quantification 
 
DNA concentration was initially quantified using a NanodropTM spectrophotometer. For 
more accurate estimates of DNA concentration, samples were visualised by agarose gel 
electrophoresis alongside 12l, 6l, 3l and 1.5l of HyperLadderTM 1kb plus (Bioline). 
The concentrations were then calculated using a marker ladder reference. 
 
2.5.4 Small-Scale Purification of Plasmid DNA 
 
For the initial screening of transformed colonies, DNA was precipitated using the 
following method: 
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Buffers P1, P2 and P3 were provided in the QIAGEN® QIAprepTM Spin column kit. 
• Inoculate 6mls of LB (including relevant selection if necessary) with a single 
colony and incubate at 37°C overnight with shaking at 200rpm 
• Pellet a total of 3ml of cells by spinning at 8000g for 3 minutes each 
• Resuspend in 250l cold P1 Buffer 
• Add 250l P2 Buffer, incubate for 2 minutes 
• Add 250l cold P3 Buffer 
• Centrifuge at max speed for 10 minutes 
• Discard pellet and add 750l Isopropanol to supernatant 
• Centrifuge at max speed for 10 minutes at 4°C 
• Remove supernatant and add 500l 70% Ethanol 
• Centrifuge at max speed for 10 minutes 
• Remove supernatant 
• Air dry in heat block at 37°C for roughly 10 minutes 
• Resuspend in 30l dH2O (MilliQ) 
 
2.5.5 Large-Scale Purification of Plasmid DNA 
 
For sequencing and for creating stocks of plasmid DNA the QIAGEN® Plasmid Midi Kit 
was used according to manufacturer’s instructions. 
 
2.5.6 Bacterial Transformations 
 
DNA products were transformed into E. coli competent cells DH10B C3019 (New England 
Biolabs) for middle entry clone construction and One Shot Top10® (Life Technologies) 
for fully assembled expression clones using the following method: 
• Defrost cells kept at -80°C on ice 
• Add DNA to cells at no more than 1:10 volume (DNA:cells) 
• Mix by flicking 
• Incubate on ice for 30 minutes 
• Pre-warm agar plates while incubating by placing in 37°C incubator  
• Heat shock in water at 42°C for 45 seconds 
• Leave on ice for 10 minutes 
• Take plates out of incubator 
• Add 250l room temperature SOC medium 
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2.5.7 Restriction Digests 
 
Each digest required different conditions, however each reaction was incubated for 3 
hours at 37°C, and was made up in the following proportions: 
Relevant Digestion Buffer 2μl 
Restriction Enzyme (each) 0.5μl 
DNA 1μg (5μl for screening 
transformants) 
MilliQ H2O To 20μl 
Digest buffers used for the following enzyme digests are shown in Table 2.7 below: 
  
Plasmid Buffer (New England 
Biolabs) 
mEmerald-MPO-N-18 (NheI-NotI) 2.1 
mEmerald-MPO-C-18 (NheI-SacII) 2.1 
pME MCS MPO-N-18 (XbaI-NotI) 3.1 
pME MCS MPO-C-18 (XbaI-SacII) CutSmart® 
pDONR221 hC5aR.Clover (HincII) CutSmart® 
hC5aR complete construct diagnostic (SacII) CutSmart® 
MPO complete construct diagnostic (XbaI) CutSmart® 
MPO complete construct diagnostic (SnaBI-NheI) CutSmart® 
Genotyping the mpx-/- NL144 allele (BtsCI) CutSmart® 
 
Table 2.7 Buffers used for restriction digests in this study 
 
• Incubate horizontally at 37°C with shaking for 1 hour 
• Plate onto selection 
• Incubate overnight at 37°C 
83 
 
2.5.8 Ligations 
 
Ligations of cut MPO plasmids into pME MCS were carried out using the following 
reaction (µl = microlitre): 
10x Ligase Buffer 2l 
T4 DNA Ligase 1l 
Molar Ratio of Insert:Vector 3:1 
dH2O To 20l 
Reactions were then incubated overnight at 16°C. 
 
2.5.9 PCR Amplification of the hC5aR Gene from pIRES hC5aR 
 
Each 20µl reaction contained: 
Reagent Quantity (µl) 
5x Q5 buffer 5 
dNTPs 0.5 
Forward primer 1.25 
Reverse primer 1.25 
Plasmid DNA 1 
Q5 polymerase 0.25 
GC enhancer 5 
dH2O 10.75 
 
After reactions were made up, they were mixed by flicking and centrifuged for ~5 
seconds to ensure thorough mixing. They were then cycled as follows: 
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1. 98°C, 30 seconds 
2. 98°C, 10 seconds 
3. 55°C, 30 seconds 
4. 72°C, 60 seconds 
5. Go to step 2, x30 cycles 
6. 72°C, 120 seconds 
7. 12°C, ∞ seconds 
To verify and quantify, PCR products were then visualised by running 1µl on a 1% 
agarose gel until resolved.  
 
2.5.10 BP Reactions 
 
Creation of entry clones for use in MultiSite Gateway® recombination reactions were 
produced via BP reaction. This involved recombining PCR products containing the 
relevant recombination sites (5’: attB4/attB1r, Middle: attB1/attB2, 3’: attB2r/attB3) 
with the pDONR vector containing the corresponding recombination sites (5’: 
attP4/attP1r, Middle: attP1/attP2, 3’: attR2/attL3). This produces entry clones 
containing the recombination sites required for the final LR reaction (5’: attL4/attR1, 
Middle: attL1/attL2, 3’: attR2/attL3) and is summarised in Figure 1.4. 
This protocol is from the Invitrogen MultiSite Gateway® Three-Fragment Vector 
Construction Kit manual. The first step involves mixing the appropriate PCR product with 
the corresponding pDONR vector in a 1.5ml eppendorf in the following proportions: 
 
 
attB PCR product (20-50fmoles) 1-7l 
pDONRTM vector (150ng/l) ~1l 
TE Buffer, pH 8.0 To 8l 
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Mix the reaction by flicking lightly, then: 
 
• Thaw the BP ClonaseTM II enzyme mix on ice for roughly 2 minutes. 
• Briefly vortex the enzyme mix twice (2 seconds each time). 
• Add 2l of the enzyme mix to the PCR product and pDONR mixture, and mix by 
vortexing twice briefly (2 seconds each time). 
• Incubate at 25°C for 1 hour (incubate overnight - ~18 hours - for 5-10 times more 
colonies, or if the PCR product is larger than 5kb). 
• Add 1l Proteinase K (2g/l) to the mix and incubate at 37°C for 10 minutes. 
 
When transforming, add 1l of the reaction to a volume of no more than 1:10 DNA:cells 
(TOP10 competent cells), and spread both 20l and 100l onto LB plates supplemented 
with kanamycin. 
 
2.5.11 LR Reactions 
 
Creation of the complete construct was performed using the MultiSite Gateway® Three-
Fragment Vector Construction Kit (detailed in Figure 1.4B) (Invitrogen). The LR reaction 
contains three DNA fragments that form the construct and a vector backbone, along 
with buffer and an LR Clonase that performs the final multi-site recombination reaction. 
Reactions were carried out in the following proportions: 
attL4/attR1 Entry Clone (5’ EC) 10 fmoles 
attL1/attL2 Entry Clone (Middle EC) 10 fmoles 
attR2/attL3 Entry Clone (3’ EC) 10 fmoles 
Destination vector (pDest) 20 fmoles 
pH8 TE Buffer To 5l total 
LR Clonase II Plus 1l 
The reaction was then incubated at 25°C overnight. Next, the mixture was treated with 
1l Proteinase K (2g/l) and incubated at 37°C for 10 minutes. When transforming, 2l 
of the reaction was added to a volume of no more than 1:10 DNA:cells (TOP10 
competent cells), and spread both at 50l and 100l onto LB plates supplemented with 
carbenicillin. 
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2.5.12 Preparation of Tol2 Transposase RNA 
 
To prepare Tol2 transposase RNA for injection into zebrafish embryos, the following 
protocol from the mMESSAGE mMACHINETM SP6 transcription kit was used. 
• Linearise 20µg of prepped DNA containing Tol2 (pCS-TP Tol2) with 1µl restriction 
enzyme (2µl, NotI/NotI-HF), for 2 hours at 37°C, 50-200µl total reaction (this 
should cut to completion most of the time). Add buffer at 1/10 the total volume. 
• PCR purify into a standard column, elute in 30µl. 
• Run 0.5µl on 1% gel to quantitate, add 5µl water and 2 µl loading dye to sample 
for loading. 
• Use 1µg for mMESSAGE mMACHINETM transcription reaction (kit) (SP6 
polymerase); increasing template amount in 20µl won’t increase yield therefore 
do multiple 20µl if more is required. 
• Follow the Phenol:chloroform extraction protocol according to mMessage 
manual – step 4 and precipitate using isopropanol OR phenol:chloroform extract 
and put through a column to concentrate. 
Extracted Tol2 RNA is then ready for injection into single-cell stage zebrafish embryos. 
 
2.6 Genotyping of mpx-/- NL144 Zebrafish 
 
To determine the genotype of mpx-/- NL144 fish, genomic DNA was first extracted from the 
tailfins of adult zebrafish. 
 
2.6.1 Zebrafish Fin Clipping 
 
Tailfins from adult zebrafish were clipped by first anaesthetising fish in Tricaine (4.2ml 
in 100ml), and cutting no more than 1/3 of the caudal fin with a pair of scissors. Place 
fins in PCR tubes containing 100µl NaOH (50mM). Clipped adults were kept separate to 
permit later identification. 
 
2.6.2 Extraction of Genomic DNA from Tailfins 
 
To extract genomic DNA from tailfins, perform the following protocol on the PCR tubes 
containing the tailfins: 
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• Boil sample at 98oC for 10 mins 
• Cool tubes on ice for 10 mins 
• Add 10l (1/10 volume of NaOH) 1M Tris pH 8 
• Vortex well  
• Spin down for 10 minutes full speed (4,200rpm) 
 
2.6.3 PCR Amplification of the mpx Gene 
 
Use the following protocol to amplify the mpx gene from the extracted genomic DNA. 
In a total reaction volume of 10µl, mix the following in a PCR tube: 
Reagent Quantity (µl) 
Forward primer (mpx Spotless For 1) 0.5 
Reverse primer (mpx Spotless Rev 1) 0.5 
DNA 1 
Firepol mix 2 
dH2O 6 
After reactions were made up, they were mixed by flicking, and centrifuged for ~5 
seconds to ensure thorough mixing. They were then cycled as follows: 
1. 95°C, 120 seconds 
2. 95°C, 30 seconds 
3. 60°C, 30 seconds 
4. 72°C, 60 seconds 
5. Go to step 2, x34 cycles 
6. 72°C, 10 minutes 
7. 12°C, ∞ seconds 
To verify and quantify, then visualised PCR products by running 1µl on a 1% agarose gel 
until resolved.  
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2.6.4 BtsCI Digest of the Amplified mpx Gene 
 
To determine the mpx allele of the clipped fish, the amplified PCR product can be 
digested with BtsCI using the following protocol. 
Mix the following in a 1.5ml Eppendorf: 
Reagent Quantity (µl) 
BtsCI 1 
Cutsmart® buffer 2 
DNA 5 
dH2O 12 
Mix thoroughly and incubate for 1 hour at 50°C. Visualise on a 2% agarose gel alongside 
a HyperLadderTM 50bp DNA ladder. 
 
2.7 Zebrafish Materials and Methods 
 
2.7.1 Zebrafish Husbandry 
 
Adult zebrafish were kept at 28°C in a continuous re-circulating closed aquarium system 
with a light-dark cycle of 14/10 hours respectively. Zebrafish embryos were kept in a 1x 
solution of E3 supplemented with methylene blue. Tg(lyz:MPO.mEmerald)sh496, 
Tg(lyz:hC5aR.Clover)sh505, Tg(lyz:nfsB.mCherry)sh260 zebrafish were maintained 
under a project licence awarded by the UK home office to the University of Sheffield. 
Experiments performed on larvae were all carried out before 5dpf, as at this age they 
are not protected under the Animals (Scientific Procedures) Act (1986). 
 
2.7.2 Zebrafish Line Maintenance  
 
Adult zebrafish lines were maintained by out-crossing to AB wild-types (or nacre wild-
type if appropriate) to ensure zebrafish lines were not inbred. This would occur when 
adults were 1-2 years old to ensure the zebrafish line was continued and a supply of 
healthy young adults was available. Where required, fin-clipping of adult zebrafish was 
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completed and subsequent genotyping/screening enabled grouping of adult fish by 
genotype/transgenic reporter, important for experimental procedures. 
 
2.7.3 Preparation of Needles for Injection 
 
Kwik-FilTM borosilicate glass capillaries (WPI) were pulled in two using a model P-1000 
Flaming/Brown micropipette puller (Sutter Instrument Company), resulting in two finely 
pointed needles that were used for injection into the zebrafish by insertion into a 
micromanipulator (WPI) connected to a pneumatic micropump (WPI). The end of the 
needle was then broken and the dose precisely calibrated using a graticule (Pfizer). 
 
2.7.4 Injection of DNA into Zebrafish Embryos 
 
To induce transgenesis, a mixture of construct DNA and Tol2 RNA was injected into 
single-cell stage zebrafish embryos; the mixture also contained phenol red, which makes 
identifying successful injection of the mixture easier. Adult paired zebrafish were 
separated by a plastic divider, which was removed 30-40 minutes prior to the beginning 
of injection. Newly laid embryos were collected and injected by mounting onto the long 
edge of a glass microscope slide placed in a Petri dish. Proportions of DNA and Tol2 RNA 
varied during optimisation, however the volumes present in the injected mixture were 
most often as follows: 
Reagent Quantity (µl) 
Construct DNA 1.25 
Phenol Red 0.5 
Tol2 RNA 2 
dH2O 1.25 
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2.7.5 Sudan Black B Staining 
 
To stain zebrafish neutrophils, the myeloperoxidase-dependent stain Sudan Black B was 
used. The following reagents were required for Sudan Black B staining: 
• Sudan Black B Staining Solution (Sigma) 
• 4% Paraformaldehyde (PFA) (defrost for 1-2 hours before use) 
• Phosphate Buffered Saline (PBS) 
• 70% Ethanol 
• PBS-Tween (0.1% Tween) (PBST) 
• 30% Glycerol (0.1% Tween):  
• For 50ml = 15ml Glycerol, 50µl Tween, to 50ml dH2O 
• 80% Glycerol (0.1% Tween):  
• For 50ml = 40ml Glycerol, 50µl Tween, to 50ml dH2O 
• Bleaching Solution (make without H2O2 then add H2O2 last): 
• 0.5x SSC, 5% Formamide, 10% H2O2 (of 30% H2O2 max stock) 
 
Staining of zebrafish larvae with Sudan Black B was performed using the following 
protocol, originally from the Lieschke lab (Peter MacCallum Cancer Centre): 
• Grow embryos for 3 days or more: (optional) add ptu to the media (E3) to remove 
pigmentation, alternatively bleach larvae using the protocol at the end. 
• After anaesthetising embryos using 1/20 Tricaine (roughly 1ml to a Petri dish), place 
a maximum of 20 embryos in a 1.5ml Eppendorf tube and wait until embryos have 
sunk to the bottom. 
• Draw off as much media as possible without disturbing embryos, and then add 1ml 
of room-temperature PFA. 
• Leave the Eppendorf on its side and allow the embryos to fix for at least an hour at 
room temperature (longer fixation is fine, can go over the weekend in fix for 
example; leave triton or tween out of the fix solution). 
• Rinse 3x 5min in PBS by drawing off PFA, adding 1ml of PBS and leaving on its side 
for 5 minutes each time. 
• Draw off PBS and add 500ul Sudan Black Staining solution for 20 minutes. 
• Carefully draw off staining solution as embryos will not be visible through the 
opaque solution; it’s not important that all the solution is drawn off, as embryos will 
be visible from the first wash. Dispose of all Sudan Black waste in a 50ml FalconTM 
throughout the staining procedure. 
• De-stain using 70% Ethanol. 4x fast rinses adding 1ml of Ethanol and drawing off. On 
fourth wash (or as long as it takes for clarity to return), leave on its side for 1 hour 
to soak. 
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• Re-hydrate embryos by adding PBST. Leave roughly 300ul of 70% Ethanol and add 
300ul PBST to the Ethanol, leave for 5 minutes, draw off and wash again by adding 
1ml PBST for five minutes. 
• Pigmentation can be removed by adding bleaching solution to the embryos and 
incubating for an hour at room temperature. Then wash away H2O2 4x 5mins in 
PBST. If storing long-term, keep in glycerol, for short-term storage (no more than a 
week) PFA will suffice. 
• For added clarity you can clear the embryos in glycerol series: add 30% Glycerol 0.1% 
Tween, then draw off and add 80% Glycerol 0.1% Tween. Then place in 24-well plate.  
 
2.8 Staphylococcus aureus 
 
2.8.1 Culture of S. aureus for Injection 
 
To prepare a liquid overnight culture of S. aureus, 5ml of BHI media (containing relevant 
selection) was inoculated with a colony of S. aureus, and incubated at 37°C overnight 
with shaking. To prepare S. aureus for injection, 50ml of BHI media (containing relevant 
selection) was inoculated with 500l of overnight culture, and incubated for roughly 2 
hours at 37°C with shaking. After ~2 hours, the culture should reach an OD600 of roughly 
1. The OD600 of each culture was measured and 40ml of the remaining culture harvested 
by centrifugation at 4,500g for 15 minutes at 4°C. The pellet was then resuspended in a 
volume of PBS appropriate to the bacterial dose required. Once the pellets were 
resuspended they were then kept on ice until required. 
 
2.8.2 S. aureus Concentration Calculation 
 
To concentrate S. aureus to the required dose for injection into zebrafish larvae, we 
must first determine the volume of PBS required to resuspend S. aureus after 
centrifugation. For this the following calculation was used, based on the measurement 
of 2x108 colony forming units (cfu) per ml of S. aureus in a culture at OD600=1. In this 
example, the culture is concentrated to 1,500cfu/nanolitre (nl): 
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In short, for a dose of 1,500cfu/nl, 40ml of culture at OD600=1 would be resuspended in 
5.3ml of PBS. To save time performing the lengthy calculation again, ‘V2’ (or, the 
‘adjustment value’) was determined for a variety of doses: 
Desired Concentration (cfu/nl) Adjustment Value (V2) 
100 80 
500 16 
1,000 8 
1,500 5.3 
2,000 4 
2,500 3.2 
3,000 2.6 
4,000 2 
 
Using these values, a shorter version of this calculation can be performed. For example, 
if a culture has an OD600 of 1.56, and we require a concentration of 3,000cfu/nl for 
injection into zebrafish larvae, the following short calculation would be performed to 
determine the volume of PBS required to resuspend the culture: 
1.56 (OD600) x 2.6 (Adjustment value) = 4.056ml of PBS 
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2.8.3 Determination of Bacterial Cell Density 
 
To determine the cell density of a bacterial culture, spectrophotometric measurements 
at 600nm (OD600) were recorded using a Beckman DU®520 spectrophotometer. Cultures 
were diluted 1 in 10 with BHI prior to measurement to avoid using excess culture. 
 
2.8.4 Direct Cell Counts 
 
To determine injected dose after infection experiments, samples of bacteria were taken 
during injection by directly injecting 4 doses into a 1.5ml Eppendorf containing 1ml of 
PBS before and after injecting a group. The bacterial concentration was determined 
using the Miles and Misra method for determining bacterial cell quantity via diluted 
surface cultured colonies (Miles et al., 1938). Samples containing 4 doses in 1ml of PBS 
were spotted in 10l volumes onto dried BHI agar plates and placed near a flame to dry. 
After overnight incubation at 37°C the number of cfu/nl was determined. 
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2.8.5 Staining of Bacteria with AlexaFluor-647 
 
The AlexaFluor-647 FarRed dye was supplied by Life TechnologiesTM, and was used to 
stain bacteria using the following protocol: 
 
• After centrifugation of bacteria and calculation of the appropriate volume of PBS 
to resuspend the bacteria in, pour off the supernatant, leaving the pellet and 
resuspend this in the required volume of PBS pH 9 
• Then, after defrosting the dye add 5l (10mg/ml) to the bottom of a foil-covered 
1.5ml eppendorf, and add 200l of bacteria to this, mixing together by prompt 
pipetting and vortexing, avoiding clumping of bacterial cells 
• Incubate the mixture at 37°C for 30 minutes, with shaking 
• To wash, add 1ml of PBS pH 8 and vortex, then centrifuge at 13,300rpm for 3 
minutes 
• Gently remove the supernatant, add 1ml of Tris pH 8.5 and vortex, then 
centrifuge as before 
• Gently remove the supernatant, add 1ml of PBS pH 8 and vortex, then centrifuge 
as before 
• Gently remove the supernatant and resuspend bacterial cells in 200l of PBS pH 
7.4 
• Keep bacteria in the 1.5ml foil-covered eppendorf on ice before use 
 
2.8.6 Fluorometry of pSPIN-GFP 
 
To investigate SPIN expression during culture growth, the pSPIN-GFP strain was grown 
alongside an isogenic non-fluorescent control strain (USA300). Cultures were grown in 
50ml of BHI (with added chloramphenicol for pSPIN-GFP) with shaking at 37°C. 1ml 
samples of each culture were taken every 30 minutes, and kept in 1.5ml Eppendorf’s on 
ice until the last time point at 12 hours. 4 replicate samples of 100µl then added to wells 
in a 96-well plate, and measured using a VICTORTM X3 multilabel plate reader (Perkin 
Ellmer®). The fluorometer then recorded the growth (OD600) and GFP expression 
(488nm) of each sample. Autofluorescence of S. aureus was controlled by subtracting 
the fluorescence recorded from the non-fluorescent USA300 strain from pSPIN-GFP at 
each timepoint. 
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2.9 Injection Techniques 
 
2.9.1 Injection into the Circulation Valley 
 
For survival assays, embryos were injected with S. aureus into the circulation valley, the 
space around the heart and above the yolk sac. Embryos at 30 hours post fertilisation 
(hpf) were mechanically dechorionated with forceps followed by immersion in 0.02% 
(w/v) Tricaine. Embryos were arranged into rows onto a microscope slide covered in a 
layer of 3% (w/v) methylcellulose for injection. Once injected (1nl), embryos were placed 
into 96 well-plates and kept in E3 at 28°C over the course of the experiment. 
 
2.9.2 Injection into the Otic Vesicle 
 
For experiments examining neutrophil migration, substances including proteins and S. 
aureus were injected into the otic vesicle, a transitory epithelial sac that later becomes 
the zebrafish ear. For injection, mounting dishes were cast using 1% agarose 
supplemented with E3, using a mould containing 3 horizontal rows composed of 3 large 
triangular indentations. Larvae anaesthetised by immersion in 0.02% (w/v) Tricaine prior 
to transfer to the mounting dish. Larvae were then arranged in rows facing right and 
with the yolk sac facing the deepest part of the indentation; all excess media was then 
drawn off to minimise free movement during injection. Larvae were then injected from 
the dorsal side of the otic vesicle. 4 hours after injection, larvae were fixed for 1 hour in 
room temperature PFA, and later stained with Sudan Black B to indicate neutrophils.  
 
2.9.3 C5a and Leukocidin Injections 
 
Zebrafish C5a (drC5a), human C5a (hC5a), PVL and HlgCB were prepared as follows prior 
to injection into the otic vesicle. Both drC5a and hC5a were injected at the maximum 
concentrations available (89µM and 10µM respectively) in 1nl to induce neutrophil 
migration. PVL and HlgCB were also injected at the maximum concentrations possible in 
1nl after mixing both subunits (PVL 30.3µM, HlgCB 16.7µM). 
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For injection of leukocidins, the toxin buffer was used as a negative vehicle control; 
bacteria from the USA300 only group was resuspended in toxin buffer rather than PBS. 
In the USA300 + PVL group, both LukS-PV and LukF-PV components were mixed in 
equimolar amounts (300µg/ml and 1,089µg/ml - 4µl and 1µl respectively) and used to 
resuspend USA300 after centrifugation. In the USA300 + HlgCB group, both HlgC and 
HlgB components were mixed in equimolar amounts (299µg/ml and 1,430µg/ml - 4µl 
and 1µl respectively) and used to resuspend USA300 after centrifugation. In the USA300 
+ HlgC group, the mixture was prepared as for the USA300 + HlgCB group, substituting 
HlgB for 1µl of toxin buffer. 
 
2.9.4 Injection into the Somite Tail Muscle 
 
For experiments involving detailed measurement of neutrophil migration to sites of 
infection, the somite tail muscle was used as an infection site. Prior to injection, Petri 
dishes containing ~25ml of solidified 1% agarose supplemented with E3 were used to 
mount larvae. Using a P10 Gilson pipette tip, regular circular indentations were made in 
the surface, which are large enough for the larvae’s head to fit, securing them for 
injection. Larvae were then anaesthetised by immersion in 0.06% (w/v) Tricaine; which 
is 3x the normal dose of Tricaine – this is necessary to prevent movement during somite 
injection. Larvae were then transferred to the mounting dish, and arranged by placing 
the heads of the larvae in the indentations. Typically, larvae were oriented facing right, 
and imaged facing left to minimise distance between the site of injection and the 
objective during microscopy. Once mounted, the larvae were injected into the somite 
adjacent to the end of the yolk extension. This was facilitated by orienting the needle in 
line with the somite to maximise the area of injection. 
 
2.9.5 Imaging of Somite Infection in vivo 
 
S. aureus was injected into the tail muscle to stimulate localised neutrophil recruitment 
to the site of infection. Once injected, larvae were washed off the plate with E3 and kept 
in a Petri dish containing 0.02% (w/v) Tricaine prior to mounting. Larvae were then 
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placed in 0.8% low melting point agarose (Sigma) supplemented with 0.02% (w/v) 
Tricaine (kept in a liquid state by maintaining at 42°C). Larvae were then mounted onto 
a circular dish with a Menzel-Gläser #0 cover slip fastened to the bottom using vacuum 
grease, and oriented facing left. 
2.9.6 Analysis of Neutrophil Migration to the Site of Infection 
 
Migration of neutrophils from Tg(lyz:nfsB.mCherry)sh260 and double transgenic 
Tg(lyz:hC5aR.Clover)sh505; Tg(lyz:nfsB.mCherry)sh260 larvae to a somite infection was 
analysed using Volocity®. Across 4 experiments, 10 neutrophils from each group were 
tracked as they migrated to the wound site using the following protocol: 
• Crop timepoints to begin at the initiation of chemotaxis, and end once all 
injected S. aureus have been phagocytosed 
• Draw a rectangular region of interest (ROI) around the injected S. aureus 
• Open a new analysis protocol and add the following to track neutrophils 
o Automatically identify neutrophils by using ‘Find using % intensity’ in the 
appropriate channel (lower = 3, upper = 100) 
o Clip to ROI 
o Exclude objects: <30µm3 
o Object size guide: 150µm3 
o Remove noise from objects: Medium filter 
o Track using the shortest path model; ignore static objects and 
automatically join broken tracks 
o Apply to all timepoints and create a new measurement item 
• Filter the measurements by tracks longer than 5 timepoints (to exclude 
neutrophils that are not captured sufficiently) 
The measurement item will contain numerous track parameters, including the average 
velocity, migration distance, displacement and meandering index. 
 
2.10 Software 
 
1. Visualisation of plasmid maps and planning of restriction digests was carried out 
using the ApE plasmid editor (v2.0.45) open source software available at: 
http://biologylabs.utah.edu/jorgensen/wayned/ape/ accessed April 2018. 
2. Image stitching individual fields of view of transgenic larvae was performed using 
the stitching plugin of FiJi® open source software available at: 
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https://fiji.sc/ accessed April 2018. 
3. For graphical representations of data and statistical analyses, Prism (v. 7.02) was 
used. Graphpad Software® 2018. 
4. Images of whole zebrafish larvae, and larvae stained with Sudan Black were 
processed using Nikon’s® NIS Elements software package (Nikon widefield 
microscope, Nikon Extended Focus). 
5. Migration of Tg(lyz:hC5aR.Clover)sh505 neutrophils to somite infections was 
analysed using Volocity (Perkin ElmerTM spinning disc confocal microscope). 
6. The Zeiss® Zen black software package was used to process images of labelled 
neutrophil granules in the Tg(lyz:MPO.mEmerald)sh496 line (Airyscanner 
confocal microscope). 
 
2.11 Microscopes 
 
1. Spinning disc confocal microscope: UltraVIEW VoX spinning disk confocal 
microscope (Perkin ElmerTM, Cambridge, UK). 405nm, 445nm, 488nm, 514nm, 
561nm and 640nm lasers were available for excitation. A 40x oil lense 
(UplanSApo 40x oil (NA 1.3)) was used for cellular level imaging. GFP, TxRed 
emission filters were used and bright field images were acquired using a 
Hamamatsu C9100-50 EM-CCD camera. Volocity software was used.  
2. A Nikon® custom-build wide-field microscope: Nikon Ti-E with a CFI Plan 
Apochromat λ 10X, N.A.0.45 objective lens, a custom built 500 μm Piezo Z-stage 
(Mad City Labs, Madison, WI, USA) and using Intensilight fluorescent illumination 
with ET/sputtered series fluorescent filters 49002 and 49008 (Chroma, Bellow 
Falls, VT, USA). 
3. A Zeiss® Airyscanner confocal: A Zeiss Axiovert LSM 880 Airyscan confocal 
microscope with a 63x Plan Apochromat oil objective (NA 1.4). Cells were 
illuminated with a 488 nm argon laser and/or a 561 nm diode laser. Images were 
processed using the Zeiss microscope software and analysed using Zen Black. 
4. A Nikon® Extended focus: Nikon SMZ1500 stereomicroscope with a Prior Z-drive 
and transmitted and reflected illumination. Equipped with a DS-Fi1 Nikon colour 
camera and the Nikon Elements software. 1x objective. 
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2.12 Statistical Analyses 
 
All statistical analyses were performed using GraphPad® Prism software (v. 7.02). 
In experiments where the means of one variable was compared between two groups, 
an unpaired t-test was used. A two-tailed t-test was used to test for relationships in both 
directions. 
In experiments where the means of two variables were compared between 3 or more 
different groups, an ordinary two-way ANOVA was used. These experiments routinely 
involved multiple comparisons, and so were adjusted for multiple comparisons using 
Bonferroni’s multiple comparisons test. 
For survival experiments, a Mantel-Cox Log-rank test was used. 
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Chapter 3: Generation of a transgenic zebrafish 
expressing the human C5a receptor 
 
3.1 Chapter Introduction 
 
The complement pathway is a fundamental component of the vertebrate immune 
system. It is a cascade of over 30 proteins that broadly perform three functions during 
bacterial infection: opsonisation of bacteria to increase the efficiency of phagocytosis 
(C3b), generation of inflammatory signals to recruit phagocytes (C3a and C5a) and the 
destruction of bacteria by formation of the membrane attack complex (C5b-C9). A 
critical complement protein is C5a, a highly potent chemoattractant that is produced as 
part of one of the earliest immune recognition events during bacterial infection 
(Woodruff et al., 2011). C5a’s cognate receptor is the C5a receptor (C5aR), a seven-
transmembrane loop G-protein coupled receptor (GPCR) that is expressed ubiquitously 
and enriched on the surface of phagocytic cells (Laumonnier et al., 2017). Together, C5a 
and its receptor govern efficient phagocyte recruitment to sites of infection, as well as 
enhancing bacterial killing by stimulating the release of reactive oxygen species (ROS) 
and granule enzymes, highlighting their significance as a central part of the immune 
system (Gerard and Gerard, 1991). Furthermore, they are also critical components 
regulating inflammation, as C5aR expression is associated with an increased 
susceptibility to chronic inflammatory conditions (Neumann et al., 2002). 
A common characteristic of the staphylococci is the secretion of species-specific 
immune modulators, which are major determinants of host tropism. This paradigm 
involves a range of animals including cattle, horses, rabbits, pigs and dogs (Fitzgerald, 
2012). S. aureus has colonised humans for at least 10,000 years (Weinert et al., 2012), 
and accordingly produces virulence factors that are highly adapted to human infection, 
many of which target the innate immune system to evade phagocytosis and bacterial 
killing. Of these factors, three target the human C5a receptor (hC5aR), disrupting 
chemotaxis and destroying phagocytes outright by forming pores in the cell membrane. 
A major leukocidal effector is the bicomponent leukocidin Panton-Valentine Leukocidin 
(PVL), which is expressed by highly virulent strains such as the community-acquired 
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methicillin resistant S. aureus (CA-MRSA) strain USA300 (Diep et al., 2010). Human-
adapted factors like PVL have been implicated in complex pathologies that have proven 
difficult to investigate, underlining a gap in knowledge and highlighting an urgent need 
to fully understand the roles of these factors during infection. 
Unfortunately, human-adapted virulence factors represent a significant challenge 
towards understanding staphylococcal infection in vivo, as established models exhibit a 
lack of targetable components. While ‘humanised’ mouse models that display increased 
susceptibility to staphylococcal infection exist, this approach is costly and technically 
difficult (Tseng et al., 2015). As an alternative, I propose to use the zebrafish as a model 
to investigate the roles of these virulence factors during infection. The zebrafish is a 
promising infection model, it is genetically tractable, suited to in vivo microscopy, and 
has a high fecundity. As an established model for investigating bacterial infection and 
inflammation, the zebrafish has delivered unique insights into the innate immune 
system (Elks et al., 2013; Mazon-Moya et al., 2017; Renshaw et al., 2006a). In addition, 
as a model of staphylococcal infection, zebrafish have revealed a complex relationship 
between neutrophils and S. aureus (Prajsnar et al., 2008, 2012). Lastly, the zebrafish 
innate immune system closely resembles humans, with homologous pattern recognition 
receptors, chemokines, phagocytes and a complement system that is functional from 
fertilisation (Wang et al., 2009). I aimed to create a transgenic zebrafish model that 
expresses a fluorescently-tagged human C5a receptor (hC5aR) on the surface of 
zebrafish neutrophils, as a tool towards investigating the interactions of human-adapted 
virulence factors with the innate immunity during staphylococcal infection. 
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3.2 Chapter Aims 
 
My hypothesis for this chapter was: 
 
Expression of the human C5a receptor in zebrafish neutrophils will enhance 
susceptibility to staphylococcal infection as a result of targeting by human-specific 
virulence factors. 
 
The aims of this chapter were to: 
 
• Establish whether human-adapted virulence factors participate in staphylococcal 
infection in wild-type zebrafish. 
• Generate transgenic zebrafish expressing a fluorescently-tagged hC5aR in 
neutrophils, determine the impact of transgene expression, and assess whether 
the hC5aR acts as a functional receptor in zebrafish neutrophils. 
• Determine if neutrophils expressing the hC5aR become susceptible to lysis by 
bicomponent pore-forming leukocidins. 
• Investigate whether zebrafish expressing the hC5aR become more susceptible to 
staphylococcal infection. 
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3.3 Results 
 
3.3.1 hC5aR-targeting virulence factors are dispensable during systemic 
staphylococcal infection in zebrafish 
 
Before creating a zebrafish line that expresses the human C5a receptor in neutrophils, 
it was important to address whether human-adapted virulence factors are able to inhibit 
the zebrafish C5a receptor. I hypothesised that if C5a receptor-targeting virulence 
factors such as γ-Haemolysin CB (HlgCB) and the chemotaxis inhibitory protein of 
staphylococcus (CHIPS) were important during zebrafish infection, then isogenic 
knockout strains should have an attenuated infection phenotype. 
Using a model of systemic staphylococcal infection (Prajsnar et al., 2008), wild-type 
zebrafish larvae (LWT) were intravenously infected with ~1,800 colony forming units 
(cfu) of wild-type USA300 or isogenic knockout strains of HlgCB (ΔHlgCB) and CHIPS 
(ΔCHIPS) at 30 hours post fertilisation (hpf). There was no significant attenuation of 
virulence in the knockout strains (Figure 3.1), suggesting that CHIPS and HlgCB do not 
significantly contribute to S. aureus infection in this model. 
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Figure 3.1 Knockout strains of human-adapted virulence factors are not 
attenuated in a zebrafish model of systemic staphylococcal infection. 
London wild-type (LWT) zebrafish were systemically infected with ~1,800cfu S. aureus 
USA300 wild-type, ΔHlgCB or ΔCHIPS at 30 hours post fertilisation (hpf); survival was 
then monitored over the next four days post infection. Values (n=70 over three 
independent experiments) were analysed using a Log-rank Mantel-Cox test; ns, p=0.189. 
 
3.3.2 Cloning strategy  
 
After establishing that human-adapted virulence factors do not significantly contribute 
to infection in the systemic model, I sought to create a transgenic zebrafish expressing 
a fluorescently-labelled human C5a receptor (hC5aR). To create the genetic construct 
that will be expressed in transgenic zebrafish, I used Gateway® cloning, a technology 
based on the att site-specific recombination system from lambda phage (Hartley et al., 
2000). To use Gateway® cloning, individual genetic elements are constructed as 
plasmids known as entry clones, which can be assembled into a single large construct in 
a modular fashion; for example (5’) promoter, (middle) gene, (3’) fluorescent protein. 
Entry clones are created by adding att sites to either end of a genetic element using the 
polymerase chain reaction (PCR); these att sites allow the element to carry out site-
specific recombination events with a specific donor vector to insert the element into the 
vector. The specific att sites used depend on whether the entry clone will be placed at a 
5’, middle or 3’ position in the full-length construct. For example, for a middle-entry 
clone the genetic element will have an attB1 and an attB2 site, allowing it to recombine 
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with a donor vector containing an attP1 and attP2 site. Site-specific recombination 
between a genetic element and a donor vector is carried out in a step known as a ‘BP 
reaction’, which utilises a BP clonase to catalyse recombination events between attB 
and attP sites, inserting the genetic element into the donor vector (Figure 3.2) (Kwan et 
al., 2007). 
 
 
 
Figure 3.2 Creation of entry clones using a BP reaction. 
Using Gateway® cloning, plasmids containing genetic elements known as ‘entry clones’ 
can be created; shown is the construction of a middle entry clone. By adding attB sites 
to either end of a genetic element by PCR (shown here as middle element), the element 
can carry out site-specific recombination into a donor vector containing attP1 and attP2 
sites using a BP clonase. This produces a functional middle entry clone. Adapted from 
Kwan et al., 2007. 
 
Once the required entry clones are created, a final reaction that assembles the full-
length construct is performed. This is named an ‘LR reaction’, as it utilises an LR clonase 
that catalyses recombination events between attL and attR sites. This inserts the middle 
entry clone between the 5’ and 3’ entry clones, before inserting the full-length fragment 
into a destination vector (Figure 3.3). In my construct, the 5’ element is the promoter 
lyz, a neutrophil-specific promoter (Yang et al., 2012); the middle element is the hC5aR 
and the 3’ entry clone is clover, a modified Green Fluorescent Protein (GFP) with 
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enhanced photostability and brightness (Lam et al., 2012). Once created, all three 
elements are assembled within the destination vector, which was ‘pDestTol2CG2’ in this 
study. This vector contains a green heart marker (cmlc2:eGFP) that provides feedback 
concerning the efficiency of transgenesis, and two ‘Tol2 arms’ which permit insertion of 
the construct into the zebrafish genome with the aid of the Tol2 transposase (Huang et 
al., 2003; Kawakami, 2007).  
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Figure 3.3 Assembly of a full-length construct using an LR reaction. 
Entry clones can be assembled in the order 5’ entry clone, middle entry clone, 3’ entry 
clone to create a single large construct. This is performed in an ‘LR reaction’, which uses 
an LR clonase to catalyse site-specific recombination events between attL and attR sites; 
this inserts the middle entry clone between the 5’ and 3’ entry clones before inserting 
the entire construct into a destination vector. Adapted from Kwan et al., 2007. 
 
3.3.3 Amplification of the hC5aR gene from the pIRES-hC5aR vector 
 
As entry clones containing the lyz promoter and clover protein had already been 
created, only the hC5aR middle entry clone had to be constructed. To create the middle 
entry clone, PCR primers were designed to amplify the hC5aR gene from the plasmid 
vector ‘pIRES-hC5aR (no FLAG)’ (a kind gift from Michiel van Gent, Utrecht Medical 
Centre), adding an attB1 and attB2 site to either side of the gene (Figure 3.4). 
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Figure 3.4 Plasmid containing the hC5aR gene. 
Construct map of pIRES-hC5aR (no FLAG); the location of the hC5aR gene is indicated by 
the red box, 993 – 2,044bp. Created by Michiel van Gent, Utrecht Medical Centre. 
 
To amplify the hC5aR gene from pIRES-hC5aR (no FLAG), primers ‘hC5aR MEC F’, ‘hC5aR 
Correct MEC R NOSTOP’ and ‘hC5aR Correct R STOP’ were designed (2.1.4 Primers), 
which amplify the hC5aR gene and add two att sites (attB1 and attB2) to either end of 
the product. The ‘hC5aR Correct R STOP’ primer leaves the stop codon of the hC5aR 
gene unchanged, while the ‘hC5aR Correct MEC R NOSTOP’ primer amplifies the hC5aR 
gene without the C-terminal stop codon, so that the hC5aR could be produced as a 
fusion protein. With the attB sites the PCR products can perform site-specific 
recombination with the attP sites of the donor vector pDONR221 using a BP reaction, 
producing the assembled middle-entry clone. 
The hC5aR gene was amplified with and without its C-terminal stop codon, creating one 
middle entry clone that contains the hC5aR gene and clover as separate elements, and 
another that contains the hC5aR as a fusion protein with clover as a C-terminal 
fluorescent tag (Figure 3.5). The C-terminal fluorescent tag permits fluorescence-based 
screening of transgenic larvae as well as identification of the intracellular location of the 
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receptor; since the tag could interfere with neutrophil function or hC5aR signalling, both 
approaches were considered.  
 
 
Figure 3.5 PCR amplification of the hC5aR gene. 
PCR products of the hC5aR gene with and without a C’ terminal stop codon, and with 
attB1 and attB2 sites added to either end of the gene. The hC5aR gene corresponds to 
a band of ~1,050bp. Dilutions of Hyperladder 1kb were used to assess PCR product 
concentrations. 
 
3.3.4 Insertion of the hC5aR gene into the pDONR221 destination vector 
 
After PCR amplification of the hC5aR gene, the products were inserted into the 
destination vector pDONR221 by site-specific recombination between the attB1 and 
attB2 sites of the PCR products and the attP1 and attP2 sites of pDONR221 (BP reaction). 
The map for pDONR221 hC5aR MEC NOSTOP is shown (Figure 3.6A); pDONR221 hC5aR 
MEC STOP is identical, but with an additional three base pairs encoding a stop codon at 
the C-terminus of the hC5aR gene. Afterwards the product of the BP reaction was 
transformed, and the DNA was extracted and verified by diagnostic digest with HincII 
(Fig 3.6B), producing the middle entry clone that was used to create the final full-length 
construct.  
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Figure 3.6 Generation of a middle entry clone containing the hC5aR gene. 
A) Map of the pDONR221 destination vector containing the hC5aR gene without a C-
terminal stop codon after BP recombination; blue boxes highlight HincII restriction sites. 
B) HincII diagnostic digest of the BP reaction product. Empty pDONR221 vector band 
sizes are: 2,513bp, 1,053bp, 845bp, 303bp and 48bp; correct band sizes are: 2,460bp 
and 1,137bp. Hyperladder 1kb. 
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3.3.5 Assembly of the lyz:hC5aR.Clover construct 
 
With the middle entry clone created, the final step was to assemble the elements of the 
construct in order within the destination vector pDestTol2CG2 using an LR reaction 
(Figure 3.7A). As it was important to know if the construct was correctly composed, I 
focused on expressing the hC5aR as a fluorescently-tagged fusion protein, as expression 
of clover in zebrafish neutrophils would confirm that the construct had been assembled 
correctly. Additionally, a fusion protein would indicate how the receptor localises within 
neutrophils, and so only the middle entry clone without a stop codon was generated. 
After the LR reaction, the product was transformed into competent cells and the DNA 
extracted. The success of the reaction was then verified by diagnostic digest with SacII 
(Fig 3.7B). 
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Figure 3.7 Construct map and diagnostic digest of pDestTol2CG2 
lyz:hC5aR.Clover. 
A) Plasmid map of pDestTol2CG2 lyz:hC5aR.Clover, with no stop codon between hC5aR 
and clover. The 5’ lyz promoter is between attB4 and attB1, then the hC5aR to attB2, 
then the 3’ clover to attB3; blue boxes indicate SacII restriction sites. B) SacII diagnostic 
digest of LR reaction colonies. Vector backbone (pDestTol2CG2): 7,796bp; correct band 
sizes are: 8,149bp, 6,478bp, 3,330bp and 1,237bp. Hyperladder 1kb. 
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3.3.6 Sequencing of the pDestTol2CG2 lyz:hC5aR.Clover construct. 
 
The DNA extracted from colony four shown in Figure 3.7B resolved to the correct band 
sizes, indicating a successfully assembled pDestTol2CG2 lyz:hC5aR.Clover construct. To 
acquire high concentrations of construct DNA sufficient for sequencing and further 
experiments, glycerol stocks of this colony were taken and streaked out, from which a 
single colony was grown up and the DNA extracted from a larger culture volume. This 
DNA was then sequenced using the primers ‘hC5aR MEC 1/2’ and ‘hC5aR MEC 2/2’ (2.1.4 
Primers), which anneal before the middle entry clone attB1 site and midway through 
the hC5aR gene respectively (Figure 3.8). Sequencing verified the successful assembly of 
the pDestTol2CG2 lyz:hC5aR.Clover construct, with the hC5aR remaining in-frame from 
the overlap with the 5’ lyz promoter and from the end of the hC5aR gene into the 3’ 
clover tag. 
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Figure 3.8 Construct map of pDestTol2CG2 lyz:hC5aR.Clover verified by DNA 
sequencing. 
pDestTol2CG2 lyz:hC5aR.Clover construct map showing regions that were verified with 
sequencing; the annealing sites and read lengths of primers ‘hC5aR MEC 1/2’ and ‘hC5aR 
MEC 2/2’ are indicated. 
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3.3.7 Generation of hC5aR.Clover transgenic zebrafish 
 
After the successful generation of the hC5aR construct, I began optimising conditions 
for transgenesis into zebrafish embryos. To facilitate the optimisation of transgenesis, 
the construct also contains a genetic element that expresses GFP in cardiac cells using 
the cmlc2 promoter (Huang et al. 2003), referred to as a green heart marker (Figure 
3.9A). In the absence of any observable expression of the construct in injected larvae, 
expression of the green heart marker indicates successful transgenesis that is useful in 
optimising injection conditions. To induce transgenesis, construct DNA is injected in 
combination with Tol2 transposase mRNA, which is translated into the functional 
protein in the embryo. Tol2 is an autonomous transposase isolated from the genome of 
the medaka fish (Oryzias latipes) that catalyses transposition of DNA between two Tol2 
sequences (Kawakami, 2007). By placing these sequences at either end of a construct, 
Tol2 can then transpose the construct into a target genome. 
A range of dilutions of DNA and transposase mRNA was tested and the rates of 
development, green heart expression and positive construct expression were recorded 
to assess transgenesis in each condition. Higher DNA and mRNA concentrations resulted 
in fewer developed larvae, and all conditions yielded a high proportion of larvae that 
expressed the green heart marker (Figure 3.9B). However, the majority of conditions 
resulted in no visible expression of the hC5aR construct, with only construct dilutions of 
1/75 (~24ng/µl) and 1/100 (~18ng/µl) in combination with 10ng/µl of transposase mRNA 
producing larvae with a labelled cell population in the caudal haematopoietic tissue 
(CHT) (Figure 3.9B). The CHT is the site of haematopoiesis in zebrafish until ~2 weeks 
post fertilisation (E. Murayama et al 2006), suggesting that the labelled cell population 
is likely to be neutrophils. Despite low overall construct expression rates (2-4% of 
developed embryos) sufficient larvae were obtained for future experiments and 
screening of a stably integrated transgenic founder. 
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Figure 3.9 Tol2 transgenesis of the lyz:hC5aR.Clover construct into the 
zebrafish genome. 
A) Schematic of the lyz:hC5aR.Clover construct, indicating expression of a fluorescently 
tagged hC5aR under the neutrophil-specific promoter lyz. B) Transgenesis data testing a 
range of DNA and Tol2 transposase mRNA concentrations injected into single-cell stage 
zebrafish embryos and screened for fluorescence at 3 days post fertilisation (dpf). All 
conditions performed as single experiments except the group marked with (*), which 
represents the mean of three independent experiments. 
 
3.3.8 Transient expression of the hC5aR transgene in zebrafish larvae 
 
The presence of a fluorescently-labelled population of cells in the CHT suggests there 
has been successful expression of the transgene in haematopoietic cells of the larval 
zebrafish. To investigate the identity of this labelled population, transient expression 
was induced by injection of the construct into the red fluorescent neutrophil reporter 
background Tg(lyz:nfsB.mCherry)sh260 and the larvae were screened at 3dpf for 
expression of both constructs. Figure 3.10 shows that a heterogeneous population of 
fluorescent cells is identifiable within the CHT of double-transgenic larvae, with a 
minority labelled with clover and the rest with mCherry. Despite both transgenes 
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distinctly labelling different cells in the CHT, both populations resemble one another 
morphologically, suggesting that the differential labelling of these cells is due to the 
mosaic nature of transient expression, and not dysfunctional expression of the construct 
in this background. Additionally, the subcellular localisation of the clover protein within 
these cells is distinct from that of mCherry, with clear differences in signal intensity 
across the cell that are not seen in lyz:nfsB.mCherry-only cells. 
 
 
 
Figure 3.10 Transient expression of the lyz:hC5aR.Clover transgene in cells 
within the CHT. 
The caudal haematopoietic tissue (CHT) (inset) of a double-transgenic Transient 
lyz:hC5aR.Clover; Tg(lyz:nfsB.mCherry)sh260 larva containing a heterogeneous 
population of clover-positive and mCherry-positive cells. 
 
3.3.9 Identification of a stable transgenic zebrafish founder 
 
To secure a number of adult zebrafish that stably express hC5aR.Clover, fluorescent 
larvae were raised and screened for germline integration of the lyz:hC5aR.Clover 
transgene by outcrossing to determine if the transgene was inherited by their offspring. 
Adults with stable integrations will produce progeny that inherit the transgene, and will 
be identifiable under fluorescent light. This second generation of transgenic larvae were 
then raised, resulting in a number of stably transgenic adult zebrafish with the 
designation Tg(lyz:hC5aR.Clover)sh505. 
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Detailed investigation of transgene expression is possible with stably transgenic larvae. 
As it was still unclear whether the hC5aR transgene fully labels zebrafish neutrophils, 
Tg(lyz:hC5aR.Clover)sh505 fish were crossed to the neutrophil reporter line 
Tg(lyz:nfsB.mCherry)sh260 and at 3dpf, double-transgenic larvae were selected and 
imaged. Figure 3.11 shows co-expression of both transgenes in a large population of 
cells spanning the length of the CHT, indicating that hC5aR.Clover is stably expressed in 
zebrafish neutrophils. 
 
Figure 3.11 Stable expression of the lyz:hC5aR.Clover transgene in zebrafish 
neutrophils.  
A double transgenic Tg(lyz:hC5aR.Clover)sh505; Tg(lyz:nfsB.mCherry)sh260 larva at 
3dpf. White arrow indicates enlarged region shown in inset. 
 
3.3.10 hC5aR.Clover is localised on the surface of zebrafish neutrophils 
 
The hC5aR is a G-Protein Coupled Receptor (GPCR) that is expressed on the surface of 
myeloid cells where they detect C5a in the surrounding environment, allowing them to 
respond and direct chemotaxis. In order for the hC5aR.Clover transgene to recapitulate 
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expression of the hC5aR, the receptor should localise to the surface of zebrafish 
neutrophils. I sought to test whether the fusion of clover to the C-terminus of the hC5aR 
produces a properly folded and expressed receptor. In vitro experiments directing 
expression of a hC5aR fusion protein with a C-terminal GFP tag in the immortalised 
myeloid cell line PLB-985 show that the receptor translocates to the cell surface, 
allowing the receptor-mediated chemotactic response to C5a to be observed (Servant G 
1999). This suggests that the hC5aR should retain the ability to localise to the cell surface 
based on these in vitro observations. 
To verify if the hC5aR is localised on the surface of zebrafish neutrophils, 
Tg(lyz:hC5aR.Clover)sh505 fish were crossed to Tg(lyz:nfsB.mCherry)sh260 and double-
transgenic larvae were imaged at high-magnification using spinning-disc confocal 
microscopy. Double-transgenic neutrophils show the distinct localisation of both 
transgenes within a single cell (Figure 3.12B). The lyz:nfsB.mCherry transgene occupies 
the cytoplasmic area of the cell, while lyz:hC5aR.Clover encircles the cell, suggesting that 
it localises to the cell membrane. Additionally, both signals were quantified using a line 
intensity profile comparing the expression patterns of both transgenes (Figure 3.12C), 
demonstrating that lyz:nfsB.mCherry has a single peak at the centre of the cell, while 
lyz:hC5aR.Clover has two peaks that occur at the cell perimeter. 
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Figure 3.12 Localisation of the Tg(lyz:hC5aR.Clover)sh505 transgene in 
zebrafish neutrophils.  
A) A zebrafish larva at 3dpf, the CHT region is outlined by a red box. B) An image of a 
double-transgenic Tg(lyz:hC5aR.Clover)sh505; Tg(lyz:nfsB.mCherry)sh260 neutrophil in 
the CHT. C) Line intensity profile of the fluorescent signal of both transgenes across the 
yellow arrow shown in B). 
 
3.3.11 Expression of the hC5aR transgene does not impact neutrophil 
haematopoiesis 
 
As the hC5aR appeared to localise with the neutrophil surface, it became relevant to ask 
whether receptor expression affects haematopoiesis. By crossing 
Tg(lyz:hC5aR.Clover)sh505 to Tg(lyz:nfsB.mCherry)sh260 then sorting at 2-3dpf based 
on transgene expression, it is possible to separate larvae into “non-humanised” 
(lyz:nfsB.mCherry only) and “humanised” (lyz:hC5aR.Clover; lyz:nfsB.mCherry) groups. 
For the remainder of the chapter, I use the terms “non-humanised” to refer to larvae 
expressing only lyz:nfsB.mCherry, and “humanised” to refer to double-transgenic 
siblings expressing lyz:hC5aR.Clover; lyz:nfsB.mCherry. Grouping larvae in this way 
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permits investigation into how hC5aR transgene expression affects neutrophil 
development and function.  
To assess how the hC5aR transgene affects haematopoiesis, non-humanised and 
humanised larvae were stained with the neutrophil stain Sudan Black B, allowing the 
total number of neutrophils within these larvae to be enumerated. Figure 3.13 shows 
that despite expression of the receptor on the neutrophil surface, there is no significant 
difference between the number of neutrophils in non-humanised and humanised larvae. 
This suggests that expression of the hC5aR transgene does not interfere quantitatively 
with neutrophil development. 
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Figure 3.13 Expression of the hC5aR.Clover transgene does not impact the 
total number of neutrophils in zebrafish larvae. 
A) 4dpf larvae from a Tg(lyz:hC5aR.Clover)sh505 x Tg(lyz:nfsB.mCherry)sh260 cross, 
separated into non-humanised (lyz:nfsB.mCherry only) and humanised 
(lyz:hC5aR.Clover; lyz:nfsB.mCherry) groups and stained with Sudan Black to detect 
neutrophils. B) Total body neutrophil counts from both groups. Values shown are mean 
± SEM (n=50 over two independent experiments); groups were analysed using an 
unpaired t-test (two-tailed). ns, p=0.1046. 
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3.3.12 Zebrafish larvae expressing the hC5aR.Clover transgene have a 
reduced neutrophil number in the area between the yolk sac and CHT 
 
As zebrafish larvae expressing the lyz:hC5aR.Clover transgene showed no significant 
reduction in their total number of neutrophils, it was concluded that the transgene does 
not interfere quantitatively with haematopoiesis. However, as humanised larvae did 
exhibit a slight reduction in neutrophil numbers compared with non-humanised larvae, 
the data was re-analysed to determine if this was due to a reduced neutrophil 
population in a specific region of the larvae. 
The total neutrophil numbers enumerated in Figure 3.13 were recorded by counting the 
neutrophils present within three regions of the 4dpf larvae, those being the head (head 
to mid-yolk sac), mid (mid-yolk sac to CHT) and tail (CHT to tail end) (Figure 3.14A); 
Figure 3.13B shows the aggregated counts from these regions of the larvae. By re-
analysing the counts from these regions, the number of neutrophils in each region can 
be compared with one another. I observed a significantly reduced number of neutrophils 
between non-humanised and humanised larvae in the region between mid-yolk sac and 
the CHT. This is likely to be due to a decrease in neutrophil motility as a result of 
overexpression of the hC5aR, leading to increased retention of neutrophils at 
haematopoietic sites. 
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Figure 3.14 Humanised larvae have fewer neutrophils between the mid-yolk 
sac and CHT. 
A) A zebrafish larva separated into three regions in which the number of neutrophils was 
enumerated after Sudan Black B staining; the head (head to mid-yolk sac), mid (mid-yolk 
sac to CHT) and tail (CHT to tail end) regions are indicated. B) The number of neutrophils 
present in the head, mid and tail regions of non-humanised (lyz:nfsB.mCherry only) and 
humanised (lyz:hC5aR.Clover; lyz:nfsB.mCherry) larvae. Values shown are mean ± SEM 
(n=50 over two independent experiments); groups were analysed using an ordinary two-
way ANOVA and adjusted using Bonferroni’s multiple comparisons test. ***, p=0.0003. 
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3.3.13 The hC5aR.Clover transgene interferes with the neutrophil-mediated 
inflammatory response 
 
The above data (Figure 3.14) suggest that hC5aR.Clover transgene expression could 
affect the migration of neutrophils during development, therefore, transgenic larvae 
were assessed for their ability to recruit to inflammatory and infectious stimuli. To assess 
the recruitment of Tg(lyz:hC5aR.Clover)sh505 neutrophils to sites of injury, I used a 
tailfin-transection model that induces neutrophil recruitment to a vertically transected 
tailfin injury (Renshaw et al., 2006a). Non-humanised and humanised larvae were tailfin-
transected at 3dpf, and the resulting recruitment of neutrophils to the site of injury was 
recorded at 3 and 6 hours post injury (hpi) (Figure 3.15). By 3hpi, there were fewer 
humanised neutrophils recruited to the wound site, suggesting that humanised 
neutrophils are impaired in their ability to respond to inflammatory stimuli. 
  
126 
 
 
Figure 3.15 Zebrafish expressing the hC5aR.Clover transgene fail to mount 
an efficient neutrophil-mediated inflammatory response.  
A) Tailfin-transections of zebrafish larvae separated into non-humanised 
(lyz:nfsB.mCherry only) and humanised (lyz:hC5aR.Clover; lyz:nfsB.mCherry) groups at 
3dpf; dashed outline represents the area in which neutrophils were counted. B) 
Neutrophil counts at the site of injury at 3 and 6 hours post injury (hpi); blue points 
denote the representative images in A). Error bars shown are mean ± SEM (n=45 over 
three independent experiments); groups were analysed using an ordinary two-way 
ANOVA and adjusted using Bonferroni’s multiple comparisons test. **, p=0.0073; ****, 
p<0.0001. 
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3.3.14 Zebrafish expressing the hC5aR.Clover transgene do not mount an 
effective response to infection in the otic vesicle 
 
As the signalling pathways governing inflammation in the zebrafish are distinct from 
those mediating infection (Deng et al., 2012), the ability of neutrophils to migrate to 
sites of infection was also investigated. To address whether the neutrophil response to 
infection is affected by transgene expression, an infection recruitment model using the 
otic vesicle of the zebrafish as an injection site was used (Benard et al., 2012). 
Tg(lyz:hC5aR.Clover)sh505 zebrafish were crossed to Tg(lyz:nfsB.mCherry)sh260 and the 
larvae separated into non-humanised and humanised groups at 2dpf. S. aureus USA300 
was then injected into the otic vesicle, and after 4 hours injected larvae were fixed and 
stained with Sudan Black to detect neutrophils. 2dpf larvae were initially used to assess 
infection recruitment, as injection of larvae at 3dpf proved difficult.  
Zebrafish injected with USA300 mount a robust immune response to USA300 in the otic 
vesicle (Figure 3.16), and respond minimally to the vehicle control PBS. Similar to my 
findings concerning the inflammatory response, humanised neutrophils are recruited to 
the otic vesicle in fewer numbers in comparison to the control. This suggests that 
expression of the hC5aR.Clover transgene broadly disrupts neutrophil chemotaxis. 
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Figure 3.16 2dpf larvae expressing the hC5aR.Clover transgene fail to mount 
an efficient neutrophil response to infection. 
A) Zebrafish larvae at 2dpf were separated into non-humanised (lyz:nfsB.mCherry only) 
and humanised (lyz:hC5aR.Clover; lyz:nfsB.mCherry) groups, and injected with the 
vehicle control PBS or 1,600cfu S. aureus USA300 in the otic vesicle. They were then 
fixed at 4 hours post infection (hpi) and stained with Sudan Black B to detect neutrophils; 
white outline indicates the otic vesicle. B) Non-humanised and humanised neutrophils 
present at the otic vesicle at 4hpi, blue points denote the representative images in A). 
Error bars shown are mean ± SEM (n=25 over two independent experiments); groups 
were analysed using an ordinary two-way ANOVA and adjusted using Bonferroni’s 
multiple comparisons test. **, p=0.0016; ***, p=0.0002; ****, p<0.0001. 
 
Since the infection recruitment data from 2dpf larvae suggested that neutrophils 
expressing the hC5aR.Clover transgene do not efficiently recruit to sites of infection 
(Figure 3.16), it was important to consider whether the same would be true with more 
developed larvae at 3dpf, as previous studies using the otic vesicle as an infection site 
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used 3dpf larvae (Deng et al., 2012). In Figure 3.17, infection recruitment to the otic 
vesicle at 4hpi was assessed using the same model as Figure 3.16 but with larvae at 3dpf. 
Again, in both groups neutrophils are recruited to the otic vesicle in large numbers when 
infected with USA300, and do not mount a major response to the vehicle control PBS 
(Figure 3.17). When comparing recruitment between non-humanised and humanised 
neutrophils, it was observed that much like the 2dpf model, transgenic neutrophils in 
3dpf larvae are recruited in fewer numbers to the otic vesicle, again suggesting a defect 
in neutrophil chemotaxis. 
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Figure 3.17 3dpf larvae expressing the hC5aR.Clover transgene fail to mount 
an efficient neutrophil response to infection. 
A) Zebrafish larvae at 3dpf separated into non-humanised (lyz:nfsB.mCherry only) and 
humanised (lyz:hC5aR.Clover; lyz:nfsB.mCherry) groups, and injected with the vehicle 
control PBS or 1,900cfu S. aureus USA300, into the otic vesicle. They were then fixed at 
4 hours post infection (hpi) and stained with Sudan Black B to detect neutrophils; white 
outline indicates the otic vesicle. B) Neutrophil recruitment to the otic vesicle at 4hpi, 
blue points denote the representative images in A). Error bars shown are mean ± SEM 
(n=25 over two independent experiments); groups were analysed using an ordinary two-
way ANOVA and adjusted using Bonferroni’s multiple comparisons test. ***, p=0.0004; 
****, p<0.0001. 
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3.3.15 Neutrophils expressing the hC5aR.Clover transgene display defects 
in chemotaxis 
 
Previous experiments show that neutrophils expressing hC5aR.Clover display a defect in 
chemotaxis, resulting in reduced neutrophil numbers at non-haematopoietic sites 
(Figure 3.14), as well as sites of injury (Figure 3.15) and infection (Figures 3.16-17). 
However, it is still unclear how expression of hC5aR.Clover affects individual neutrophil 
recruitment. To assess the impact of transgene expression on neutrophil behaviour, a 
somite tail muscle infection model was utilised to image the migration of neutrophils to 
the infection site (Benard et al., 2012). S. aureus USA300 stained with the FarRed 
fluorescent dye Alexafluor-647 was injected at a dose of ~1,000cfu into the somite tail 
muscles of non-humanised and humanised larvae at 3dpf, which were then imaged 
using spinning disc confocal microscopy. Humanised neutrophils were recruited to the 
infection site, phagocytosing all injected USA300 in under 2 hours (Figure 3.18), 
confirming that humanised neutrophils retain the ability to recruit to sites of infection 
and phagocytose S. aureus. 
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Figure 3.18 Neutrophils expressing the hC5aR.Clover transgene retain the 
ability to migrate to sites of infection and phagocytose bacteria. 
A) Image of a 3dpf zebrafish larva; a somite tail muscle is outlined in red. B) Timelapse 
of a somite tail muscle injection of S. aureus ~1,000cfu USA300 stained with Alexafluor-
647 into a humanised (lyz:hC5aR.Clover; lyz:nfsB.mCherry) larva at 3dpf. USA300 is 
shown in magenta, neutrophils are shown in both red and green. C) An enlarged view of 
the area indicated in B) by the dashed white box, denoting the site in which neutrophil 
recruitment was tracked. White arrowheads indicate initial phagocytic events. Images 
shown at 15 minute intervals; scale bars B) 54µm and C) 27µm. 
 
 
133 
 
As shown in Figure 3.18, neutrophils expressing hC5aR.Clover retain the ability to recruit 
to sites of infection and phagocytose bacteria, however, it remained unclear whether 
this recruitment was significantly disrupted when compared with non-humanised 
neutrophils. To gain quantitative information regarding neutrophil migration to the site 
of infection, non-humanised and humanised neutrophils were analysed during 
recruitment to a somite tail muscle infection using tracking software (Volocity®). 
Compared with non-humanised neutrophils, humanised neutrophils showed a 
significant reduction in their migration velocity (Figure 3.19A), migration distance 
(Figure 3.19C) and displacement (Figure 3.19D). Additionally, humanised neutrophils 
showed no reduction in meandering index (Figure 3.19B), potentially as a result of their 
reduced migration distance. The data confirm that neutrophils expressing the 
hC5aR.Clover transgene have a defect in chemotaxis to sites of infection. 
 
Figure 3.19 hC5aR.Clover neutrophils have a defect in chemotaxis to sites 
of infection. 
Comparisons between non-humanised (lyz:nfsB.mCherry only) and humanised 
(lyz:hC5aR.Clover; lyz:nfsB.mCherry) neutrophils migrating to a site of somite tail muscle 
infection. A) Velocity (µm/second), B) Meandering index, C) Distance migrated (µm) and 
D) Displacement (µm). Values shown are mean ± SEM (n=15 over four independent 
experiments); groups were analysed using an unpaired t-test (two-tailed). **, p>0.009; 
***, p=0.0002; ns, p=0.0933. 
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3.3.16 Panton-Valentine Leukocidin reduces the number of humanised 
neutrophils present at a site of otic infection 
 
A key question regarding neutrophils that express the hC5aR.Clover transgene is 
whether expression of the receptor confers susceptibility to bicomponent pore-forming 
leukocidins, resulting in neutrophil lysis and cell death. As the hC5aR localises to the cell 
surface in zebrafish neutrophils (Figure 3.12), they should be susceptible to lysis from 
Panton-Valentine Leukocidin (PVL) and γ-Haemolysin CB (HlgCB) (Spaan et al., 2013b, 
2014).  
To investigate if neutrophils expressing the hC5aR.Clover transgene become susceptible 
to lysis from PVL, an otic infection with ~4,000cfu of USA300 was performed on non-
humanised and humanised larvae at 3dpf, with and without 30.3µM of PVL in the 
suspension buffer. The half-maximal concentration for PVL-induced lysis in human 
neutrophils is 0.9nM (Spaan et al., 2013b), and the PVL stock used here was used in 
unpublished in vitro work with monocyte-like U937 cells expressing the hC5aR, reporting 
a lytic concentration of 303.03nM (Michiel van Gent, unpublished). For injection into the 
otic vesicle, 30.3µM of PVL per nl was used, which should be sufficient to induce lysis in 
vivo. 
As demonstrated previously, USA300 elicits a major immune response, recruiting many 
neutrophils to the otic vesicle, while a vehicle control produces only a minimal response 
(Figures 3.16-17). Injection of USA300 with PVL also produces an immune response in 
both groups, however, humanised larvae injected with USA300 and PVL demonstrated 
a reduced neutrophil number at the otic vesicle that was not observed in non-
humanised larvae (Figure 3.20). This suggests that humanised neutrophils are 
susceptible to PVL induced lysis or inhibition of chemotaxis, leading to a reduction in the 
number of neutrophils present at the site of infection. 
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Figure 3.20 Neutrophils expressing the hC5aR.Clover transgene are 
susceptible to targeting by Panton-Valentine Leukocidin. 
A) Zebrafish larvae at 3dpf were separated into non-humanised (lyz:nfsB.mCherry only) 
and humanised (lyz:hC5aR.Clover; lyz:nfsB.mCherry) groups and injected into the otic 
vesicle with a vehicle control, ~4,000cfu of S. aureus USA300, or ~4,000cfu USA300 
suspended in 30.3µM of PVL. After injection, larvae were fixed in paraformaldehyde 
(PFA) at 4 hours post infection (hpi) and stained with Sudan Black B to detect 
neutrophils; white outline indicates the otic vesicle. B) Neutrophils present at the otic 
vesicle at 4hpi, blue points denote the representative images in A). Error bars shown are 
mean ± SEM (n=22-26 over two independent experiments); groups were analysed using 
an ordinary two-way ANOVA and adjusted using Bonferroni’s multiple comparisons test. 
*, p=0.0471; **, p=0.0015; ****, p<0.0001; ns, p>0.9999. 
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3.3.17 γ-Haemolysin CB reduces the number of humanised neutrophils 
present at a site of otic infection 
 
While PVL appears to reduce the number of humanised neutrophils present at the otic 
vesicle, I cannot exclude that fewer neutrophils may be recruited to the injection site 
due to competitive inhibition of the hC5aR by LukS-PV, the receptor-targeting subunit 
of PVL. To investigate this, I tested a second human-specific pore-forming leukocidin, 
HlgCB, which also targets the hC5aR. Using the same approach described in 3.3.16, I 
injected non-humanised and humanised larvae with a vehicle control, USA300, USA300 
suspended in HlgC or USA300 suspended in HlgCB. The inclusion of a group suspended 
in HlgC will determine whether a reduction in the number of humanised neutrophils at 
the injection site is due to inhibition of the hC5aR, or pore-formation of humanised 
neutrophils. 
Recapitulating previous experiments, injection of USA300 into the otic vesicle results in 
robust recruitment of neutrophils to the site of injection in both non-humanised and 
humanised larvae. All groups injected into non-humanised larvae produced a similar 
level of neutrophil recruitment to the otic vesicle; however in humanised larvae, the 
USA300 and USA300 + HlgC groups showed a similar level of neutrophil recruitment, 
while the USA300 + HlgCB group exhibited a significant reduction in the number of 
neutrophils present at the injection site (Figure 3.21). This suggests that the reduction 
in humanised neutrophils at the wound site observed in Figure 3.20 and 3.21 are the 
result of lysis by pore-forming leukocidins PVL and HlgCB, and not due to competitive 
inhibition by the receptor targeting subunits of these toxins. 
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Figure 3.21 Neutrophils expressing the hC5aR.Clover transgene are 
susceptible to targeting by HlgCB, and not HlgC. 
A) Zebrafish larvae at 3dpf were separated into non-humanised (lyz:nfsB.mCherry only) 
and humanised (lyz:hC5aR.Clover; lyz:nfsB.mCherry) groups and injected into the otic 
vesicle with a vehicle control, ~3,000cfu of S. aureus USA300, ~3,000cfu USA300 
suspended in 16.7µM of HlgC, or ~3,000cfu of S. aureus USA300 suspended in 16.7µM 
of HlgCB. After injection, larvae were fixed in paraformaldehyde (PFA) at 4 hours post 
infection (hpi) and stained with Sudan Black B to detect neutrophils; white outline 
indicates the otic vesicle. B) Neutrophils present at the otic vesicle at 4hpi, blue points 
denote the representative images in A), scale 100µm. Error bars shown are mean ± SEM 
(n=32-41 over three independent experiments); groups were analysed using an ordinary 
two-way ANOVA and adjusted using Bonferroni’s multiple comparisons test. ns, 
p>0.9999; *, p=0.0304; **, p=0.0023; ****, p<0.0001. 
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3.3.18 Neutrophils expressing the lyz:hC5aR.Clover transgene migrate to 
injected human C5a 
 
Another question regarding neutrophils expressing the hC5aR.Clover transgene is 
whether they are capable of responding to human C5a (hC5a). Several experiments 
show that neutrophils expressing the transgene retain the ability to recruit to sites of 
infection and inflammation despite impairment (Figures 3.15-20), and are therefore 
capable of responding to chemotactic signals within the larva. As hC5aR.Clover localises 
to the neutrophil surface (Figure 3.12), humanised neutrophils should be able to bind 
and respond to a gradient of hC5a. 
To investigate whether neutrophils expressing the hC5aR are able to respond to hC5a, I 
used an otic injection model to measure neutrophil recruitment. Larvae were separated 
into non-humanised and humanised groups and injected with a PBS vehicle control, 
zebrafish C5a (drC5a) or human C5a (hC5a) into the otic vesicle at 3dpf. As a readout of 
C5a binding to the C5a receptor, studies use the calcium mobilisation step that occurs 
when GPCRs bind their ligand to infer the activation of the receptor that precedes 
chemotaxis. Reported values for C5a-induced calcium mobilisation are between 1nM for 
hC5a in human neutrophils (Spaan et al., 2013b) and 1µM for drC5a in U937 cells 
transfected with the zebrafish C5a receptor (Michiel van Gent, unpublished). For 
injection into the otic vesicle, 1nl of 10µM hC5a and 89µM drC5a was used, which is in 
excess of the optimal values, and so should be sufficient to induce chemotaxis in vivo. 
As shown in Figure 3.22, humanised neutrophils are recruited to an injection of hC5a, 
and are recruited less to drC5a, suggesting that hC5aR.Clover actively responds to hC5a 
and mediates chemotaxis, taking precedence over the endogenous drC5a receptor in 
doing so. Conversely, non-humanised neutrophils do not respond to hC5a, and are 
recruited normally to an injection of drC5a. The data confirm that hC5aR.Clover acts as 
a functional C5a receptor on the surface of neutrophils, and is capable of mediating 
chemotaxis in response to hC5a. 
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Figure 3.22 Neutrophils expressing the hC5aR.Clover transgene are 
recruited to an injection of purified human C5a. 
A) Zebrafish larvae at 3dpf were separated into non-humanised (lyz:nfsB.mCherry only) 
and humanised (lyz:hC5aR.Clover; lyz:nfsB.mCherry) groups and injected with a PBS 
vehicle control, 89µM of zebrafish C5a (drC5a) or 10µM human C5a (hC5a) into the otic 
vesicle. After injection, larvae were fixed in PFA at 4 hours post infection (hpi) and 
stained with Sudan Black B to detect neutrophils. B) Neutrophils present at the otic 
vesicle at 4hpi, blue points denote the representative images in A). Error bars shown are 
mean ± SEM (n=22-26 over two independent experiments); groups were analysed using 
an ordinary two-way ANOVA and adjusted using Bonferroni’s multiple comparisons test. 
****, p<0.0001; ns, p=0.0513.  
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3.3.19 Expression of hC5aR.Clover does not increase susceptibility to 
staphylococcal infection 
 
A final consideration is whether Tg(lyz:hC5aR.Clover)sh505 fish are more susceptible to 
staphylococcal infection as a result of expression of the hC5aR. To investigate this, 
Tg(lyz:hC5aR.Clover)sh505 fish were crossed to the non-pigmented nacre background 
(White et al., 2008b) and the embryos screened for expression of the lyz:hC5aR.Clover 
transgene at 30hpf. Transgenic embryos can be identified early in development by 
expression of the cmlc2:eGFP green heart marker that is present in the lyz:hC5aR.Clover 
construct for transgenesis optimisation (Huang et al., 2003). After separating non-
humanised (wild-type – no green heart) and humanised (hC5aR.Clover-positive – green 
heart) larvae, both groups were infected with ~1,800cfu of USA300, and their survival 
monitored over four days. The systemic model of staphylococcal infection was used 
here, as it is highly dependent on phagocytes for control and clearance of infection 
(Prajsnar et al., 2008, 2012). Additionally, the systemic model allows a high number of 
embryos to be assessed simultaneously, at a relatively mid-range dose of S. aureus. 
Figure 3.23 shows that both groups are equally susceptible to staphylococcal infection, 
and that humanisation does not confer susceptibility to S. aureus USA300 in this model.  
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Figure 3.23 Expression of the hC5aR.Clover transgene does not affect 
survival in a model of systemic staphylococcal infection. 
Tg(lyz:hC5aR.Clover)sh505 zebrafish were crossed to the non-pigmented nacre 
background and their embryos screened for expression of the hC5aR.Clover transgene 
at 30hpf. Non-humanised (wild-type) and humanised (lyz:hC5aR.Clover positive) 
embryos were injected into the circulation valley with ~1,800cfu USA300; survival was 
then monitored over the next four days. Values (n=80 over three independent 
experiments) were analysed using a Log-rank Mantel-Cox test; ns, p=0.7032. 
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3.4 Discussion 
 
An essential aspect of S. aureus infection is the adaptation of virulence factors to its 
host. The versatility of S. aureus in infecting different species is considerable, with 
species-specific virulence factors identified across the vast majority of S. aureus strains. 
This species-specific activity has impaired the investigation of many virulence factors, 
including those targeting the human C5a receptor. To address the gap in understanding 
surrounding the role of virulence factors targeting the hC5aR in vivo, a zebrafish model 
expressing the hC5aR on zebrafish neutrophils was created. The zebrafish offers a 
unique way of approaching this issue, and could offer several benefits over the 
conventional mouse model. Several in vitro studies have demonstrated the specific 
interaction of virulence factors with the hC5aR (Spaan et al., 2013b, 2014), but there are 
few that have been able to determine their importance in vivo. 
 
3.4.1 Virulence factors targeting the human C5a receptor (hC5aR) do not 
participate in systemic staphylococcal infection in the zebrafish 
 
As S. aureus produces at least three virulence factors that target the hC5aR, it is clearly 
a significant target during infection. These factors target chemotaxis (chemotaxis 
inhibitory protein of staphylococcus – CHIPS) and cause neutrophil lysis (Panton-
Valentine Leukocidin (PVL) and γ-Haemolysin CB (HlgCB)) to impair the innate immune 
system and establish infection. An increasing number of these factors are known to be 
highly adapted to infection in humans, creating a gap in understanding between them 
and in vivo studies of staphylococcal infection. As there is currently no established and 
reliable model for investigating the activity of human-adapted virulence factors during 
infection, a new model is required. I aimed to create a transgenic zebrafish model that 
expresses a fluorescently-tagged hC5aR on the surface of zebrafish neutrophils. 
The zebrafish is a powerful model for investigating staphylococcal infection. A systemic 
infection model has revealed that neutrophils play a central role in the persistence and 
dissemination of S. aureus, suggesting a complex relationship between them (Prajsnar 
et al., 2012). Before creating the Tg(lyz:hC5aR.Clover)sh505 line, I sought to clarify 
whether targeting by human-adapted virulence factors is an important aspect of 
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infection in this model. I systemically infected wild-type zebrafish larvae at 30 hours post 
fertilisation (hpf) with the CA-MRSA strain USA300, and compared this against infection 
with isogenic knockout strains of CHIPS and HlgCB.  
Although I observed that knockout strains did not become attenuated in this model, this 
does not directly show that they are unable to target the zebrafish C5a receptor 
(drC5aR) during infection. The importance of the drC5aR during zebrafish infection is 
unknown due to a lack of studies concerning the receptor, therefore, it is unclear 
whether targeting of the receptor would result in a survival advantage during S. aureus 
infection. Additionally, the systemic model could be unsuitable for investigating 
functional targeting by CHIPS and HlgCB, which primarily target neutrophils, as the 
systemic model chiefly depends on macrophages for bacterial clearance (Colucci-Guyon 
et al., 2011). Moreover, due to the absence of a ΔPVL strain, it is unfortunate that I was 
unable to assess whether PVL contributes to infection in this model. 
It is unclear whether virulence factors such as CHIPS and HlgCB are expressed in the 
zebrafish model, as the optimum temperature used in zebrafish studies is 28°C, while 
most in vivo work concerning S. aureus is at 37°C. This could be investigated at the 
transcriptional level using quantitative PCR (qPCR), with S. aureus cultured at different 
temperatures; this would address whether there is a reduction in expression of these 
genes in the zebrafish model. This can be followed up with experiments determining 
whether these changes in gene expression lead to changes in the production of these 
virulence factors.  
 
3.4.2 Construction of a zebrafish line expressing the human C5a receptor 
 
To create a transgenic zebrafish expressing the hC5aR in neutrophils, I used Gateway® 
cloning in combination with Tol2-mediated transgenesis. To provide information 
concerning the intracellular localisation of the receptor, as well as enable fluorescence-
based screening of transgenic larvae, I fused the fluorescent protein clover to the C-
terminus of the hC5aR and expressed it in neutrophils using the neutrophil-specific 
promoter lyz (Yang et al., 2012). Clover was fused to the C-terminus, as an N-terminal 
fusion could disrupt C5a binding or interfere with the activity of virulence factors such 
144 
 
as HlgCB and PVL, which require an intact N-terminus to induce optimal pore-formation 
(Spaan et al., 2013b, 2014).  
A C-terminally tagged hC5aR should be capable of activation and signalling, as in vitro 
studies demonstrate that fusion of a fluorescent tag to the C-terminus of the hC5aR does 
not interfere with the receptor function or the ability of neutrophils to respond to C5a 
(Servant et al., 1999). Additionally, as I aimed to visualise localisation of the receptor 
within neutrophils, I expressed hC5aR.Clover as a fusion protein by removing the 
terminal stop codon of hC5aR before creating the final construct. Another construct with 
an intact stop codon was generated, however it was not used for transgenesis, as I 
wished to visualise the intracellular location of the receptor in zebrafish neutrophils. 
Once the three entry clones were created, they were fused together in the pDestTolCG2 
destination vector in the order 5’ lyz – Middle hC5aR – 3’ Clover, creating the full-length 
construct. 
Once the pDestTol2CG2 lyz:hC5aR.Clover construct was successfully created, the 
transgene was inserted into the zebrafish genome using Tol2 transposase-mediated 
transgenesis. Higher concentrations of DNA injected into zebrafish embryos resulted in 
a lower rate of development and survival, matching published observations (Stuart et 
al., 1988). Additionally, transgenesis into embryos resulted in transient expression rates 
of 2-4%, which is lower than expected. Despite this, adult fish had a germline integration 
rate of roughly 15%, which is in line with Tol2-mediated integration rates for constructs 
over 10kb (Suster et al., 2011); the reduced levels of transient expression could be in 
part due to the size of the construct (Tol2 arm – Tol2 arm 15.9kb), and not due to 
inefficient insertion. 
Inducing transient expression of lyz:hC5aR.Clover in Tg(lyz:nfsB.mCherry)sh260 embryos 
resulted in larvae with a heterogeneous population of neutrophils expressing either the 
lyz:nfsB.mCherry or lyz:hC5aR.Clover transgene within the same larva. This 
heterogeneous expression pattern was initially viewed as advantageous for 
investigating the susceptibility of hC5aR.Clover-positive neutrophils to PVL/HlgCB, as 
non-transgenic neutrophils within the same fish would provide an internal control for 
cell lysis. However, after numerous attempts, it was apparent that the transient 
expression rate of 2-4% was too low to be technically feasible for experimental use. 
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Once a stable transgenic founder was identified, it was observed that the hC5aR.Clover 
transgene was stably expressed in neutrophils at the cell surface. I show that the 
lyz:hC5aR.Clover transgene is enriched at the neutrophil membrane, suggesting that the 
receptor is successfully translated and localises to the neutrophil cell surface, 
recapitulating expression of the receptor in human neutrophils. This also suggests that 
the receptor should be capable of binding hC5a as a ligand to mediate chemotaxis. 
Additionally, lyz:hC5aR.Clover neutrophils were often observed with intracellular 
puncta, which could indicate internalisation and recycling of the receptor after 
activation, a phenomenon that is also observed in vitro (Servant et al., 1999). This 
suggests that in future experiments, this model could also be used to investigate how 
the hC5aR localises within the cell under different conditions. 
 
3.4.3 Expression of hC5aR.Clover results in a defect in neutrophil 
chemotaxis 
 
I determined the impact of the hC5aR.Clover transgene on neutrophil function by 
crossing Tg(lyz:hC5aR.Clover)sh505 fish to Tg(lyz:nfsB.mCherry)sh260 fish, and sorting 
into non-humanised (lyz:nfsB.mCherry only) and humanised (lyz:hC5aR.Clover; 
lyz:nfsB.mCherry) groups at 2-3 days post fertilisation (dpf). These groups were 
compared with one another for two reasons: Tg(lyz:nfsB.mCherry)sh260 fish were kept 
as a mixture of heterozygous and homozygous, meaning that a group expressing only 
the lyz:hC5aR.Clover transgene was not consistently available; also, by comparing 
lyz:nfsB.mCherry-only with double-transgenic lyz:hC5aR.Clover; lyz:nfsB.mCherry fish, 
only expression of hC5aR.Clover separated the two groups. 
After generating the Tg(lyz:hC5aR.Clover)sh505 line, I assessed how expression of the 
transgene affects neutrophil haematopoiesis and function. While I found that the total 
neutrophil number of lyz:hC5aR.Clover-positive fish is unaffected by transgene 
expression, the unpaired t-test used to compare total neutrophil numbers from non-
humanised and humanised larvae gave a P-value approaching significance (p=0.1046) 
which suggested that the data should be re-analysed. By comparing the number of 
neutrophils in separate regions of non-humanised and humanised larvae, I observed a 
reduced number of neutrophils between the mid-yolk sac and caudal-haematopoietic 
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tissue (CHT) in 4dpf larvae. This is likely to be a consequence of the impaired neutrophil 
migration observed elsewhere, as at this stage of development there are defined 
migrations of haematopoietic cells from the tail towards the thymus that could be 
disrupted in lyz:hC5aR.Clover-positive larvae (Murayama et al., 2006). Also, the 
retention of neutrophils at haematopoietic sites within the larva could have made the 
precise enumeration of neutrophils at these sites more difficult. 
In addition to the observed changes in the neutrophil population throughout the larva, 
I investigated if expression of the hC5aR.Clover transgene resulted in any defects in the 
neutrophil response to inflammation and infection. Using a model of neutrophilic 
inflammation, I demonstrated that neutrophils expressing the hC5aR.Clover transgene 
were recruited to sites of injury in reduced numbers, implying an impaired response to 
chemotactic signals. These points were measured at 3 and 6 hours post injury, 
corresponding to peak recruitment and early resolution stages respectively, providing a 
more complete picture of neutrophil function (Renshaw et al., 2006a). However, it is 
unclear whether inflammation resolution is influenced by hC5aR.Clover expression; this 
could be determined by assessing the number of neutrophils present at the site of injury 
from 6-12 hours post injury. 
As the chemotactic signals governing recruitment to sites of infection are distinct from 
those governing inflammation in the zebrafish model (Deng et al., 2013), I investigated 
the recruitment of hC5aR.Clover neutrophils to sites of infection using an otic vesicle 
infection model in addition to a somite muscle infection model. Tissue injection models 
precede an efficient neutrophil-driven immune response to the site of infection, as 
neutrophils are predominantly recruited to surface-associated microbes (Colucci-Guyon 
et al., 2011). The otic vesicle and somite infection models yielded similar results to the 
tailfin injury inflammation recruitment data, with hC5aR.Clover neutrophils recruiting 
ineffectively to sites of infection. The somite infection model also showed that 
hC5aR.Clover neutrophils exhibit a defect in chemotaxis, resulting in reduced migration 
velocity and distance. Interestingly, the meandering index was shown to be increased in 
lyz:hC5aR.Clover; lyz:nfsB.mCherry neutrophils, which is likely to be a product of the 
reduced migration distance observed in these cells. 
It is currently unclear whether this defect is the result of constitutive receptor signalling, 
or ‘dilution’ of the endogenous chemotactic receptors. To determine this, another 
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hC5aR transgene could be constructed with a truncated Gα signalling domain, resulting 
in receptor expression without functional activation (Oldham and Hamm, 2008). As the 
N-terminal portion of the receptor would remain intact, it could still be used to 
investigate functional interactions with virulence factors, and should not interfere with 
neutrophil chemotaxis. Unpublished data suggest that the hC5aR is unable to bind 
zebrafish C5a (drC5a) at levels below 1µM (Michiel van Gent), however the average 
concentrations of drC5a produced by zebrafish are unknown due to a lack of published 
studies surrounding the complement cascade in zebrafish. Assuming that zebrafish 
produce a similar level of C5a to humans (maximum plasma concentration 100nM 
during sepsis), I can suggest that zebrafish should not produce enough C5a to 
constitutively activate the hC5aR (Ward and Gao, 2009). Compounding this is the 
increased expression level of the hC5aR in Tg(lyz:hC5aR.Clover)sh505 fish compared 
with human neutrophils, and as a result they could be more sensitive to C5a 
concentrations. This is likely to be the case, as hC5aR expression is correlated with 
susceptibility to PVL activity (Spaan et al., 2013b), and could also be true regarding hC5a 
sensitivity. 
This defect in chemotaxis could also impair antimicrobial capacity by interfering with 
essential pattern recognition receptors such as TLRs or chemotactic receptors located 
at the cell surface. Activation of the hC5aR is typically accompanied by a burst of reactive 
oxygen species, which could contribute to microbial killing, however this is unlikely to 
be properly coordinated in these neutrophils (Guo et al., 2003). Bacterial killing and ROS 
generation could be assessed using fluorescence microscopy, with the aid of ROS-
sensitive dyes, or by simply recovering the bacteria from infected humanised larvae and 
comparing with non-humanised larvae (Elks et al., 2014; Mugoni et al., 2014; Prajsnar et 
al., 2012). The ability of these cells to efficiently phagocytose bacteria could also be 
examined using these approaches. 
In several characterisation experiments, fixed larvae were stained with Sudan Black B in 
place of a fluorescent microscopy approach. The fixed larvae approach permitted a 
greater number of larvae to be assessed in a single experiment, allowing assessment of 
a higher number of groups. A drawback of this approach is that it provides no 
information concerning transgene expression in these neutrophils. Sudan Black is 
myeloperoxidase-dependent, therefore, this approach measures only the number of 
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myeloperoxidase-positive neutrophils at the otic vesicle at 4 hours post infection (hpi) 
(Pase et al., 2012). It is therefore feasible to conclude that the reduced number of 
neutrophils recruited to sites of injury and infection could represent only those 
expressing lyz:hC5aR.Clover at a lower level than lyz:nfsB.mCherry, potentially 
overcoming the chemotactic defects that are associated with lyz:hC5aR.Clover 
expression. However, in stable larvae, every double-transgenic lyz:hC5aR.Clover; 
lyz:nfsB.mCherry neutrophil examined in these experiments expressed both transgenes 
to a more or less equal degree across all experiments. This suggests that the likelihood 
of a ‘less-humanised’ neutrophil that expresses lyz:hC5aR.Clover at a reduced level and 
therefore is recruited more efficiently to the wound/infection site is extremely low, and 
therefore it is unlikely that Sudan Black staining excludes certain transgenic neutrophil 
populations in humanised larvae. 
 
3.4.4 Humanised neutrophils are targeted by pore-forming leukocidins and 
are recruited to hC5a 
 
Despite hC5aR.Clover neutrophils displaying a defect in chemotaxis, it remained 
important to test functionality of the hC5aR in this model. An important aspect of 
creating the hC5aR.Clover transgene was to investigate if expression of the hC5aR at the 
neutrophil surface confers susceptibility to bi-component leukocidins including Panton-
Valentine Leukocidin (PVL) and γ-Haemolysin CB (HlgCB). To test this, I used the otic 
vesicle infection model to compare neutrophil recruitment between non-humanised 
and humanised larvae by injecting USA300 alone or USA300 in a suspension containing 
30.3µM of PVL, and in a second experiment, also USA300 and 16.7µM HlgC or USA300 
and 16.7µM HlgCB. The concentrations of these toxins should be sufficient, as they are 
many times greater than the minimum concentration required for cell lysis (PVL 0.9nM, 
HlgCB 63nM) (Spaan et al., 2013b, 2014).  
I demonstrated that there are fewer humanised neutrophils present at the otic vesicle 
when injected with PVL or HlgCB compared with USA300 alone. As this was not observed 
in the non-humanised groups, or in the USA300 + HlgC group, it suggests that humanised 
neutrophils become susceptible to pore-formation by these leukocidins, and are not 
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reduced in number at the otic vesicle due to competitive inhibition by the receptor-
targeting subunits LukS-PV and HlgC. 
Direct evidence of neutrophil lysis is not shown in these experiments, however the 
concentration of PVL injected and the length of time required for lysis should be 
sufficient. In vitro, lysis is shown to occur before 3 hours post exposure, while here I fix 
injected larvae at 4hpi (Spaan et al., 2013b). An additional experiment that could be 
performed is to investigate whether the otic vesicle contains a greater proportion of lytic 
products after 4hpi, as I have not conclusively demonstrated that neutrophil lysis occurs. 
As DNA is released from neutrophils upon membrane permeabilisation and cell lysis, the 
fluorescent intercalating agent propidium iodide could be used to assess leukocidin-
mediated pore-formation in humanised neutrophils (Halverson et al., 2015). 
Additionally, leukocidins are known to bind and activate the C5a receptor at sub lytic 
concentrations (~0.25nM), triggering receptor activation and intracellular calcium 
release (Tawk et al., 2015). As mentioned, lyz:hC5aR.Clover neutrophils have been 
observed to undergo receptor internalisation and recycling, indicating an interaction 
between hC5aR ligands and the receptor. Using the receptor-binding subunits of PVL 
and HlgCB (LukS-PV, HlgC), it should be feasible to demonstrate receptor activation in 
response to LukS-PV binding, in a similar manner to hC5a.  
To test the hC5aR as a functional receptor in zebrafish neutrophils, recruitment to 
zebrafish (drC5a) and human (hC5a) was also tested; as the hC5aR is expressed at the 
cell surface, it should be able to bind and respond to hC5a. It was shown that humanised 
neutrophils are recruited to a site of hC5a injection in the otic vesicle, and respond 
partially to an injection of drC5a (ns, p=0.513), as they still possess the endogenous 
drC5a receptor. Non-humanised neutrophils do not recruit to hC5a, and retain the ability 
to respond to drC5a, suggesting that expression of the hC5aR desensitises neutrophils 
to endogenous drC5a.  
The injected concentrations of both drC5a and hC5a are in excess of those required for 
receptor activation and initiation of chemotaxis, with a higher concentration used for 
injection with drC5a (89µM) than with hC5a (10µM). Unpublished data suggest that cells 
transfected with the drC5a receptor require a 1,000-fold greater concentration of drC5a 
to achieve a comparable response to hC5aR-expressing cells binding hC5a (Michiel van 
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Gent). This suggests that the difference in C5a concentration used for each group is 
unlikely to result in a disproportionate response beyond those discussed. Additionally, 
as the hC5aR is overexpressed on the surface of zebrafish neutrophils, it could require a 
much lower concentration for functional activation. 
Activation of the hC5aR could be investigated by examining whether a rapid and 
transient spike of intracellular calcium (Ca2+) occurs after treatment with hC5a, a 
hallmark of G-protein coupled receptor (GPCR) activation (Bockaert, 1999). By isolating 
hC5aR.Clover-positive neutrophils and treating them with a Ca2+ sensitive dye, the Ca2+ 
level of the cells could be measured after treatment with hC5a, allowing receptor 
function to be determined (Spaan et al., 2013b). This approach also has potential 
applications in studying signalling of the drC5a receptor in response to drC5a, which is 
currently unknown. 
 
3.4.5 Zebrafish expressing hC5aR.Clover do not become susceptible to 
systemic staphylococcal infection 
 
To investigate the impact of hC5aR.Clover on survival against systemic staphylococcal 
infection, I outcrossed the Tg(lyz:hC5aR.Clover)sh505 line to the nacre background; this 
enabled us to screen embryos as early as 30hpf for expression of the hC5aR.Clover 
transgene using the green heart marker. Using this approach, I observed no difference 
in survival following systemic infection between non-transgenic and transgenic larvae, 
suggesting that expression of the hC5aR transgene does not confer susceptibility to 
staphylococcal infection in this model. Heterozygous Tg(lyz:hC5aR.Clover)sh505 fish 
were crossed to nacre rather than heterozygous Tg(lyz:nfsB.mCherry)sh260 fish, 
producing two genotypes instead of instead of four and reducing the number of larvae 
required for screening prior to the experiment. Additionally, hC5aR.Clover-expressing 
embryos were identified at 30hpf by their expression of a green heart marker, which is 
not present in the Tg(lyz:nfsB.mCherry)sh260 line. Therefore, if the standard 
Tg(lyz:hC5aR.Clover)sh505 x Tg(lyz:nfsB.mCherry)sh260 cross were used, double-
transgenic embryos would be indistinguishable from single-transgenic embryos, 
creating variation between the tested groups. As double-transgenic lyz:hC5aR.Clover; 
lyz:nfsB.mCherry larvae could be in effect ‘less humanised’ than single-transgenic 
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lyz:hC5aR.Clover larvae, they could exhibit a reduced susceptibility to S. aureus 
infection. Therefore, this cross may produce a mix of larvae with varying susceptibility 
to infection due to their transgene expression, and was avoided. 
Numerous experiments can be performed to determine if Tg(lyz:hC5aR.Clover)sh505 
fish are susceptible to staphylococcal infection, using survival models that are governed 
by a neutrophil-driven immune response, as the systemic model is largely driven by 
macrophages (Colucci-Guyon et al., 2011). One approach would be to suppress the 
macrophage transcription factor irf8, preventing macrophage development and 
enlarging the neutrophil population by skewing myeloid lineage development, 
producing larvae with a neutrophil-only phagocyte response (Li et al., 2011). 
Investigating the susceptibility of larvae to staphylococcal infection using neutrophil-
driven infection routes was also considered, but involved extremely high bacterial 
inocula to induce mortality. The otic vesicle is an unsuitable model for examining survival 
against infection, with doses of up to 63,000cfu of P. aeruginosa being required to 
produce a 50% survival rate (Deng et al., 2012). 
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3.5 Future Directions 
 
I demonstrated using a systemic model of staphylococcal infection that knockout strains 
of the virulence factors chemotaxis inhibitory protein of staphylococcus (CHIPS) and γ-
Haemolysin CB (HlgCB) did not result in an attenuation of virulence, suggesting that they 
are dispensible during infection in this model. Future studies should determine whether 
this is also the case in neutrophil-driven infection models such as larvae with a 
phagocyte population of predominantly neutrophils, induced using the irf8 morpholino 
(Li et al., 2011). Panton-Valentine Leukocidin (PVL) also targets the human C5a receptor 
(hC5aR), however I was unable to assess if a PVL knockout strain was also attenuated in 
this model. Further experiments using the systemic infection model should be carried 
out to assess whether this is the case. 
As there is a major temperature difference between human cells (37°C) and the 
zebrafish model (28°C), there are concerns surrounding the expression of hC5aR-
targeting virulence factors in the zebrafish. Differences in expression could be assessed 
using quantitative PCR (qPCR), which would permit comparison between virulence 
factor transcript levels at these two temperatures (Duquenne et al., 2010). Accordingly, 
any changes in gene expression should be validated by determining whether this 
correlates with changes in protein levels. 
Although not shown clearly in these results, neutrophils in the 
Tg(lyz:hC5aR.Clover)sh505 line exhibited intracellular clover puncta, suggesting that the 
hC5aR is internalised and recycled in these neutrophils. This is a hallmark of G-protein 
coupled receptor (GPCR) activation after ligand binding, and suggests that the hC5aR 
could be functionally recycled after activation in these neutrophils (Barak et al., 1997; 
Servant et al., 1999). A similar observation has been made in vitro using PLB-985 cells 
expressing the hC5aR with a C-terminal GFP tag, where the receptor is shown to be 
internalised and recycled after agonist treatment, in addition to localising with the 
lagging edge of the cell during chemotaxis (Servant et al., 1999). GPCRs are also known 
to undergo constitutive endocytosis and internalisation in the absence of agonist 
(Scarselli and Donaldson, 2009), although the functional implications of this are 
unknown. Internalisation of hC5aR.Clover as a consequence of functional activation of 
the receptor could be investigated using a number of C5aR antagonists (Woodruff et al., 
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2011), or by generating a second transgenic line with a truncated signalling domain, and 
observing whether internalisation still occurs. Additionally, receptor dynamics during 
chemotaxis in hC5aR.Clover neutrophils could be investigated to determine whether 
they recapitulate in vitro observations regarding agonist-mediated receptor 
internalisation. 
Unfortunately, Tg(lyz:hC5aR.Clover)sh505 zebrafish exhibit a defect in neutrophil 
migration to sites of infection and inflammation. This is likely due to disruption of 
endogenous chemotactic signalling as a result of overexpression of the hC5aR at the cell 
surface. It also could be a consequence of constitutive signalling by the hC5aR, 
accounting for the reduced migration velocity and distance observed in these 
neutrophils (Figure 3.19). To correct this, a second hC5aR line could be made with a 
truncated C-terminal signalling domain, preventing the constitutive signalling of the 
receptor that disrupts chemotaxis, but retaining targeting by hC5aR-binding factors, 
which act using the N-terminus of the receptor (de Haas et al., 2004; Spaan et al., 2013b, 
2014). It was not investigated whether overexpression of the hC5aR in these neutrophils 
produced any change in bactericidal activity. In human neutrophils, activation of 
chemotactic receptors such as the C5aR is generally accompanied by the initiation of the 
respiratory burst, which could be amplified in these fish and produce an enhanced 
antimicrobial capacity (Hato and Dagher, 2015). Equally, the constitutive activation of 
these neutrophils may be detrimental to the antimicrobial response, as the production 
of ROS is induced specifically to destroy pathogens. The antimicrobial capacity of 
humanised neutrophils could be addressed by imaging neutrophils infected with S. 
aureus and probing with ROS and pH-sensitive dyes (Mugoni et al., 2014; Page et al., 
2013), or by recovering the bacteria from ‘humanised’ larvae after infection and 
comparing against ‘non-humanised’ larvae.  
I demonstrated that neutrophils from Tg(lyz:hC5aR.Clover)sh505 larvae can migrate to 
purified hC5a, and are only partially able to migrate to drC5a. This suggests that the 
receptor functions as a chemotactic receptor in these cells, however I did not directly 
demonstrate functional receptor signalling. Receptor signalling could be investigated by 
isolating hC5aR.Clover-positive neutrophils and assessing whether a release of 
intracellular calcium ions (Ca2+) occurs after ligand binding, which is a hallmark of GPCR 
activation (Tawk et al., 2015). This approach would be possible with a Ca2+ sensitive 
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probe, and could also be used to determine whether virulence factors that inhibit hC5aR 
activation are functional against these neutrophils, such as CHIPS or sublytic 
concentrations of PVL/HlgCB (Tawk et al., 2015). 
Zebrafish have orthologous genes for most components of the complement system, and 
are able to form a membrane attack complex (MAC) to lyse gram-negative bacteria from 
fertilisation (Wang and Zhang, 2010; Wang et al., 2009; Zhang and Cui, 2014). Despite 
these studies, there is a shortage of data concerning the functional importance of the 
complement system in zebrafish larvae, and several important complement 
components have yet to be genetically identified, including complement receptor 1 
(CR1), CR2, inactivated C3b (iC3b) and C3b (Zhang and Cui, 2014). Experiments could be 
carried out to address a wide variety of questions, including where these factors are 
expressed, how they contribute to opsonophagocytosis and their roles in the 
inflammatory response in zebrafish. To assess expression of complement components 
and receptors in zebrafish larvae, whole-mount in situ hybridisation (WISH) experiments 
can be performed, as the importance of central components such as C3a, C5a and their 
cognate receptors C3aR and C5aR are currently largely unknown. Additionally, in vivo 
reporter lines of endogenous complement components can be generated using bacterial 
artificial chromosome (BAC) technology (Suster et al., 2011), and could be paired with 
microscopy techniques, genetic manipulation techniques for transient gene knockdown, 
and approaches examining Ca2+ release to determine the impact of C3 on phagocytosis, 
as well as the concentrations of C3a or C5a required for recognition by their cognate 
receptors. 
I showed that Tg(lyz:hC5aR.Clover)sh505 neutrophils were present in reduced numbers 
at the otic vesicle when injected with USA300 resuspended in PVL; this suggests that PVL 
is able to target and lyse these neutrophils. Although I did not directly demonstrate PVL-
induced lysis of humanised neutrophils, further experiments to confirm this could be 
carried out. This could be accomplished by assessing whether there is a level of products 
released after lysis present at the injection site, potentially using a fluorescent probe 
that stains DNA, such as propidium iodide or DAPI (Sandell et al., 2012). The same 
approaches can be used to investigate the related pore-forming leukocidin HlgCB, which 
also forms pores in the cell membrane by binding to the hC5aR. 
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Although I demonstrate using a systemic model of staphylococcal infection that 
Tg(lyz:hC5aR.Clover)sh505 fish do not become more susceptible to infection, further 
experiments should be performed to confirm this. It has been noted that zebrafish 
neutrophils only effectively phagocytose pathogens that are associated with tissue, 
while macrophages are the prevalent phagocyte during systemic infections (Colucci-
Guyon et al., 2011). Future experiments should focus on using neutrophil-driven 
infection approaches, either by using infection routes that produce a neutrophil-driven 
immune response such as the otic vesicle or somite tail muscle, or by skewing myeloid 
lineage development using an irf8 morpholino, producing larvae with no macrophages 
and an expanded neutrophil population (Colucci-Guyon et al., 2011; Li et al., 2011). 
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3.6 Conclusions 
 
In this chapter, I created a transgenic zebrafish that expresses a fluorescently-labelled 
human C5a receptor (hC5aR) on the surface of zebrafish neutrophils, in order to 
investigate interactions of human-adapted virulence factors with the immune system. 
Neutrophils from Tg(lyz:hC5aR.Clover)sh505 fish exhibited a defect in neutrophil 
recruitment to sites of infection and injury, implicating the disruption of endogenous 
chemotactic receptor signalling. As staphylococcal leukocidins such as Panton-Valentine 
Leukocidin and γ-haemolysin CB (PVL, HlgCB) require only the N-terminal region of the 
hC5aR to bind and cause neutrophil lysis, I investigated this using the 
Tg(lyz:hC5aR.Clover)sh505 line. The data suggest that the hC5aR imparts a susceptibility 
to lysis from these toxins, matching in vitro studies using human neutrophils. 
Additionally, I demonstrated that the hC5aR is functional in these neutrophils, as 
evidenced by their ability to migrate to hC5a, and not zebrafish C5a. 
I also demonstrate that S. aureus strains lacking the human-adapted virulence factors 
CHIPS and HlgCB (chemotaxis inhibitory protein of staphylococcus and γ-Haemolysin CB) 
are not attenuated in a model of systemic staphylococcal infection, suggesting that they 
are unable to target the zebrafish C5a receptor to confer a survival advantage. Lastly, 
Tg(lyz:hC5aR.Clover)sh505 zebrafish are not more susceptible to systemic 
staphylococcal infection, however further investigation into virulence factor expression 
and neutrophil-driven infection models could demonstrate a heightened susceptibility 
to infection in these fish.
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Chapter 4: Creation of a transgenic zebrafish 
expressing human myeloperoxidase 
 
4.1 Chapter Introduction 
 
A key feature of neutrophils is their ability to generate a respiratory burst, where large 
amounts of reactive oxygen species (ROS) are released to mediate microbial killing. A 
major enzyme involved in this process is myeloperoxidase (MPO), which potentiates the 
respiratory burst by catalysing the conversion of hydrogen peroxide (H2O2) into 
hypochlorous acid (HOCl), a highly reactive oxidative product that enhances the 
destruction of microbes. Despite MPO’s central role in generating ROS, patients with 
MPO deficiency are not uncommon (1 in 2,000 – 4,000 people) and exhibit no major 
susceptibilities to infection with the exception of fungal infections from C. albicans 
(Nauseef, 1988). In contrast, patients with chronic granulomatous disease (CGD) – who 
lack the phagocyte NADPH oxidase – are susceptible to a variety of bacterial and fungal 
infections, and have a high risk of childhood mortality (Assari, 2006). This comparison 
raises doubts surrounding the importance of MPO in oxidative defence, suggesting that 
it could play a dispensable role in microbial killing. 
In addition to potentiating the respiratory burst, MPO is a key regulator of the 
inflammatory response. MPO deficiency is associated with a higher risk and severity of 
chronic inflammatory conditions such as atherosclerosis and cardiovascular disease 
(Brennan et al., 2001; Kutter et al., 2000). MPO regulates inflammation by inactivating 
pro-inflammatory mediators and stimulating the release of enzymes that limit tissue 
destruction at the site of injury (Clark and Klebanoff, 1979; Weiss et al., 1985). 
Additionally, MPO is a major regulator of H2O2, as observed in MPO-deficient 
neutrophils that produce uncontrolled levels of H2O2, escaping from neutrophils and 
damage surrounding tissues (Schürmann et al., 2017). Limiting H2O2 production is also 
one of the earliest anti-inflammatory events, as H2O2 acts as a chemoattractant that is 
sensed by neutrophils through a redox-sensitive kinase (Pase et al., 2012; Yoo et al., 
2011). Despite the lack of a correlation between MPO deficiency and susceptibility to 
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infection, MPO and its products play important roles during both infection and 
inflammation, highlighting its significance in mediating the functions of neutrophils. 
Staphylococcus aureus is an increasing threat to public health, utilising a wide variety of 
virulence factors to establish infection. After phagocytosis, S. aureus employs several 
factors that allow it to resist phagosomal killing by targeting oxidative agents including 
H2O2 and superoxide (O2-). Recently, a virulence factor was discovered that targets MPO 
by acting as a ‘molecular plug’ that occludes the active site, preventing MPO from 
functioning (de Jong et al., 2017). Produced by almost all strains of S. aureus, the 
staphylococcal peroxidase inhibitor (SPIN) contributes towards evasion of the oxidative 
defence, highlighting MPO’s importance during infection. Importantly, SPIN can only 
inhibit human MPO, joining a growing list of virulence factors that are highly adapted to 
infection within the context of a human host. 
Human-adapted virulence factors like SPIN highlight a major obstacle towards 
elucidating their importance during infection, as there is currently no established 
humanised model for investigating infection in vivo. Studies using the mouse model have 
determined that it is unsuitable towards investigating MPO, as there are many 
differences between the human and murine enzymes. Human neutrophils contain 5 to 
10-fold more MPO, and major differences exist in the promoter, enhancer and inducer 
regions of the two enzymes (Rausch and Moore, 1975; Zhao et al., 1997). To address 
these problems, a novel model that enables the investigation of human-adapted 
virulence factors during infection is required. 
The zebrafish is a promising infection model; it is genetically tractable, suited to in vivo 
microscopy, and has high fecundity. As an established model for investigating bacterial 
infection and inflammation, the zebrafish has delivered unique insights into the roles of 
the innate immune system (Elks et al., 2013; Mazon-Moya et al., 2017; Renshaw et al., 
2006a). Additionally, as a model of staphylococcal infection it has revealed complex 
interactions between neutrophils and S. aureus (Prajsnar et al., 2008, 2012). Using the 
zebrafish model, I aimed to create a transgenic line that expresses a fluorescently-
tagged human MPO in zebrafish neutrophils, permitting investigation into the role of 
SPIN during staphylococcal infection. Additionally, by expressing MPO as a fusion 
protein with a fluorescent tag, the line could be used to visualise MPO-containing 
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primary granules in vivo, creating a valuable tool towards understanding granule 
dynamics during infection.  
We aimed to express MPO in zebrafish neutrophils for several reasons. Its importance 
as an enzyme outwith potentiating the oxidative burst is not fully understood, and 
extends to mediating inflammatory signals and pathways; therefore, a transgenic MPO 
line could provide useful insights into the functions of MPO in vivo. Although MPO plays 
several roles, it is not essential for survival, and therefore overexpression is unlikely to 
disrupt normal development and homeostasis of the zebrafish; additionally, transgenic 
lines can be generated relatively quickly without much difficulty. There is currently no in 
vivo reporter of granule dynamics, and a transgenic line expressing fluorescent MPO in 
neutrophil granules would represent a useful tool with which this could be studied. 
Lastly, at the beginning of this project, SPIN was only recently discovered, and my work 
here would complement this data well if similar experiments could be performed using 
the zebrafish model. 
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4.2 Chapter Aims 
 
My hypothesis for this chapter was: 
 
Expressing myeloperoxidase in zebrafish neutrophils will enhance susceptibility to 
staphylococcal infection due to targeting by the human-specific staphylococcal 
peroxidase inhibitor. 
 
The aims of this chapter were to: 
 
• Determine the dynamics of SPIN expression during infection in the zebrafish 
model, and assess whether SPIN is important during infection in wild-type 
zebrafish. 
• Generate transgenic zebrafish expressing fluorescently-tagged MPO in 
neutrophils, and assess the impact of transgene expression, as well as whether 
MPO is functional in zebrafish neutrophils. 
• Create a transgenic zebrafish that produces MPO in the absence of Mpx, to 
enable the investigation of interactions between SPIN and MPO. 
• Determine if zebrafish expressing MPO become more susceptible to 
staphylococcal infection, and whether Mpx plays an important role during 
infection. 
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4.3 Results 
 
4.3.1 The staphylococcal peroxidase inhibitor (SPIN) is dispensable during 
systemic staphylococcal infection in the zebrafish 
 
To determine whether the zebrafish is a suitable model for investigating the impact of 
SPIN expression during infection, I first had to know whether SPIN is able to inhibit 
endogenous zebrafish myeloperoxidase (Mpx). As SPIN inhibits only human 
myeloperoxidase (MPO) (de Jong et al., 2017), it should be unable to inhibit Mpx, and 
so infection using a ΔSPIN strain should not differ from a wild-type S. aureus infection.  
To investigate whether SPIN can inhibit Mpx in vivo, I used a systemic model of 
staphylococcal infection (Prajsnar et al., 2008) in which a dose of S. aureus is injected 
into the circulation of larvae at 30 hours post fertilisation (hpf); survival is then 
monitored over the next four days. Survival of wild-type zebrafish (London Wild-Type - 
LWT) injected with the CA-MRSA strain USA300 was compared against survival of wild-
type zebrafish infected with an isogenic SPIN knockout strain (ΔSPIN). If SPIN is able to 
inhibit Mpx, the severity of infection should be attenuated, resulting in greater survival. 
Infection with ΔSPIN did not result in any significant attenuation (Figure 4.1) suggesting 
that SPIN does not inhibit Mpx during systemic infection. 
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Figure 4.1 SPIN is dispensable during systemic infection in wild-type 
zebrafish.  
Wild-type (LWT) zebrafish were systemically infected with ~1,800cfu S. aureus USA300 
or an isogenic ΔSPIN strain at 30 hours post-fertilisation (hpf) and monitored over the 
next four days post infection. Groups (n=66 over three independent experiments) were 
analysed using a Mantel-Cox Log-rank test; ns, p=0.0756. 
 
4.3.2 Investigation of SPIN expression in vitro 
 
As infection with a ΔSPIN strain results in no significant attenuation of virulence during 
systemic staphylococcal infection, I asked whether this was the result of an inability to 
inhibit Mpx, or a lack of SPIN expression during infection. Using the pSPIN-GFP reporter 
strain, it was possible to visualise the dynamics of SPIN expression during infection. 
pSPIN-GFP contains GFP fused to the SPIN promoter, resulting in GFP production in 
conditions where SPIN is expressed. In human neutrophils, SPIN is upregulated as early 
as 40 minutes post phagocytosis (de Jong et al., 2017). To test whether this was 
replicated in the zebrafish model, pSPIN-GFP was injected into the somite tail muscle of 
transgenic red neutrophil reporter Tg(lyz:nfsB.mCherry)sh260 zebrafish, permitting 
timelapse microscopy of neutrophil recruitment to the site of infection. Initial attempts 
to investigate SPIN expression after phagocytosis in zebrafish neutrophils revealed that 
expression of pSPIN-GFP was extremely low after normal S. aureus preparation, 
resulting in a low level of GFP that made microscopy difficult. Therefore, before 
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microscopy was possible it was necessary to investigate how pSPIN-GFP is expressed 
during culture growth.  
Expression of pSPIN-GFP during culture growth was measured using fluorometry, with 
samples taken from a 50ml culture inoculated with 500µl of overnight culture. The 
culture was shaken at 37°C, and samples were taken once every 30 minutes for 12 hours 
with one final timepoint at 24 hours. At these timepoints, the samples were measured 
for growth (absorbance OD600) and fluorescence (488nm). There was no increase in GFP 
levels until mid-exponential phase at around 4 hours 30 minutes (OD600=0.7), where it 
then continues to increase over 24 hours (Figure 4.2). This explained the problems 
encountered while attempting to image pSPIN-GFP, as normal preparation of S. aureus 
for injection into zebrafish involves culturing bacteria for a maximum of 3 hours 
(OD600=0.05), where the GFP level is far lower. 
 
 
 
Figure 4.2 Expression of pSPIN-GFP in shaking culture. 
The absorbance (OD600) and fluorescence (488nm) of pSPIN-GFP during 50ml shaking 
culture growth at 37°C over a 24-hour period. A control strain of the same S. aureus 
background (USA300) was grown simultaneously and subtracted from pSPIN-GFP to 
correct for background autofluorescence. Data shown are mean ± SEM. 
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4.3.3 pSPIN-GFP expression does not increase within 90 minutes after 
phagocytosis by zebrafish neutrophils 
 
As pSPIN-GFP is expressed at higher levels after a longer duration of culture prior to 
preparation (Figure 4.2), pSPIN-GFP was cultured for 5 hours and injected into the 
somite tail muscles of red neutrophil reporter Tg(lyz:nfsB.mCherry)sh260 larvae at 3 
days post fertilisation (dpf). Recruitment of neutrophils to the site of infection was 
imaged using timelapse microscopy, and compared against infection with the USA300 
GFP strain, which produces GFP constitutively. Both strains were clearly visible within 
the zebrafish somite (Figure 4.3B), and were rapidly phagocytosed by neutrophils, 
confirming that experiments investigating the impact of SPIN during infection could 
require a longer culture time prior to infection in the zebrafish. 
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Figure 4.3 pSPIN-GFP is visible within zebrafish somites after an extended 
culture length. 
A) A 3dpf zebrafish larva with a somite tail muscle outlined with a dashed red box. B) 
USA300 GFP and pSPIN-GFP injected into the somite tail muscle of red neutrophil 
reporter Tg(lyz:nfsB.mCherry)sh260 larvae at 3dpf and imaged as neutrophils are 
recruited to the site of infection. Neutrophils are shown in magenta, and S. aureus in 
green. Shown at intervals of 30 minutes; dashed white box indicates the enlarged region 
below each panel. Scale bar = 18µm. 
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As I had identified conditions that would allow me to investigate pSPIN-GFP expression 
in zebrafish neutrophils, the GFP level of pSPIN-GFP after phagocytosis was analysed by 
comparing the levels of GFP within neutrophils containing pSPIN-GFP with the levels of 
those containing USA300 GFP. I could not demonstrate any increase in GFP signal in 
either USA300 GFP or pSPIN-GFP before 90 minutes post phagocytosis (Figure 4.4), 
suggesting a difference in regulation of the SPIN gene by S. aureus within zebrafish and 
human neutrophils. Despite the absence of an upregulation of SPIN after phagocytosis, 
these experiments confirmed that SPIN is expressed by S. aureus during infection in the 
zebrafish model, suggesting that it can be used to investigate interactions between SPIN 
and MPO in vivo. 
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Figure 4.4 pSPIN-GFP expression does not increase within 90 minutes of 
phagocytosis. 
Fold change (%) in GFP signal of USA300 GFP and pSPIN-GFP strains at A) 30, B) 60 and 
C) 90 minutes post phagocytosis (mpp). Error bars shown are mean ± SEM (n=30 
neutrophils over two independent experiments); groups were analysed using an 
unpaired t-test (two-tailed); ns, p=0.2818. 
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4.3.4 Cloning strategy  
 
After establishing that S. aureus can produce SPIN during zebrafish infection, and that 
SPIN does not significantly contribute to infection in the systemic model, I sought to 
create a transgenic zebrafish expressing a fluorescently-labelled human MPO. To create 
the genetic construct that will be expressed in transgenic zebrafish, I used Gateway® 
cloning, a technology based on the att site-specific recombination system from lambda 
phage (Hartley et al., 2000). To use Gateway® cloning, individual genetic elements are 
constructed as plasmids known as entry clones, which can be assembled into a single 
large construct in a modular fashion; for example (5’) promoter, (middle) gene, (3’) 
fluorescent protein. As I used an identical cloning strategy to produce the 
lyz:hC5aR.Clover line in chapter 3, refer to this chapter for details concerning the 
Gateway® cloning strategy for generating transgenic zebrafish lines (Section 3.3.2). 
Briefly, I first required an entry clone containing the MPO gene, which can then be used 
to generate a complete construct containing a neutrophil promoter and a fluorescent 
tag via an LR reaction. In my MPO construct, the 5’ element is the promoter lyz, a 
neutrophil-specific promoter (Yang et al., 2012); the middle element is fluorescently-
tagged MPO and the 3’ entry clone is a polyA tail, which confers stability to messenger 
RNA (mRNA). Once created, all three elements are assembled within the destination 
vector, which was ‘pDestTol2CG2’ in this study. This vector contains a green heart 
marker (cmlc2:eGFP) that provides feedback concerning the efficiency of transgenesis, 
and two ‘Tol2 arms’ which permit insertion of the construct into the zebrafish genome 
with the aid of the Tol2 transposase (Huang et al., 2003; Kawakami, 2007). 
 
4.3.5 Creation of a middle entry clone containing the MPO gene 
 
As entry clones containing the lyz promoter and a polyadenylation sequence had been 
constructed previously, only the middle entry clone containing a fluorescently-tagged 
MPO gene was required. The fluorescent tag is an important feature of the construct, 
permitting fluorescence-based screening of transgenic larvae as well as indicating the 
intracellular localisation of the fusion protein. In human neutrophils, MPO undergoes 
extensive post-translational modification, including a step that involves cleavage of an 
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N-terminal pro-peptide region during protein maturation (Hansson et al., 2006). Due to 
this cleavage step, two fluorescent fusion protein strategies were implemented, one 
being MPO with a C-terminal tag and the other with an N-terminal tag, increasing the 
likelihood of an approach that produces fluorescently-tagged MPO that successfully 
localises to neutrophil granules. 
Two vectors (Figure 4.5BC) containing MPO with a C-terminal (pmEmerald-MPO-N-18) 
and N-terminal (pmEmerald-MPO-C-18) fusion of the fluorescent protein mEmerald, a 
5-fold brighter derivative of eGFP (Cubitt et al., 1999), were ordered from addgeneTM 
and used to create the middle entry clone by ligation into the empty middle entry clone 
vector pME MCS (Figure 4.5A). 
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Figure 4.5 Plasmid maps of pME MCS and plasmids containing a 
fluorescently-tagged MPO gene.  
A) pME MCS, a donor vector containing attL1 and attL2 sites required to act as a middle 
entry clone. Restriction sites used to ligate the MPO gene into the plasmid are shown in 
red (XbaI), blue (NotI) and green (SacII) boxes. B and C) Plasmid vectors containing the 
MPO gene with C-terminal and N-terminal fusions of the fluorescent protein mEmerald 
respectively. Restriction sites that were used to cut and ligate the MPO gene from these 
plasmids into the pME MCS vector are shown in red (NheI), blue (NotI) and green (SacII) 
boxes.  
 
 
 
 
 
 
171 
 
Both MPO.mEmerald (pmEmerald-MPO-N-18) and mEmerald.MPO (pmEmeraldMPO-C-
18) sequences were separately ligated into the empty middle entry clone vector pME 
MCS, which contains the attL1 and attL2 sites required for creation of the full-length 
construct. Due to differences between the two MPO vectors, two different pairs of 
restriction enzymes were used to extract the tagged MPO gene from the plasmids; for 
pmEmerald MPO-N-18, NotI and NheI were used, and for pmEmerald MPO-C-18, SacII 
and NheI were used. For pME MCS, XbaI was used in place of NheI, and was suitable for 
ligation due to the compatible DNA overhang that is generated by XbaI and NheI (5’ 
GATC 3’). After digesting the plasmids with the indicated restriction enzymes, the 
digestion products were visualised by agarose gel electrophoresis, and bands of the 
expected sizes were cut and gel extracted (Figure 4.6). 
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Figure 4.6 Extraction of the tagged MPO gene from pmEmerald MPO-N-18 
and pmEmerald MPO-C-18. 
Restriction digests of the middle entry vector pME MCS, alongside A) pmEmerald MPO-
N-18 and B) pmEmerald MPO-C-18. In A) pME MCS is cut with XbaI and NotI (2,759bp) 
and pmEmerald MPO-N-18 is cut with NheI and NotI (3,052bp). In B) pME MCS is cut 
with XbaI and SacII (2,749bp) and pmEmerald MPO-C-18 is cut with NheI and SacII 
(3,055bp). The digested products were cut from the gels in the positions indicated by 
the red boxes. Hyperladder 1kb plus. 
173 
 
Once the digested DNA was gel extracted, the tagged MPO gene was ligated into the 
pME MCS middle entry vector. This created two middle entry vectors, pME MCS 
mEmerald-MPO-N-18 (MPO.mEmerald) and pME MCS mEmerald-MPO-C-18 
(mEmerald.MPO) (Figure 4.7), which could then be used to assemble the full-length 
construct. 
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Figure 4.7 Maps of tagged MPO middle entry clones pME MCS mEmerald-
MPO-N-18 and pME MCS mEmerald-MPO-C-18.  
Plasmid maps containing the tagged MPO gene with a A) C-terminal (MPO.mEmerald) 
and B) N-terminal (mEmerald.MPO) fusion of the fluorescent protein mEmerald. 
Restriction sites used for diagnostic digests are shown in A) red (XbaI) and blue (NotI) 
boxes and B) red (XbaI) and green (SacII) boxes. 
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After ligation, the reaction products were transformed into competent cells and the 
ligated DNA was extracted. To confirm the successful construction of the middle entry 
clones, diagnostic digests using XbaI and NotI (pME MCS mEmerald-MPO-N-18) or XbaI 
and SacII (pME MCS mEmerald-MPO-C-18) were carried out. After digestion and 
visualisation by agarose gel electrophoresis, both digests produced fragments 
corresponding to the correct sizes (Figure 4.8), indicating that both MPO fragments had 
been successfully ligated into pME MCS. 
 
 
Figure 4.8 Diagnostic digest of middle entry clones containing fluorescently-
tagged MPO. 
Diagnostic digest of pME MCS mEmerald-MPO-N-18 and pME MCS mEmerald-MPO-C-
18. Correct band sizes for pME MCS mEmerald-MPO-N-18 are 3,167bp and 2,644bp; for 
pME MCS mEmerald-MPO-C-18, 3,904bp and 1,900bp. Hyperladder 1kb plus. 
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4.3.6 Assembly of the lyz:MPO.mEmerald and lyz:mEmerald.MPO 
constructs 
 
With the successful construction of the middle entry clones, the final step was to carry 
out a Gateway® recombination reaction known as an ‘LR reaction’, which fuses a 5’ and 
a 3’ element to either side of a middle entry clone element within a destination vector. 
The lyz promoter (5’), fluorescently-tagged MPO (MPO.mEmerald, mEmerald.MPO; 
middle) and polyadenylation tail (3’) were fused together in the destination vector 
‘pDestTol2CG2’, producing the plasmids pDestTol2CG2 lyz:MPO.mEmerald (Figure 4.9A) 
and pDestTol2CG2 lyz:mEmerald.MPO (Figure 4.9B). 
 
 
 
Figure 4.9 Plasmid maps of pDestTol2CG2 lyz:MPO.mEmerald and 
pDestTol2CG2 lyz:mEmerald.MPO. 
Plasmid maps of A) pDestTol2CG2 lyz:MPO.mEmerald and B) pDestTol2CG2 
lyz:mEmerald.MPO. Sites used for diagnostic digests are shown in red boxes for XbaI and 
in blue boxes for SnaBI and NheI. 
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To confirm the successful generation of the assembled MPO constructs, the LR reaction 
products were transformed into competent cells and the DNA extracted from colonies 
of each construct; the extracted DNA was then tested via diagnostic digest. Both 
constructs were digested with XbaI (Figure 4.10A) and to ensure the accuracy of the 
result from the initial digest, both were digested again using both SnaBI and NheI (Figure 
4.10B). Both digests produced DNA bands indicating the successful assembly of the 
constructs (Figure 4.10), confirming that MPO plasmids which can be used for 
transgenesis into zebrafish embryos had been created. 
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Figure 4.10 Diagnostic digests of pDestTol2CG2 lyz:MPO.mEmerald and 
pDestTol2CG2 lyz:mEmerald.MPO.  
A) XbaI digests of pDestTol2CG2 lyz:MPO.mEmerald and pDestTol2CG2 
lyz:mEmerald.MPO colonies: correct bands for MPO.mEmerald are 14,627bp, 3,422bp, 
2,210bp and 625bp; for mEmerald.MPO 14,627bp, 2,668bp, 2,210bp and 1,372bp. B) 
Second digest of colonies (SnaBI-NheI): correct bands for MPO.mEmerald are 9,980bp, 
6,356bp and 4,458bp; for mEmerald.MPO 9,980bp, 6,356bp and 4,541bp. Hyperladder 
1kb plus. 
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To verify the successful construction of pDestTol2CG2 lyz:MPO.mEmerald and 
pDestTol2CG2 lyz:mEmerald.MPO, high concentrations of construct DNA were acquired 
by extracting DNA from bacterial stocks at an increased culture volume. The DNA from 
both constructs was then sequenced using the primers ‘MPO attB1 For’ (both), ‘MPO-N 
Linker’ (lyz:MPO.mEmerald) and ‘MPO-C Linker’ (lyz:mEmerald.MPO) (2.1.4 Primers) 
which anneal at the attB1 site before the start of the middle entry clone, and at the 
linker region between MPO and mEmerald in both constructs (Figure 4.11). Sequencing 
confirmed the successful assembly of pDestTol2CG2 lyz:MPO.mEmerald and 
pDestTol2CG2 lyz:mEmerald.MPO, with MPO and mEmerald remaining in-frame from 
the overlap at the end of the 5’ lyz promoter and the overlap between MPO and 
mEmerald in both cases. 
 
 
 
Figure 4.11 Sequencing of pDestTol2CG2 lyz:MPO.mEmerald and 
pDestTol2CG2 lyz:mEmerald.MPO. 
Maps of A) pDestTol2CG2 lyz:MPO.mEmerald and B) pDestTol2CG2 lyz:mEmerald.MPO, 
showing regions that were verified by sequencing; the annealing sites and read lengths 
of primers ‘MPO attB1 For’, ‘MPO-N Linker’ and ‘MPO-C Linker’ are also indicated. 
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4.3.7 Generation of lyz:MPO.mEmerald transgenic zebrafish 
 
Once the MPO constructs had been created, conditions for effective transgenesis were 
optimised by testing a range of concentrations of construct DNA and Tol2 transposase 
mRNA. Tol2 is an autonomous transposase isolated from the genome of the medaka fish 
(Oryzias latipes) that catalyses transposition of DNA between two Tol2 sequences, 
integrating the construct into the zebrafish genome (Kawakami, 2007). In addition to 
the 5’, middle and 3’ elements, the construct also contains a green heart marker (Huang 
et al., 2003) (Figure 4.12A), which provides feedback concerning the efficiency of 
transgenesis in the form of eGFP expression over the heart. At 3 days post fertilisation 
(dpf), the number of developed larvae, the number of larvae expressing the green heart 
marker and the number of larvae expressing the transgene was recorded (Figure 4.12B). 
During protein maturation, MPO undergoes several post-translational modifications, 
including a step involving the cleavage of an N-terminal pro-peptide region (Hansson et 
al., 2006). With this in mind, I predicted that the C-terminal fusion of mEmerald to MPO 
should remain intact once MPO has been processed and localises to neutrophil granules, 
and so only the lyz:MPO.mEmerald construct was injected into zebrafish embryos. 
Higher concentrations of DNA and Tol2 mRNA resulted in reduced development (Figure 
4.12B), and at a construct DNA dilution of 1/75 (13ng/µl) and 10ng/µl Tol2 mRNA, ~2-
4% of larvae had a fluorescently labelled cell population in the CHT. At 50ng/µl of Tol2 
mRNA, DNA dilutions of 1/100 and 1/50 (~10-20ng/µl) also yielded a small percentage 
of fluorescent larvae (Figure 4.12B), and showed an increase in transgenesis from 4-7% 
across both groups. As the CHT is the primary site of haematopoiesis until ~2 weeks post 
fertilisation (Murayama et al., 2006), this suggested that the transgene is likely to be 
expressed in zebrafish neutrophils. Once these conditions had been confirmed to induce 
transgenesis in zebrafish larvae, sufficient larvae were raised for screening of a stably 
integrated transgenic founder. 
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Figure 4.12 Tol2 transgenesis of the lyz:MPO.mEmerald construct into the 
zebrafish genome.  
A) Schematic of the lyz:MPO.mEmerald construct, which includes the neutrophil-specific 
promoter (lyz), the MPO gene with a C-terminal fluorescent tag (MPO.mEmerald) and a 
green heart marker to aid optimisation of transgenesis (cmlc2:eGFP). B) Transgenesis 
data testing a range of DNA and Tol2 transposase mRNA concentrations injected into 
zebrafish embryos at the single-cell stage and screened for construct expression at 3dpf. 
All performed as single experiments excluding groups marked with * and +, which 
represent the means of five and three independent experiments respectively. 
 
4.3.8 Transient expression of the MPO transgene 
 
Expression of the MPO.mEmerald transgene within the CHT suggests that the transgene 
is expressed by haematopoietic cells of the zebrafish. To investigate the identity of these 
cells further, transient construct expression was induced in the red fluorescent 
neutrophil reporter line Tg(lyz:nfsB.mCherry)sh260, which labels neutrophils with the 
red fluorescent protein mCherry. At 3dpf, larvae were screened for co-expression of 
both transgenes. 
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Double-transgenic Transient lyz:MPO.mEmerald; Tg(lyz:nfsB.mCherry)sh260 larvae 
express both transgenes within neutrophils in the CHT (Figure 4.13B), confirming that 
the lyz:MPO.mEmerald transgene is expressed in zebrafish neutrophils. Interestingly, 
although mEmerald and mCherry are expressed in the same cells, they display distinct 
expression patterns (Figure 4.13B inset), with regions of the cell containing mCherry 
where there is no mEmerald signal. This suggests that lyz:MPO.mEmerald and 
lyz:nfsB.mCherry localise to distinct intracellular compartments, and could indicate 
localisation of MPO.mEmerald to neutrophil granules.  
 
 
Figure 4.13 Transient expression of the lyz:MPO.mEmerald transgene in 
zebrafish neutrophils.  
A) A 3dpf zebrafish larva, the CHT region is indicated by the red box. B) The CHT of a 
double-transgenic Transient lyz:MPO.mEmerald; Tg(lyz:nfsB.mCherry)sh260 larva with a 
population of neutrophils expressing both mEmerald and mCherry. Arrowhead indicates 
neutrophil shown in inset; scale bar = 20µm. 
 
4.3.9 Identification of a stable transgenic zebrafish founder 
 
To secure a number of adult zebrafish with stable germline integrations of the 
lyz:MPO.mEmerald transgene, larvae that transiently express the transgene were raised 
and outcrossed to determine whether the transgene was inherited by their offspring. 
An adult that produced larvae with a cell population labelled with mEmerald was 
identified and its progeny raised to provide a tank of stable fish expressing the MPO 
transgene, with the designation Tg(lyz:MPO.mEmerald)sh496. To confirm whether the 
lyz:MPO.mEmerald transgene is expressed in zebrafish neutrophils in stably transgenic 
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fish, they were crossed to the red neutrophil reporter line Tg(lyz:nfsB.mCherry)sh260, 
and screened for any co-expression of fluorescent proteins. Both transgenes were 
expressed in neutrophils throughout the CHT (Figure 4.14), demonstrating that 
lyz:MPO.mEmerald is expressed in zebrafish neutrophils in stably transgenic larvae. 
 
 
 
Figure 4.14 Stable expression of the lyz:MPO.mEmerald transgene in 
zebrafish neutrophils. 
A double-transgenic Tg(lyz:MPO.mEmerald)sh496; Tg(lyz:nfsB.mCherry)sh260 zebrafish 
larva (3dpf). White arrow indicates the enlarged region shown in inset. 
 
4.3.10 Tg(lyz:MPO.mEmerald)sh496 transgenic zebrafish produce 
mEmerald signal that localises with a granular subcellular destination 
 
MPO is located in the primary granules of neutrophils where it can be delivered to the 
phagosome, resulting in ROS generation and antimicrobial activity (Klebanoff et al., 
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2012). In order for the lyz:MPO.mEmerald transgene to recapitulate MPO expression in 
human neutrophils, mEmerald should localise to the granules of zebrafish neutrophils 
and be delivered to sites of infection and injury (Pase et al., 2012).  
To investigate the intracellular localisation of the MPO transgene, 
Tg(lyz:MPO.mEmerald)sh496 fish were outcrossed to Tg(lyz:nfsB.mCherry)sh260, and at 
3dpf the larvae were imaged in high detail using an Airyscanner confocal microscope. 
Both transgenes are expressed in the same cells (Figure 4.15BC), with MPO.mEmerald 
localising with a granular subcellular destination (Figure 4.15C), suggesting that the 
MPO.mEmerald fusion protein is trafficked to and packaged within zebrafish neutrophil 
granules. Additionally, as observed in Figure 4.13B, there is a region of the neutrophil 
that contains mCherry, but no mEmerald (Figure 4.15B), suggesting that the subcellular 
location of mCherry and mEmerald differs. 
 
 
Figure 4.15 MPO.mEmerald localises with granular structures in zebrafish 
neutrophils. 
A) A 3dpf larva, the CHT is outlined by the red box. B and C) Airyscanner confocal images 
of neutrophils within the CHT of a double-transgenic Tg(lyz:MPO.mEmerald)sh496; 
Tg(lyz:nfsB.mCherry)sh260 larva at 3dpf. C) An enlarged image of the neutrophil 
highlighted by the dashed white box in B). Scale bars B) 20µm and C) 5µm. 
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4.3.11 Expression of the MPO transgene does not impact neutrophil 
haematopoiesis 
 
As the MPO.mEmerald fusion protein appears to localise with neutrophil granules, I 
began to investigate how expression of the transgene affects neutrophil haematopoiesis 
and the response to inflammation and infection. To investigate these questions, 
Tg(lyz:MPO.mEmerald)sh496 was crossed to Tg(lyz:nfsB.mCherry)sh260 and their larvae 
sorted at 2-3dpf based on transgene expression into “non-humanised” 
(lyz:nfsB.mCherry only) and “humanised” (lyz:MPO.mEmerald; lyz:nfsB.mCherry) 
groups. For the remainder of the chapter, I use the terms “non-humanised” to refer to 
larvae expressing only lyz:nfsB.mCherry, and “humanised” to refer to double-transgenic 
siblings expressing lyz:hC5aR.Clover; lyz:nfsB.mCherry. Using this method of grouping 
larvae, the impact of transgene expression on a number of neutrophil functions could 
be assessed. 
To investigate how the lyz:MPO.mEmerald transgene affects haematopoiesis, non-
humanised and humanised larvae were fixed with paraformaldehyde (PFA) at 4dpf and 
stained with Sudan Black B to detect neutrophils; the total neutrophil number found 
throughout the larvae was then counted. Non-humanised and humanised larvae had 
comparable neutrophil numbers (Figure 4.16), suggesting that lyz:MPO.mEmerald 
expression does not interfere with neutrophil haematopoiesis. Additionally, neutrophils 
were found throughout the whole body of humanised fish (Figure 4.16A), suggesting 
that transgenic neutrophils are able to leave the CHT. 
 
186 
 
 
Figure 4.16 Expression of the MPO transgene does not affect 
haematopoiesis.  
A) 4dpf larvae from a Tg(lyz:MPO.mEmerald)sh496 x Tg(lyz:nfsB.mCherry)sh260 cross, 
sorted into non-humanised (lyz:nfsB.mCherry only) and humanised (lyz:MPO.mEmerald; 
lyz:nfsB.mCherry) groups, fixed with PFA, and then stained with Sudan Black B to detect 
neutrophils. B) Total body neutrophil counts from non-humanised and humanised 
groups. Values shown are mean ± SEM (n=60 over two independent experiments) and 
were analysed using an unpaired t-test (two-tailed); ns, p=0.9089. 
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4.3.12 Expression of lyz:MPO.mEmerald does not interfere with the 
neutrophil-mediated inflammatory response 
 
To assess the impact of humanisation on the neutrophil-mediated inflammatory 
response, I used a tailfin-transection model that initiates neutrophil recruitment to a 
vertically transected tailfin injury in zebrafish larvae (Renshaw et al., 2006a). Non-
humanised and humanised 3dpf larvae were injured and the recruitment of neutrophils 
to the site of injury was imaged at 3 and 6 hours post injury (hpi) (Figure 4.17A). Both 
groups demonstrated comparable migration of neutrophils to the site of injury at 3 and 
6hpi (Figure 4.17B), suggesting that lyz:MPO.mEmerald does not interfere with 
neutrophil recruitment to sites of injury. 
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Figure 4.17 Neutrophil recruitment to sites of injury is unaffected by 
expression of lyz:MPO.mEmerald. 
A) Non-humanised (lyz:nfsB.mCherry only) and humanised (lyz:MPO.mEmerald; 
lyz:nfsB.mCherry) 3dpf larvae with tailfins transected to induce neutrophil recruitment; 
dashed outline represents the area in which neutrophils were counted. Scale bar = 
250µm. B) Neutrophil numbers at the site of injury at 3 and 6 hours post injury (hpi); 
blue points denote the representative images in A). Error bars shown are mean ± SEM 
(n=45 over three independent experiments); groups were analysed using an ordinary 
two-way ANOVA and adjusted using Bonferroni’s multiple comparisons test; ns, 
p>0.9999. 
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4.3.13 lyz:MPO.mEmerald expression does not impact neutrophil 
recruitment to sites of infection 
 
To address whether the neutrophil response to infection is affected by expression of 
lyz:MPO.mEmerald, I used an otic vesicle infection model to investigate neutrophil 
recruitment (Benard et al., 2012; Deng et al., 2013). After separating larvae into non-
humanised and humanised groups, they were injected with either a PBS vehicle control 
or S. aureus USA300 into the otic vesicle at 3dpf. The larvae were then fixed in 
paraformaldehyde (PFA) at 4 hours post infection (hpi) and stained with Sudan Black B 
to detect neutrophils. Injection of USA300 induces robust recruitment of neutrophils to 
the otic vesicle, with comparable numbers recruited between non-humanised and 
humanised larvae (Figure 4.18). This confirms that expression of the lyz:MPO.mEmerald 
transgene does not interfere with neutrophil recruitment to sites of infection. 
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Figure 4.18 Neutrophil recruitment to sites of infection is unaffected by 
expression of lyz:MPO.mEmerald.  
A) Non-humanised (lyz:nfsB.mCherry only) and humanised (lyz:MPO.mEmerald; 
lyz:nfsB.mCherry) zebrafish larvae injected with either a PBS vehicle control or 1,400cfu 
S. aureus USA300 into the otic vesicle at 3dpf, then fixed in paraformaldehyde (PFA) at 
4 hours post infection (hpi) and stained with Sudan Black B to detect neutrophils; dashed 
white outline indicates the otic vesicle. B) Neutrophils present at the otic vesicle at 4hpi, 
blue points denote the representative images in A). Error bars shown are mean ± SEM 
(n=25 over two independent experiments); groups were analysed using an ordinary two-
way ANOVA and adjusted using Bonferroni’s multiple comparisons test. ****, p<0.0001; 
ns, p>0.9999. 
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4.3.14 Breeding and genotyping of Spotless (mpxNL144) fish, which do not 
produce an endogenous myeloperoxidase 
 
As I aimed to investigate the role of SPIN during infection, I required a model that would 
permit inhibition of myeloperoxidase by SPIN. As SPIN is a human-adapted virulence 
factor (de Jong et al., 2017), I required fish that do not produce endogenous zebrafish 
myeloperoxidase (Mpx), as this could interfere with SPIN activity. I acquired zebrafish (A 
kind gift from Annemarie Meijer, Leiden University) with a mutated myeloperoxidase 
gene known as Spotless (mpxNL144). Spotless have a premature stop mutation in the first 
exon of the myeloperoxidase gene that prevents translation of the enzyme (Elks et al., 
2014). As I wished to characterise the role of Mpx in detail, I also required sibling controls 
that produce Mpx. Accordingly, I bred a new generation of Spotless fish with a 
heterogeneous mix of wild-type and mutant alleles. 
To create a new generation with a mixture of Mpx-positive and Mpx-null fish, Spotless 
(mpxNL144) fish were outcrossed to a wild-type background (mpxwt) (AB) (Figure 4.19). 
These heterozygous (mpxwt/NL144) fish were then incrossed, producing zebrafish that are 
either heterozygous (mpxwt/NL144) or homozygous (mpxwt, mpxNL144), in the ratio 1mpxwt: 
2mpxwt/NL144: 1mpxNL144 (Figure 4.19); this mixed clutch of fish was then raised. 
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Figure 4.19 Genetic crosses producing a clutch of fish that heterogeneously 
express mpx. 
Spotless (mpxNL144) fish were outcrossed to the AB background (mpxNL144), producing a 
clutch of heterozygous (mpxwt/NL144) fish. These were then incrossed to produce fish with 
an allelic ratio of 1mpxwt: 2mpxwt/NL144: 1mpxNL144 which were then raised. 
 
4.3.15 The mpxNL144 allele can be genotyped by restriction digest 
 
As the heterogeneous mpxNL144 fish could not be identified by eye, it was necessary to 
design a method of identifying fish based on their expression of the mpxNL144 allele. Fish 
with this mutation can be identified by PCR amplification of the mutated gene from 
genomic DNA and carrying out a restriction digest on the PCR product. The restriction 
enzyme BtsCI recognises 5’ GG ATG NN 3’ sites in DNA, one of which is present within 
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the mpxNL144 mutation (GGA TGA) but not the wild-type mpxwt gene (GGA CGA) (Figure 
4.20A). This means that BtsCI is able to discriminate the mpxNL144 allele when used to 
digest a PCR product of the mpx gene. 
Primers ‘mpx Spotless For 1’ and ‘mpx Spotless Rev 1’ (2.1.4 Primers) were designed to 
amplify the region of the mpx gene mutated in Spotless fish and tested using genomic 
DNA from mpxwt, mpxwt/NL144 and mpxNL144 fish. The primers were successful in 
amplifying the mutated region in the mpx gene from all groups (Figure 4.20B), and once 
digested with BtsCI produced different DNA fragments depending on the mpxNL144 allele 
of the fish (Figure 4.20C), confirming BtsCI digestion as an efficient means of genotyping 
the mpxNL144 allele. The accuracy of the restriction digest was confirmed further by 
sequencing the PCR products, confirming that the fish identified by restriction digest 
each have the specific basepair in the expected position (Figure 4.20D). 
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Figure 4.20 The Spotless mutation can be genotyped by restriction digest.  
A) Diagram of a WT (mpxwt) and mutated (mpxNL144) gene, showing the restriction site of 
BtsCI cutting only the mutated mpxNL144 gene. B) PCR amplification of the mpx gene from 
the genomic DNA of mpxwt, mpxwt/NL144 and mpxNL144 fish – fragment 312bp; control DNA 
is a positive control from a separate genotyping experiment. Hyperladder 1kb. C) 
Diagnostic digest of the PCR product from mpxwt, mpxwt/NL144 and mpxNL144 fish. Band 
sizes: mpxwt- 312bp, mpxNL144- 230bp, mpxwt/NL144- 312bp and 230bp. Hyperladder 100bp 
plus. D) DNA sequencing of the PCR products to confirm the accuracy of the BtsCI digest. 
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4.3.16 Sudan Black B staining is dependent on functional mpx expression 
 
To confirm whether this method of genotyping is functionally accurate, I used Sudan 
Black B to detect neutrophils producing myeloperoxidase. As discussed previously, 
Sudan Black is an established stain for detecting neutrophils, and is dependent on the 
activity of myeloperoxidase (Pase et al., 2012). Three groups of genotyped larvae (mpxwt, 
mpxwt/NL144 and mpxNL144) were fixed at 4dpf and stained with Sudan Black to confirm the 
accuracy of genotyping. The mpxwt and mpxwt/NL144 groups stained with Sudan Black 
(Figure 4.21), confirming the genotyping results and indicating that only a single copy of 
mpx is required for staining with Sudan Black B. The mpxNL144group did not stain with 
Sudan Black (Figure 4.21), again confirming their genotype and demonstrating the 
myeloperoxidase-dependent staining of Sudan Black. The results confirm that the 
genotyping described in Figure 4.20 can identify fish with the non-functional Spotless 
mpxNL144 mutation. 
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Figure 4.21 Sudan Black B stains neutrophils that produce zebrafish 
myeloperoxidase.  
mpxwt, mpxwt/NL144 and mpxNL144 larvae fixed at 4dpf and stained with Sudan Black B. 
Larvae with at least one functional mpx allele stained (57/58 mpxwt, 20/20 mpxwt/NL144) 
and larvae that do not produce Mpx did not stain (32/32 mpxNL144). Inset shows an 
enlarged view of the region indicated by the dashed white box. Scale bar = 200µm. 
 
4.3.17 Endogenous zebrafish Mpx is dispensable during systemic 
staphylococcal infection 
 
It is well known that myeloperoxidase is an important element of antimicrobial activity 
in human neutrophils, and also acts to regulate the inflammatory response (Clark and 
Klebanoff, 1979; Pase et al., 2012). However, it is currently unclear how essential 
myeloperoxidase is for antimicrobial activity in the zebrafish neutrophil. Clinical and 
experimental data have suggested that myeloperoxidase is dispensable for microbial 
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killing, as the levels of reactive oxygen species generated in the absence of 
myeloperoxidase are sufficient to kill a number of pathogens (Klebanoff et al., 2012; 
Schürmann et al., 2017). 
To investigate the importance of Mpx during staphylococcal infection, London Wild-
Type (LWT) and Spotless (mpxNL144) embryos were systemically infected with S. aureus 
USA300 at 30hpf, and the survival of the two backgrounds was compared. By 90 hours 
post infection, only 30% of infected Spotless embryos survived, contrasting with the 50% 
survival of LWT embryos observed at this timepoint (Figure 4.22). No mortality was 
observed in groups injected with the vehicle control PBS, suggesting that mortality was 
not caused by physical damage incurred during injection. This indicates that embryos 
without a functional myeloperoxidase are more susceptible to staphylococcal infection.  
  
 
Figure 4.22 Endogenous zebrafish myeloperoxidase is important during 
systemic staphylococcal infection.  
Wild-type London Wild Type (LWT) and Spotless (mpxNL144) zebrafish were injected with 
a vehicle control (PBS) or infected with ~1,000cfu S. aureus USA300 at 30hpf and 
monitored for four days after infection. Values (n=78 over three independent 
experiments) were analysed using a Mantel-Cox logrank test; ****, p<0.0001. 
 
While LWT embryos are less susceptible to staphylococcal infection than Spotless 
embryos, I was concerned that the observed difference in susceptibility was due to 
genetic susceptibility rather than an absence of myeloperoxidase. Therefore, I decided 
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to compare survival between mpxwt and mpxNL144 siblings that I had generated previously 
(Figure 4.20). Sibling mpxwt and mpxNL144 fish were systemically infected with USA300 at 
30hpf and monitored over the next four days (Prajsnar et al., 2008). There was no 
difference between mpxwt and mpxNL144 fish in their ability to resist systemic infection 
(Figure 4.23), suggesting that Mpx is dispensable for survival during systemic infection, 
and that the observations in Figure 4.22 can be attributed to a difference in genetic 
susceptibility to infection. 
 
 
Figure 4.23 Endogenous zebrafish myeloperoxidase is dispensable during 
systemic staphylococcal infection.  
Sibling mpxwt and mpxNL144 zebrafish were infected with ~1,000cfu S. aureus USA300 at 
30hpf and monitored for four days after infection. Values (n=110 over four independent 
experiments) were analysed using a Mantel-Cox logrank test; ns, p=0.7431. 
 
4.3.18 Generation of Tg(lyz:MPO.mEmerald)sh496 fish that do not produce 
endogenous Mpx 
 
With a new generation of Spotless (mpxNL144) fish, it was possible to create fish 
expressing the human MPO transgene in the absence of endogenous zebrafish Mpx. This 
was achieved by a number of genetic crosses (Figure 4.24). First, stably transgenic 
Tg(lyz:MPO.mEmerald)sh496 fish were outcrossed to mpxNL144, producing a clutch of fish 
that heterozygously express the mpxNL144 allele; these were then outcrossed to Spotless 
again produce a mixture of fish with an allelic ratio of 1mpxwt/NL144 :1mpxNL144. 
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To determine whether the MPO transgene produces functional MPO using Sudan Black, 
I required Tg(lyz:MPO.mEmerald)sh496; mpxNL144 fish, in addition to sibling controls that 
do not express the MPO transgene and fish that are heterozygous for functional Mpx 
(mpxwt/NL144). Four different genotypes of fish were raised: 
Tg(lyz:MPO.mEmerald)sh496; mpxNL144, Tg(lyz:MPO.mEmerald)sh496; mpxwt/NL144, 
mpxNL144 and mpxwt/NL144 (Figure 4.24). 
 
 
Figure 4.24 Creation of a lyz:MPO.mEmerald-positive mpxNL144 zebrafish 
line. 
Transgenic Tg(lyz:MPO.mEmerald)sh496 fish were outcrossed to Spotless (mpxNL144), 
producing transgenic fish that heterozygously express the (mpxNL144) allele. This was 
repeated, producing fish with an allelic ratio of 1mpxwt/NL144: 1mpxNL144. Of these fish 
transgenic and non-transgenic fish were raised, resulting in four genotypes: 
Tg(lyz:MPO.mEmerald)sh496; mpxNL144, Tg(lyz:MPO.mEmerald)sh496; mpxwt/NL144, 
mpxNL144 and mpxwt/NL144. 
 
 
200 
 
4.3.19 The MPO transgene is successfully expressed in mpxNL144 fish 
 
To ensure that larvae successfully express the MPO transgene in the absence of 
endogenous Mpx, expression of the transgene in Tg(lyz:MPO.mEmerald)sh496; mpxNL144 
fish was compared with non-transgenic siblings. At 3dpf, Tg(lyz:MPO.mEmerald)sh496; 
mpxNL144 and Tg(lyz:MPO.mEmerald)sh496; mpxwt/NL144 larvae have a labelled neutrophil 
population in the CHT (Figure 4.25C) compared with the lack of any labelled neutrophils 
in non-transgenic siblings (Figure 4.25B). This confirms that the MPO transgene is 
successfully expressed in mpxNL144 larvae. 
 
 
Figure 4.25 Expression of lyz:MPO.mEmerald in mpxNL144 larvae. 
A) The caudal haematopoietic tissue (CHT) of a 3dpf larva indicated by the red box. B) 
Representative image of the CHT of a non-transgenic sibling of the larva shown in C). C) 
Representative image of the CHT of a Tg(lyz:MPO.mEmerald)sh496 mpxNL144/mpxwt/NL144 
larva. Scale bar = 100µm. 
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4.3.20 The MPO transgene does not produce functional human 
myeloperoxidase 
 
An important consideration concerning the Tg(lyz:MPO.mEmerald)sh496 line is whether 
the MPO.mEmerald fusion protein is produced as a functional enzyme. This could be 
assessed using Sudan Black B staining in Tg(lyz:MPO.mEmerald)sh496; mpxNL144 larvae, 
due to staining being dependent on myeloperoxidase activity (Pase et al., 2012). If 
Tg(lyz:MPO.mEmerald)sh496; mpxNL144 larvae stain with Sudan Black, I could assume 
that MPO.mEmerald is enzymatically active in transgenic fish. To investigate whether 
MPO.mEmerald is functional, Sudan Black was used to detect neutrophils in 
Tg(lyz:MPO.mEmerald)sh496; mpxNL144 fish; staining was also compared against 
Tg(lyz:MPO.mEmerald)sh496; mpxwt/NL144, mpxNL144 and mpxwt/NL144 fish as controls.  
Tg(lyz:MPO.mEmerald)sh496; mpxNL144 larvae did not stain with Sudan Black (22/22), 
while positive and negative controls mpxwt/NL144 and mpxNL144 stained as expected, with 
18/18 positive and 20/20 negative respectively (Figure 4.26). 
Tg(lyz:MPO.mEmerald)sh496; mpxwt/NL144 larvae also stained (16/16) (Figure 4.26) 
indicating that a single copy of mpx is the only condition tested that confers staining. 
This demonstrates that expression of the lyz:MPO.mEmerald transgene fails to confer 
staining with Sudan Black, suggesting that the MPO.mEmerald fusion protein is not 
functional within zebrafish neutrophils. 
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Figure 4.26 Expression of the lyz:MPO.mEmerald transgene does not confer 
staining with Sudan Black B. 
Four groups of larvae were fixed at 4dpf and stained with Sudan Black B: mpxwt/NL144, 
Tg(lyz:MPO.mEmerald)sh496; mpxwt/NL144, mpxNL144 and Tg(lyz:MPO.mEmerald)sh496; 
mpxNL144. mpxwt/NL144 and Tg(lyz:MPO.mEmerald)sh496; mpxwt/NL144 stained (18/18, 
16/16 respectively); mpxNL144 and Tg(lyz:MPO.mEmerald)sh496; mpxNL144 did not stain 
(20/20, 22/22 respectively). Dashed outline indicates the enlarged region shown 
adjacent. Scale bar = 200µm. 
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4.4 Discussion 
 
4.4.1 The ΔSPIN strain is not attenuated in a zebrafish model of systemic 
infection 
 
SPIN confers a resistance to phagosomal killing, allowing S. aureus to persist within 
phagocytes by inhibiting MPO and mitigating the production of reactive oxygen species 
(ROS) (de Jong et al., 2017). Experiments in the zebrafish model suggest that neutrophils 
represent a privileged intraphagocyte niche for S. aureus, relying on virulence factors 
such as SPIN to do so (Prajsnar et al., 2012). Accordingly, before creating the 
Tg(lyz:MPO.mEmerald)sh496 line, I established whether SPIN was an important 
virulence factor during staphylococcal infection in the zebrafish model. Using a systemic 
infection model (Prajsnar et al., 2008), I examined survival of wild-type larvae against 
the CA-MRSA strain USA300 - which was used in all infection experiments - and 
compared this with an isogenic SPIN knockout strain (ΔSPIN). I hypothesised that SPIN 
is inactive during systemic infection in the zebrafish larva, as SPIN is human-adapted and 
should be unable to inhibit zebrafish myeloperoxidase (Mpx). I found that infection with 
the ΔSPIN strain resulted in no attenuation of virulence, suggesting that SPIN is unable 
to inhibit Mpx to a sufficient degree to confer a survival advantage. 
SPIN could still participate in systemic infection in the zebrafish, as later experiments 
revealed that SPIN is not produced at high levels in culture before mid-exponential 
phase, when most S. aureus cultures are prepared for injection into the zebrafish. 
Additionally, the lack of a virulent phenotype does not directly indicate a lack of 
inhibition, as SPIN confers a survival advantage towards phagosomal killing, and does 
not directly contribute to virulence (de Jong et al., 2017). To identify whether SPIN is 
able to inhibit zebrafish Mpx, it would be useful to compare bacterial killing between 
USA300 and ΔSPIN by assessing bacterial burden over time in infected larvae; this would 
give insight into whether the ΔSPIN strain is more susceptible to phagosomal killing. 
Additionally this could be tested by investigating whether SPIN is able to remove 
myeloperoxidase-dependent Sudan Black staining from zebrafish neutrophils (Pase et 
al., 2012). 
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4.4.2 SPIN is expressed by S. aureus, but is not upregulated after 
phagocytosis by zebrafish neutrophils 
 
Using a fluorescent reporter strain consisting of GFP fused to the SPIN promoter (pSPIN-
GFP), it was shown that SPIN is significantly upregulated as early as 40 minutes after 
phagocytosis in human neutrophils, suggesting that SPIN is produced in situ to combat 
MPO (de Jong et al., 2017). To investigate if SPIN upregulation also occurs in the 
zebrafish model, I established conditions under which pSPIN-GFP produced detectable 
levels of GFP using fluorometry, and measured pSPIN-GFP signal after phagocytosis in 
zebrafish neutrophils. Using the somite tail muscle infection model to produce a 
neutrophil-driven immune response (Benard et al., 2012; Colucci-Guyon et al., 2011), 
the GFP signal of a constitutively active USA300 GFP strain was compared with pSPIN-
GFP. I could not demonstrate an increase in SPIN expression within the first 90 minutes 
after phagocytosis, suggesting that a discrepancy exists between published observations 
using human neutrophils and the zebrafish model. Despite this observation, I cannot 
exclude that SPIN is not upregulated in zebrafish neutrophils, as staphylococci can 
survive within individual leukocytes for far longer than 90 minutes (Kapral and 
Shayegani, 1959; Prajsnar et al., 2012). 
A potential source of variation between experiments may be the external temperature, 
as phagocytosis-dependent upregulation of SPIN was observed using an ex vivo 
approach with human neutrophils at 37°C (de Jong et al., 2017), while confocal 
experiments in zebrafish larvae are performed at roughly room temperature. As 
virulence factors such as enterotoxins are produced at reduced levels below 37°C, there 
could also be reduced SPIN production at these temperatures (Schmitt et al., 1990). 
Experiments examining virulence factor expression at the zebrafish optimal 
temperature of 28°C and below are required for definitive conclusions to be drawn. 
 
4.4.3 Creation of a zebrafish expressing fluorescently-tagged human 
myeloperoxidase 
 
The lyz:MPO.mEmerald construct was created using Gateway® cloning, combining the 
neutrophil-specific lyz promoter, MPO with a C-terminal fluorescent tag and a 
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polyadenylation sequence together in a single reaction. I fused a fluorescent protein to 
MPO to permit fluorescence-based screening of transgenic larvae, in addition to 
providing information regarding the intracellular localisation of the fusion protein. 
When creating the construct, my initial approach involved amplifying the MPO gene 
from neutrophil complementary DNA (cDNA) followed by fusion of a fluorescent protein 
sequence to either the N or C-terminus. PCR amplification from cDNA was unsuccessful, 
and was initially thought to be due to the reduced level of MPO transcripts in mature 
neutrophils (Hansson et al., 2006; Lieschke et al., 2001). Despite this, studies have shown 
that MPO can be amplified from mature neutrophils (Yang et al., 2004), leaving the 
difficulties encountered with this approach uncertain.  
Consequently, a second approach with preconstructed plasmids containing MPO fused 
to the fluorescent protein mEmerald was used to create the middle entry clone. 
Ultimately, only MPO with a C-terminal fusion of mEmerald was used to establish the 
Tg(lyz:MPO.mEmerald)sh496 line, as an important post-translational step during MPO 
maturation is the cleavage of an N-terminal propeptide (Hansson et al., 2006). As an 
additional aim, I felt that the Tg(lyz:MPO.mEmerald)sh496 line could allow in vivo 
visualisation of neutrophil granule dynamics, and as this N-terminal cleavage step could 
result in differential localisation of MPO and mEmerald, I opted to focus on MPO with a 
C-terminal mEmerald fusion. 
Once the pDestTol2CG2 lyz:MPO.mEmerald construct was made, it was introduced into 
the genomes of nacre zebrafish embryos using Tol2-mediated transgenesis. As 
mentioned previously, the construct contains a cmlc2:eGFP element that labels cardiac 
cells with eGFP (Huang et al., 2003); this provides feedback concerning the efficiency of 
transgenesis, facilitating optimisation. Transient expression rates for lyz:MPO.mEmerald 
were lower than expected, with 2-4% of developed larvae expressing the construct. 
Despite this, they displayed an adequate germline insertion rate of roughly 15%, in line 
with Tol2-mediated integration of constructs over 10kb (Suster et al., 2011). 
A notable trait of the Tg(lyz:MPO.mEmerald)sh496 line is the presence of an 
exceptionally bright heart marker, that was often expressed in the absence of transgene 
expression. This resulted in numerous difficulties while screening stably integrated 
Tg(lyz:MPO.mEmerald)sh496 fish, as outcrossed larvae often had a high proportion of 
green heart marker positive larvae that did not express lyz:MPO.mEmerald. As the 
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cmlc2:eGFP green heart marker is comparatively small (1.6kb), it could insert 
independently into the genome and at a higher frequency relative to the full-length 
construct (Tol2 arm – Tol2 arm 17.6kb) (Suster et al., 2011); multiple insertions would 
also explain the increased brightness of the heart marker. Once the presence of 
Tg(lyz:MPO.mEmerald)sh496 fish that did not express the transgene was discovered, an 
F2 generation was raised consisting only of larvae that stringently expressed the 
transgene.  
 
4.4.4 The MPO.mEmerald transgene localises with an intracellular 
destination 
 
I utilised high-resolution microscopy to investigate how MPO.mEmerald localises within 
neutrophils of double-transgenic lyz:MPO.mEmerald; lyz:nfsB.mCherry larvae. 
MPO.mEmerald was successfully produced, and exhibited subcellular localisation within 
neutrophils while mCherry labelled the cytoplasm. This subcellular localisation consisted 
of a large number of highly dynamic intracellular puncta, believed to be neutrophil 
primary granules (although further experiments are required to confirm this). Another 
observation is that double-transgenic lyz:MPO.mEmerald; lyz:nfsB.mCherry neutrophils 
often contained a region that remains unlabelled by mEmerald, but is labelled with 
mCherry. As this distinct compartment appears to be excluded from the cytoplasm, it is 
likely to represent the nucleus; this could be confirmed by staining double-transgenic 
neutrophils with the nuclear marker DAPI (Sandell et al., 2012). 
Double-transgenic lyz:MPO.mEmerald; lyz:nfsB.mCherry neutrophils showed a 
heterogeneous expression pattern, with some neutrophils displaying mEmerald-
labelled intracellular puncta and others exhibiting an mEmerald pattern resembling the 
cytoplasmic labelling of lyz:nfsB.mCherry (Figures 4.13, 4.15). This could indicate an age-
dependent phenotype, as neutrophils with visible granules should be more mature, and 
therefore contain a greater number of primary granules. As mentioned previously, 
mature neutrophils contain reduced levels of MPO transcripts (Hansson et al., 2006). At 
72hpf, larvae should have a population of mature neutrophils as well as a number of 
immature neutrophils, evidenced by a reduced but present mpx transcript level at this 
stage (Lieschke et al., 2001). This supports the observation of a heterogeneous 
207 
 
population of granule-packed mature neutrophils in addition to a number of 
cytoplasmically-labelled, immature neutrophils. In future, to confirm whether granule 
labelling is dependent on the age of larvae, expression of the transgene could be 
compared between larvae at different days post fertilisation. 
The heterogeneous expression of lyz:MPO.mEmerald could also be due to the lyz 
promoter, which is a general myeloid lineage promoter that is expressed in both 
macrophages and neutrophils (Hall et al., 2007). This would explain why some cells do 
not contain labelled puncta, as macrophages do not possess primary granules and do 
not typically express myeloperoxidase (Hansson et al., 2006). To correct this, a second 
transgenic line expressing MPO.mEmerald under the neutrophil-specific mpx promoter 
could be made (Renshaw et al., 2006a). 
It is also possible that non-granular labelling could be the product of altered MPO 
processing by zebrafish neutrophils. MPO undergoes extensive post-translational 
modifications prior to localisation with primary granules, including a penultimate step 
that involves cleavage of an N-terminal pro-peptide, allowing MPO to be packaged 
within primary granules (Hansson et al., 2006). If the N-terminal pro-peptide remains 
uncleaved, localisation to the primary granules does not occur, and instead MPO is 
exported to the neutrophil cytoplasm, where it is targeted for recycling. The 
MPO.mEmerald protein could retain its N-terminal pro-peptide due to changes in these 
post-translational modifications; this could produce the cytoplasmic mEmerald signal 
observed in some neutrophils. Processing of MPO.mEmerald could be assessed by 
determining the size of the protein within these neutrophils. A normally processed MPO 
monomer consists of two subunits 13.5kDa and 59kDa in size (13.5kDa and 85kDa with 
mEmerald), while unprocessed forms are a single protein 74-90kDa in size (100-116kDa 
with mEmerald) (Hansson et al., 2006). While much is known about the complex 
proteolytic steps required to produce mature MPO, the precise enzymes and 
chaperones involved at each step are almost entirely unknown, suggesting a potential 
use for the Tg(lyz:MPO.mEmerald)sh496 line as a tool for investigating post-
translational processing of MPO. 
Additionally, it is unclear whether the labelling observed in Tg(lyz:MPO.mEmerald)sh496 
neutrophils is specific to primary granules, as MPO.mEmerald could localise with other 
granule types or intracellular bodies. If MPO.mEmerald does label neutrophil granules, 
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they should fuse with maturing phagosomes to induce bacterial killing. This process 
could be observed by performing somite infection experiments using the 
Tg(lyz:MPO.mEmerald)sh496 line, and investigating whether the granules traffic to and 
fuse with phagosomes. To determine whether primary granules are specifically labelled, 
mEmerald expression can be compared with a peroxidase-sensitive stain (e.g. TSA or o-
dianisidine), distinguishing primary granules from other granule subsets (Gilbert et al., 
1993; Lieschke et al., 2001; Robertson et al., 2014). 
 
4.4.5 Characterisation of MPO.mEmerald-positive neutrophils 
 
To identify if MPO.mEmerald expression has an impact on neutrophil behaviour and 
function, Tg(lyz:MPO.mEmerald)sh496 fish were outcrossed to 
Tg(lyz:nfsB.mCherry)sh260, and separated into non-humanised (lyz:nfsB.mCherry only) 
and humanised (lyz:MPO.mEmerald; lyz:nfsB.mCherry) groups at 2-3dpf. These groups 
were compared with one another for two reasons: Tg(lyz:nfsB.mCherry)sh260 fish were 
kept as a mixture of heterozygous and homozygous, meaning that a group expressing 
only the lyz:MPO.mEmerald transgene was not consistently available; also, by 
comparing lyz:nfsB.mCherry-only with double-transgenic lyz:hC5aR.Clover; 
lyz:nfsB.mCherry fish, only expression of MPO.mEmerald separates the two groups. 
To establish whether haematopoiesis was affected, non-humanised and humanised 
larvae were fixed at 4dpf and stained with Sudan Black to detect neutrophils; the total 
number of neutrophils in each fish was enumerated and both groups were compared. 
No difference was found in neutrophil number between the two groups, suggesting that 
expression of the MPO.mEmerald transgene does not affect haematopoiesis. In contrast 
with Tg(lyz:hC5aR.Clover)sh505, I found no difference in the number of neutrophils 
found in each region of the larvae, suggesting that Tg(lyz:MPO.mEmerald)sh496 
neutrophils are able to exit the haematopoietic tissues and circulate normally. While this 
provides quantitative data suggesting that the transgene does not disrupt total 
neutrophil numbers, I did not investigate whether haematopoiesis is qualitatively 
disrupted. This could be determined by assessing whether major haematopoietic genes 
are affected by transgene expression, using whole-mount in situ hybridisation (WISH). 
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Using the tailfin-transection model, no difference was observed between non-
humanised and humanised larvae in their capacity to recruit to sites of injury, suggesting 
that MPO.mEmerald does not interfere with the inflammatory response. Whether early 
recruitment is affected by the MPO.mEmerald transgene is unknown, but would be 
simple to examine using fluorescent microscopy. It is also unclear whether inflammation 
resolution is affected by MPO.mEmerald; this could be tested by assessing neutrophils 
present at the wound site from 6-12 hours post injury (Renshaw et al., 2006a). 
With the otic vesicle infection model, I investigated the capacity of 
Tg(lyz:MPO.mEmerald)sh496 neutrophils to recruit to sites of infection. As with 
haematopoiesis and the inflammatory response, I found no difference between non-
humanised and humanised neutrophils in their ability to migrate to sites of infection. 
This confirms that MPO.mEmerald does not impair neutrophil development or 
chemotaxis. This contrasts with the Tg(lyz:hC5aR.Clover)sh505 line, which displays a 
defect in chemotaxis to injury and infection (Figures 3.15-19). This could be due to the 
intracellular localisation of MPO.mEmerald, which does not interfere with chemotactic 
receptors present at the neutrophil surface. 
While MPO.mEmerald has no effect on neutrophil haematopoiesis or chemotaxis, it is 
unclear whether MPO.mEmerald influences bacterial killing. A wide variety of 
fluorescent probes exist that would give insight into the phagosomal conditions created 
in Tg(lyz:MPO.mEmerald)sh496 neutrophils, including those sensitive to ROS and pH 
(Mugoni et al., 2014; Page et al., 2013). In combination with examining bacterial killing 
in these neutrophils, approaches using fluorescent microscopy techniques would reveal 
much about whether antimicrobial capacity is affected by transgene expression. 
 
4.4.6 Creating an Mpx-null, MPO-positive zebrafish line 
 
As I aimed to investigate how SPIN interacts with MPO in vivo, I required a line that 
expresses MPO in the absence of the endogenous zebrafish myeloperoxidase Mpx, in 
order to rule out any contribution of the endogenous enzyme during infection. Using a 
novel method of genotyping and Sudan Black B staining, a mixed population of fish 
heterogeneously expressing the mpxNL144 allele were created and verified; these fish do 
not produce Mpx due to a stop codon in the first exon of the gene (Elks et al., 2014). 
210 
 
Once established, mpxNL144 fish were crossed with the Tg(lyz:MPO.mEmerald)sh496 line, 
generating Tg(lyz:MPO.mEmerald)sh496; mpxNL144 fish that produce MPO but not Mpx.  
Tg(lyz:MPO.mEmerald)sh496; mpxNL144 fish were then used to identify whether 
MPO.mEmerald acts as a functional enzyme using Sudan Black staining. As this stain is 
dependent on myeloperoxidase activity (Pase et al., 2012), successful staining of the 
Tg(lyz:MPO.mEmerald)sh496; mpxNL144 line would indicate a functional MPO enzyme. 
This was not the case, as Tg(lyz:MPO.mEmerald)sh496; mpxNL144 larvae did not stain with 
Sudan Black despite successful expression of the transgene and positive staining in the 
control (mpxwt) groups. This suggests that the Tg(lyz:MPO.mEmerald)sh496 line does 
not produce a functional MPO enzyme, making investigation of the interactions 
between SPIN and MPO using this line difficult to demonstrate.  
The C-terminal mEmerald tag could sterically interfere with the dimerisation of MPO by 
preventing the formation of disulphide bonds between two monomers, however this 
should not affect the catalytic activity of the enzyme. Recombinant monomeric MPO 
and a cleaved, monomeric version of the mature dimer both produce active monomeric 
enzymes that are catalytically identical to the dimeric form (Andrews and Krinsky, 1981; 
Moguilevsky et al., 1991). During processing, MPO remains non-functional prior to 
incorporation of haem, which is also essential for localisation to primary granules 
(Nauseef et al., 1992). Subsequently, it is unclear why MPO.mEmerald produces a non-
functional enzyme, as targeting of MPO to the primary granules universally correlates 
with normal MPO activity (Hansson et al., 2006). Across all MPO-deficiencies, MPO fails 
to be processed to a mature form that is targeted to the primary granules, and is 
generally retained in the endoplasmic reticulum before being degraded (DeLeo et al., 
1998; Nauseef, 2004; Nauseef et al., 1996, 2000). This suggests that either my conclusion 
that MPO.mEmerald is non-functional is false, or the assertion that MPO.mEmerald 
localises with the primary granules is false. Further experiments should be carried out 
to determine the accuracy of these observations. 
The lack of observable myeloperoxidase activity could depend on the specificity of 
Sudan Black staining, which stains intracellular lipids located in primary granules and 
does not directly represent peroxidase activity (Colucci-Guyon et al., 2011). Accordingly, 
myeloperoxidase activity of MPO.mEmerald should also be investigated using 
peroxidase-sensitive techniques. O-dianisidine and TSA staining are two techniques 
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used to examine neutrophils in terms of their peroxidase activity, and would confirm 
whether MPO.mEmerald is an inactive enzyme (Colucci-Guyon et al., 2011; Lieschke et 
al., 2001; Robertson et al., 2014). Additionally, by crossing the 
Tg(lyz:MPO.mEmerald)sh496; mpxNL144 line to the ratiometric H2O2 reporter line HyPer, 
it is possible to visualise H2O2 levels in these neutrophils (Niethammer et al., 2009). This 
would provide insight into whether MPO.mEmerald is a functional enzyme, as MPO 
regulates H2O2 levels at the wound site during inflammation (Pase et al., 2012). 
The localisation of MPO.mEmerald to the primary granules could be confirmed by 
comparing localisation of Mpx with MPO.mEmerald using either specific antibodies or 
peroxidase-sensitive stains. The bactericidal activity of Tg(lyz:MPO.mEmerald)sh496; 
mpxNL144 neutrophils during infection could also be assessed; however the importance 
of Mpx during bacterial infection should be established first, as it could be redundant 
for phagosomal killing (Schürmann et al., 2017). Lastly, further experiments investigating 
how MPO.mEmerald is processed in zebrafish neutrophils could be performed. With an 
antibody for MPO.mEmerald it would be possible to determine if it undergoes any post-
translational modifications (~106kDa), if it is processed into a monomeric form (13.5kDa 
and ~85kDa) or if it successfully dimerises into the mature enzyme (~197kDa).  
 
4.4.7 Mpx is dispensable during systemic staphylococcal infection in the 
zebrafish 
 
As it was still unknown whether zebrafish Mpx is important for survival against 
staphylococcal infection, I investigated whether mpxNL144 larvae become susceptible to 
infection. Using the systemic infection model, I compared the survival of London wild-
type (LWT) larvae with mpxNL144 larvae injected with USA300 at 30hpf. This revealed a 
pronounced susceptibility to S. aureus infection in the mpxNL144 larvae, suggesting that 
Mpx is important for survival against systemic staphylococcal infection. However, I was 
concerned that the comparison of nacre zebrafish against the unrelated mpxNL144 line 
could have produced misleading results, as one background could be innately more 
susceptible to infection. Therefore, in another experiment I compared survival of larvae 
during systemic infection between siblings mpxwt and mpxNL144, and found that both 
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were equally susceptible to systemic infection with S. aureus, suggesting that mpx is 
dispensable for survival against systemic infection. 
Despite these results it is important to note that the systemic model cannot fully 
represent the role of neutrophils during infection, as macrophages typically engulf 
microbes present in the blood and fluid-filled cavities, while neutrophils respond to 
tissue-resident stimuli (Colucci-Guyon et al., 2011). Accordingly, experiments in 
neutrophil-driven infection models could be performed. One approach would be to 
suppress the macrophage transcription factor irf8, preventing macrophage 
development and enlarging the neutrophil population by skewing myeloid lineage 
development, producing larvae with a neutrophil-only phagocyte response (Li et al., 
2011). 
There are also neutrophil-driven infection routes in the zebrafish, namely the otic vesicle 
and somite tail muscle; these injection routes typically require extremely high inocula of 
bacteria to induce mortality. In one study a dose of 63,000cfu of P. aeruginosa into the 
otic vesicle was required to produce 50% survival in larvae (Deng et al., 2012). 
 
4.5 Future Directions 
 
I have demonstrated that the ΔSPIN strain is not attenuated in a zebrafish model of 
systemic staphylococcal infection and that wild-type and mpx-null (mpxNL144) larvae are 
equally susceptible to infection. However, these experiments should be performed in a 
model where neutrophil actions more directly determine the outcome of infection, as 
the systemic model is highly dependent on the activity of macrophages for bacterial 
clearance (Colucci-Guyon et al., 2011). While injection routes that produce neutrophil-
driven immune responses exist, these require supraphysiological concentrations of 
bacteria to induce mortality, and so are an unattractive approach (Deng et al., 2012). By 
genetically manipulating zebrafish larvae using the irf8 morpholino, macrophage 
development is suppressed, producing larvae with a phagocyte population chiefly 
composed of neutrophils (Li et al., 2011; Prajsnar et al., 2008). irf8 morphants represent 
a suitable infection model that may be used to answer these questions. While it is still 
possible for neutrophils to kill bacteria normally in the absence of MPO (Schürmann et 
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al., 2017), its importance for phagosomal killing in zebrafish neutrophils is still unclear, 
and may be elucidated using this approach. 
As discussed previously, there is a major temperature difference between the internal 
temperature of humans (37°C) and the optimum temperature of the zebrafish model 
(28°C), and is a source of concern regarding the expression of virulence factors such as 
SPIN. Differences in expression could be assessed using quantitative PCR (qPCR), which 
would permit comparison between virulence factor transcript levels at these two 
temperatures (Duquenne et al., 2010). Accordingly, any changes in gene expression 
should be validated by determining whether this correlates with changes in protein 
levels. 
I also demonstrated using the S. aureus USA300 pSPIN-GFP reporter strain that SPIN is 
produced during infection under specific culture conditions. In contrast with the 
literature (de Jong et al., 2017), I did not observe upregulation of SPIN expression within 
90 minutes of phagocytosis. As S. aureus is known to persist within neutrophils over 
much longer periods of time (Prajsnar et al., 2012), it would be appropriate to determine 
whether SPIN is upregulated during infection over a greater length of time. This is 
possible using microscopy techniques that involve low phototoxicity, such as light-sheet 
fluorescence microscopy (LSFM). Using this technique, a transgenic neutrophil reporter 
line such as Tg(lyz:nfsB.mCherry)sh260 could be infected with pSPIN-GFP and imaged 
over a greater period of time.  
Using Gateway® cloning and Tol2-mediated transgenesis, I generated a transgenic line 
that expresses the MPO gene with a C-terminal fusion of the fluorescent protein 
mEmerald in zebrafish neutrophils. Imaging experiments indicated that the transgene 
localises with intracellular neutrophil granules, recapitulating MPO localisation in 
human neutrophils. To confirm that the intracellular puncta observed in 
Tg(lyz:MPO.mEmerald)sh496 larvae are neutrophil granules, several experiments could 
be performed. By combining high-magnification imaging with immunohistochemistry, 
labelled granules in Tg(lyz:MPO.mEmerald)sh496 neutrophils could be investigated for 
colocalisation with granule proteins, such as proteinase-3, cathepsin G and elastase, 
which are found in teleost neutrophils (Wernersson et al., 2006). Additionally, one 
region of MPO.mEmerald neutrophils remains unlabelled by mEmerald, and is likely to 
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be the nucleus; this should be verified using a nuclear stain such as DAPI (Sandell et al., 
2012), as the granules should occupy a compartment that is distinct from the nucleus. 
The MPO.mEmerald transgene is expressed heterogeneously in zebrafish larvae at 3dpf, 
with some neutrophils exhibiting labelled granules and others displaying apparently 
cytoplasmic labelling. This could be an age-dependent neutrophil phenotype, as by 3dpf 
larvae should possess mature and immature neutrophils, which may resemble the 
heterogeneous neutrophil population observed in Figures 4.13 and 4.15. To determine 
whether this is the case, the presence of labelled granules should be assessed at several 
timepoints between 3dpf and 5dpf, to determine whether the number of neutrophils 
without labelled granules diminishes as neutrophils become mature. 
By crossing Tg(lyz:MPO.mEmerald)sh496 fish into the mpxNL144 background, I generated 
larvae expressing only human MPO. These larvae did not stain with the 
myeloperoxidase-dependent stain Sudan Black B, indicating that the transgene does not 
produce a functional MPO enzyme. As Sudan Black is not a direct means of verifying 
peroxidase activity, other peroxidase-sensitive techniques such as TSA staining could be 
used to confirm whether MPO.mEmerald is non-functional. 
The observation that MPO.mEmerald is not a functional enzyme is contradicted by its 
localisation with intracellular granules, as across all MPO-deficiencies, the enzyme is 
non-functional and universally fails to be targeted to the granules (DeLeo et al., 1998; 
Nauseef, 2004; Nauseef et al., 1996, 2000). This suggests key differences between the 
post-translational modifications identified in human neutrophils and the steps that 
occur in zebrafish neutrophils. Although the zebrafish genome shares 70% homology 
with the human genome (Howe et al., 2013), it is possible that important post-
translational mechanisms, such as glycosylation, are altered in the zebrafish. 
Additionally, the linker region between MPO and mEmerald is relatively short (18 amino 
acids), and may interfere with processing in neutrophils. With an MPO-specific antibody, 
the protein form of MPO.mEmerald could be investigated, as there are defined protein 
sizes for numerous steps of MPO maturation. As discussed, this approach would 
determine whether MPO.mEmerald undergoes any post-translational modifications 
(~106kDa), if it is processed into a monomeric form (13.5kDa and ~85kDa) or if it 
successfully dimerises into the mature enzyme (~197kDa). 
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In vitro assays of neutrophil degranulation have been described for numerous fish, 
including fathead minnows (Palić et al., 2005), and zebrafish (Palić et al., 2007). 
Assuming that the granules of Tg(lyz:MPO.mEmerald)sh496 larvae are successfully 
labelled, this line would be the first example of an in vivo reporter line of neutrophil 
granules; its potential in this regard should be assessed in detail. Imaging experiments 
to determine whether these granules fuse with the phagosome to induce bacterial 
killing should be relatively simple to perform, and could be combined with pH and ROS-
sensitive dyes to visualise phagosomal killing (Mugoni et al., 2014; Page et al., 2013). 
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4.6 Conclusions 
 
In this chapter, I created a transgenic zebrafish line that expresses a fluorescently-tagged 
human myeloperoxidase in their neutrophils. I observed that neutrophils of the 
Tg(lyz:MPO.mEmerald)sh496 transgenic line exhibit what is likely to be labelled primary 
granules, recapitulating localisation in human neutrophils and highlighting a potential 
use as a tool for investigating granule dynamics in vivo. The lyz:MPO.mEmerald 
transgene did not interfere with neutrophil migration to sites of infection and 
inflammation, however any impact on antimicrobial capacity was not investigated. To 
investigate interactions between SPIN and MPO without interference from endogenous 
zebrafish Mpx, an MPO-positive, Mpx-null line was generated (lyz:MPO.mEmerald; 
mpxNL144), revealing that MPO was enzymatically inactive in these fish. Consequently, 
interactions between SPIN and MPO were not investigated. 
SPIN was found to be dispensable during systemic infection in wild-type zebrafish, and 
is potentially unable to inhibit Mpx due to human-specificity. Using confocal microscopy 
and the pSPIN-GFP reporter strain, I demonstrated that in contrast with published 
experiments using human neutrophils, SPIN is not upregulated after phagocytosis in 
zebrafish neutrophils, highlighting a discrepancy between the zebrafish model and 
human neutrophils. Lastly, the role of Mpx during systemic staphylococcal infection was 
clarified, and was revealed to be non-essential in this model. To confirm this finding, 
experiments using infection models that are dependent on a neutrophil-driven immune 
response should be performed.
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Chapter 5: Overall Discussion 
 
In this study, I describe the creation of two transgenic zebrafish lines: one expressing 
the human C5a receptor (hC5aR), - Tg(lyz:hC5aR.Clover)sh505, and another expressing 
human myeloperoxidase (MPO), Tg(lyz:MPO.mEmerald)sh496. Both are expressed as 
fusion proteins, with the green fluorescent proteins clover (hC5aR) and mEmerald 
(MPO) fused to the C-terminus of both proteins. These fusion proteins are expressed in 
zebrafish neutrophils via the myeloid-specific promoter lyz (Hall et al., 2007), producing 
transgenic zebrafish neutrophils that express human proteins. Matching human 
neutrophils, the hC5aR is expressed at the cell surface and MPO localises to the 
neutrophil granules, demonstrating that these lines effectively recapitulate expression 
in human neutrophils. 
These lines represent a novel in vivo approach to investigating the impact of human-
adapted virulence factors during infection. Humanised mouse models exist, and display 
increased susceptibility to staphylococcal infection (Tseng et al., 2015), however this 
approach is technically difficult to implement, as each mouse has to be kept specific 
pathogen-free and immunosuppressed before engraftment with human 
haematopoietic stem cells. Transgenic mice expressing MPO have also been created, but 
have not been used to study MPO beyond its association with atherosclerosis (Castellani 
et al., 2006). By contrast, once a transgenic zebrafish line has been established, large 
quantities of larvae can be acquired quickly and consistently, and are amenable to in 
vivo microscopy due to their transparency prior to 6-8 days post fertilisation (van der 
Sar et al., 2004). Most bacterial pathogens display some degree of virulence factor-
dependent host restriction, and accordingly, the techniques described in this study 
could be applied equally to other bacteria with host-specific virulence factors. In 
addition to other human-specific targets of S. aureus (which apart from MPO and the 
hC5aR include the formyl peptide receptors, CXCR2 and CCR receptors), this approach 
could be used to study other important human pathogens, including enteropathogenic 
Escherichia coli, Salmonella typhi, and Streptococcus pyogenes (Spano and Galan, 2012; 
Svensson et al., 2000; Tobe and Sasakawa, 2002). 
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In this study, hC5aR.Clover and MPO.mEmerald are overexpressed in zebrafish 
neutrophils using the lyz promoter. A drawback of this approach is that the hC5aR and 
MPO genes are not expressed endogenously, as hC5aR.Clover is not driven by the 
zebrafish C5a receptor promoter, and MPO.mEmerald is not driven by the mpx 
promoter. Additionally, the full lyz promoter, including enhancer and intron regions, was 
not used due to its large size. As this approach causes overexpression of these human 
proteins it could produce unrepresentative results, particularly with regards to the 
hC5aR.Clover transgene, as C5aR receptor expression is correlated with susceptibility to 
leukocidins (Spaan et al., 2013b). Future studies could implement a BAC-targeting 
approach, driving these proteins under the appropriate endogenous promoter in its 
entirety (Suster et al., 2011); however, endogenous expression of these proteins is not 
a major concern regarding studies investigating interactions between a virulence factor 
and its target, as was the case in this study with Panton-Valentine Leukocidin/γ-
Haemolysin CB and the hC5aR. 
In this study, the genetic constructs for both transgenes were created using Gateway® 
cloning and introduced into the zebrafish genome by Tol2-mediated transgenesis. Both 
constructs reported transient expression rates that fell short of published expectations 
(Suster et al., 2011), potentially as a consequence of the size of the constructs exceeding 
10kb. These constructs also contained a genetic element that expresses GFP driven by 
the cardiac cell promoter cmlc2, known as a green heart marker (Huang et al., 2003). In 
Tg(lyz:hC5aR.Clover)sh505 larvae, transgene expression was always accompanied by 
expression of the heart marker, suggesting a single clean insertion of the construct into 
the zebrafish genome. Conversely, the Tg(lyz:MPO.mEmerald)sh496 line often produced 
larvae that expressed the heart marker but not the MPO.mEmerald transgene, which 
suggests the presence of multiple independent insertions, possibly facilitated by the 
heart marker’s small size (1.6kb); this would also explain the unusual brightness of the 
Tg(lyz:MPO.mEmerald)sh496 line’s heart marker. This made future genetic crosses 
difficult, as MPO.mEmerald-negative larvae were often raised in error. The observations 
noted here, as well as the hazards encountered involving the green heart marker, should 
be considered when designing and executing future studies. 
In addition to the efficiency of insertion into the zebrafish genome, functionality of the 
expressed proteins also differed between the two lines. MPO.mEmerald was 
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demonstrated to be non-functional by Sudan Black B staining, however this should be 
verified using peroxidase-sensitive probes such as TSA or o-dianisidine (Gilbert et al., 
1993; Lieschke et al., 2001; Robertson et al., 2014). The reason that MPO.mEmerald is 
non-functional is unclear, however proper maturation of MPO is a highly co-ordinated 
and complex process, requiring numerous post-translational modifications for 
functional MPO expression in human neutrophils.  
Some aspects of the MPO.mEmerald fusion protein may disrupt MPO maturation. The 
18 amino acid linker protein between MPO and mEmerald, in addition to mEmerald itself 
could interfere with important protein folding steps after translation, such as the 
formation of disulphide bonds between the α- and β- subunits or between MPO 
monomers during dimerisation. Additionally, there could be major differences between 
human and zebrafish neutrophils, as highly controlled glycosylation, proteolytic 
modification, and pH regulation is necessary for successful protein folding and 
maturation of MPO (Hansson et al., 2006). As zebrafish possess their own homologues 
of the essential molecular chaperones calreticulin and calnexin (Hung et al., 2013), 
glycosylation and transport through the endoplasmic reticulum are unlikely to be 
significantly different in the zebrafish, however it is difficult to surmise which proteolytic 
modification steps may differ in the zebrafish, as the enzymes responsible for terminal 
MPO maturation are largely unknown. 
That MPO.mEmerald appears to localise with the primary granules suggests that many 
early steps in protein folding, proteolytic modification and targeting to the granules is 
unaltered in zebrafish neutrophils. Across all known genotypes of MPO-deficiency, MPO 
is non-functional and fails to be targeted to the primary granules (DeLeo et al., 1998; 
Nauseef, 2004; Nauseef et al., 1996, 2000), suggesting that this study contains entirely 
novel observations concerning MPO maturation in neutrophils. During MPO maturation, 
the N-terminal propeptide is important for targeting to acidic compartments after 
exiting the endoplasmic reticulum and prior to/during packaging into primary granules 
(Gullberg et al., 1999). Cleavage of the propeptide occurs at acidic pH, before a final 
cleavage step occurs at neutral pH, producing mature MPO (Akin and Kinkade, 1986). A 
simple explanation could be that targeting and cleavage of the propeptide proceeds 
normally in zebrafish neutrophils, however the final cleavage step does not, preventing 
MPO.mEmerald from being processed into a functional enzyme. Determining the 
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protein form of MPO.mEmerald would be very insightful, and could be carried out with 
an MPO-specific antibody. This approach would also provide useful information 
concerning the maturation of myeloperoxidase in neutrophils. 
In contrast to MPO.mEmerald, hC5aR.Clover is an active chemotactic receptor in 
zebrafish neutrophils, responding to hC5a and conferring susceptibility to targeting by 
leukocidins. Compared with MPO, the hC5aR is a relatively simple protein requiring no 
complex post-translational modifications across the whole receptor for functional 
activity. A previous study demonstrated successful expression of a C5aR-GFP fusion 
protein in PLB-985 cells without impairing functional activity (Servant et al., 1999), 
suggesting that the C-terminal clover tag in hC5aR.Clover neutrophils is unlikely to 
interfere with protein folding or processing. Expression of simpler proteins such as the 
G-protein coupled receptors is easily achieved using the zebrafish model, and should be 
considered in future studies involving transgenic expression of proteins in the zebrafish. 
Despite being a functional receptor in Tg(lyz:hC5aR.Clover)sh505 neutrophils, transgene 
expression disrupted neutrophil migration to sites of injury and infection. This was not 
observed in Tg(lyz:MPO.mEmerald)sh496 larvae, most likely because MPO.mEmerald is 
non-functional and is not a major mediator of neutrophil chemotaxis. The most likely 
explanation of this would be constitutive activation and internalisation of the receptor, 
however whether this occurs in the Tg(lyz:hC5aR.Clover)sh505 line was not investigated 
in any detail. It is unclear why the receptor should be activated and internalised, as the 
hC5aR is not activated by drC5a at likely physiological concentrations <1µM 
(unpublished, Michiel van Gent). This suggests that either drC5a is produced at much 
higher concentrations in situ than reported, or that hC5aR.Clover is activated by 
alternative means. 
The C5aR is known to heterodimerise with other C5a receptors on the cell surface prior 
to activation (Croker et al., 2013), consequently, it is possible that the hC5aR is able to 
form dimers with the endogenous drC5aR. This dimer could be activated by drC5a, and 
may account for the visible internalisation of hC5aR.Clover in unstimulated neutrophils. 
It is also possible that the unstimulated receptor is constitutively recycled by the cell, 
although this phenomenon has no known functional consequence (Scarselli and 
Donaldson, 2009). Whether the receptor is internalised as a result of activation, or is 
simply due to constitutive recycling could be investigated assessing intracellular Ca2+ 
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release. As G-protein coupled receptors rapidly release Ca2+ after activation (Tawk et al., 
2015), crossing Tg(lyz:hC5aR.Clover)sh505 to a transgenic Ca2+ flux reporter line would 
permit the investigation of whether a rapid release of intracellular Ca2+ precedes 
internalisation (Beerman et al., 2015), and is therefore a result of receptor activation. 
Targeting of zebrafish Mpx and the drC5aR by human-adapted virulence factors during 
systemic infection was also investigated using isogenic knockout strains of CHIPS, HlgCB 
and SPIN. I observed no attenuation in these knockout strains during infection, however 
there are numerous questions regarding these experiments that could be addressed. 
Firstly, the extent to which these virulence factors are expressed at 28°C - the optimum 
temperature for zebrafish - is unknown, raising concerns over the expression of these 
virulence factors under these conditions. This question could be addressed by 
investigating the expression of virulence factors at different temperatures using 
quantitative PCR (qPCR). 
Secondly, as the systemic infection model used for these experiments is largely 
dependent on macrophages for bacterial clearance (Colucci-Guyon et al., 2011), it may 
not fully represent targeting by these virulence factors during infection, as they are more 
likely to target neutrophils. While injection routes that produce neutrophil-driven 
immune responses exist, these typically require high bacterial inocula to induce 
mortality (Deng et al., 2012), potentially making any findings unrepresentative of a 
human infection. Using the irf8 morpholino, macrophage development can be 
suppressed to produce embryos with a phagocyte population consisting almost entirely 
of neutrophils (Li et al., 2011). This would produce a systemic model of infection that 
could be performed at normal doses at S. aureus and would include only the neutrophil 
response to staphylococcal infection. If this approach proves to be more representative 
of these virulence factors, all survival experiments described in this study should be 
repeated using this approach, as it could more effectively represent the interactions of 
these factors during infection. 
Unfortunately, the length of time that was required to produce the 
Tg(lyz:MPO.mEmerald)sh496 transgenic line described in this study was significant, and 
limited further and more extensive characterisation of both lines; this happened for 
numerous reasons. The rate of transgenesis into zebrafish embryos was extremely low 
(roughly 2% of all injected embryos), which made generating a sufficient number of 
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stably transgenic founders difficult. There was also a higher than expected level of green 
heart expression, which interfered with my perception of how efficiently transgenesis 
was occurring; moreover, the construct was very dim, making identification of 
construct-positive larvae difficult. I spent a considerable amount of time optimising 
injection conditions without gaining any improvement over the 2% level mentioned, and 
accounted for a large time delay. Many factors that may have limited the efficiency of 
transgenesis were tested: the successful construction of the MPO construct was verified 
by sequencing data; several batches of Tol2 RNA were prepared and tested without any 
improvement in transgenesis, making degradation of the stock Tol2 RNA as the reason 
for inefficient construct insertion unlikely; potential introduction of RNAses into the 
capillary needle used to inject the construct DNA and Tol2 RNA during loading by pipette 
was ruled out by using needles that load by capillary action, and do not require 
specialised pipette tips. One factor that was not tested was to change the construct DNA 
used for in vitro transcription and preparation of Tol2 RNA for injection, which may have 
limited the quality of Tol2 that I prepared for injection. 
Ultimately, MPO was an ambitious choice of target to express in zebrafish, as it is a 
complex enzyme that requires several controlled post-translational modifications. MPO 
was chosen as it was believed to be a relatively simple target to express in zebrafish, it 
was novel, and could be used to investigate the activity of a newly discovered 
staphylococcal virulence factor. Other host factors that are targeted by human-specific 
virulence factors are likely to have been more successful, for example CXCR2, which is 
targeted by several factors including HlgAB. 
In summary, I produced two novel models of human-adapted staphylococcal infection 
using the zebrafish. Tg(lyz:MPO.mEmerald)sh496 fish successfully expressed human 
MPO that was targeted to a subcellular destination within zebrafish neutrophils, and 
may be a useful tool towards investigating MPO maturation and granule dynamics in 
neutrophils; however, the MPO.mEmerald fusion protein was found to be non-
functional using Sudan Black B staining. The Tg(lyz:hC5aR.Clover)sh505 line expressed 
the hC5aR at the neutrophil surface, and conferred the ability to migrate to human C5a, 
as well as susceptibility to targeting by the staphylococcal bicomponent leukocidins 
Panton-Valentine Leukocidin and γ-haemolysin CB; however, expression on the 
neutrophil surface interfered with endogenous neutrophil chemotaxis, impairing 
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neutrophil recruitment to sites of infection and inflammation. In future, functional 
characterisation of these transgenes would be facilitated by the ability to thoroughly 
test them in transient, non-stable larvae prior to creating a stably transgenic zebrafish 
line. This initial step would permit rapid screening and iteration of the transgene, leading 
to improved construction that would minimise deleterious and unwanted off-target 
effects prior to establishing the stable transgenic line. 
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